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ABSTRACT OF THE DISSERTATION

Identification and Characterization of Control Elements
within the Murine CD4 Gene

by
Zhong Deng
Doctor of Philosophy, Graduate Program in Biochemistry
Loma Linda University, June 2000
Dr. Aladar A. Szalay, Chairperson

The control of CD4 gene expression is essential for T lymphocyte development.
Since the molecular mechanism for the control of CD4 gene expression during T cell
development had not been elucidated, a study of the factors that control CD4 gene
expression may lead to further. Toward these goals, we have made a series of
recombinant DNA constructs to define the c/s-acting transcriptional control elements in
the murine CD4 locus that control CD4 gene expression during T cell development. In
this study, we have identified multiple cfs-acting control elements, which are critical for
regulating the expression of the murine CD4 gene. Two intronic enhancers, which are
located in a 122 bp Alul-Alul fragment 5' of the first intron and a 174 bp Pstl-SaR
fragment 3' of the first intron, act in an orientation- and position-independent manner in
both CD4+ and CD4' T cells. DNase I footprint analyses revealed the location of
potential transcription factor-binding sequences in the protected regions include GATA1, Elf-1, and AP-1 for the 5' intronic enhancer, and PU.l, IRF-1, and GATA-1 for the 3'
intronic enhancer. Among them, Elf-1 and PU.l, members of the Ets protein family, and
AP-1 have been implicated in the regulation of T cell-specific gene expression. An
xiv

intronic promoter is located in the 138 bp fragment within the first intron. This promoter
is activated preferentially in the CD4+CD8' T cells. Primer extension analysis indicates
that the transcription initiation is located 107 bp upstream from the ATG site. A silencer
element is loctaed in a 250 bp fragment corresponding to DH8, has a negative effect on
the CD4 promoter activation in an orientation- and position-independent way in T cells.
In summary, the molecular mechanisms, which control CD4 gene expression during T
cell development, are complex and the result of coordinate interplay of multiple
transcriptional control elements.
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CHAPTER ONE
I.

BACKGROUND

A. INTRODUCTION
T lymphocytes morphologically express surface receptors for antigens that are subject
to allelic exclusion. Progression of thymocytes through distinct developmental stages is
marked by induced or repressed expression of numerous regulatory components and cell
surface molecules (Kruisbeek, 1993). Among these, expression of the CD4 and the CDS
co-receptor molecules most clearly defines the different stages of thymocyte ontogeny
(Swain, 1983). Coordinated upregulation of CD4 and CDS on thymocytes marks the
successful antigen-independent selection of double negative (DN, CD4'CD8 ) cells with
functionally rearranged T cell receptor (TCR)-p chain genes and their transit to the
double positive (DP, CD4+CD8+) stage during which they proceed to rearrange the TCRcc chain gene and undergo antigen-dependent positive and negative selection (von
Boehmer, 1994). The subsequent downregulation of either CD4 or CDS is a hallmark of
positive selection of T cells with functionally useful TCRs, which is also coupled to the
commitment of the single positive (SP, CD4+CD8‘ or CD4 CD8+) T cells to become
helper (CD4+CD8 ) or cytotoxic (CD4‘CD8+) effector cells. The molecular mechanism
underlying the developmental choice toward either the helper or the cytotoxic phenotype
is not known. Since the expression of the CD4 or CDS co-receptor proteins generally
correlates with the phenotype of the differentiated T cell, there is a strong likelihood that
factors regulating transcription of these genes also participate in directing double positive
(DP) thymocytes toward the helper or cytotoxic T cell lineages. It is hyperthsized that
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understanding the mechanisms regulating CD4 and CDS gene expression will not only
provide insights into transcriptional control mechanisms in T cells, but may also result in
understanding the mechanisms controlling T cell development. Therefore, it is important
to understand how the CD4 and CDS genes are transcriptionally regulated during T cell
development and to identify cis- and £ra«s-acting elements involved in their regulation.
Therefore, the specific aims of my studies were: 1) to identify and characterize the
positive cw-acting elements (enhancers) within the first intron of the murine CD4 gene;
2) to identify the possible internal promoter within the first intron of the murine CD4
gene; and 3) to identify the negative c/s-acting elements associated with the 5' CD4
promoter.

B. CD4 GENE STRUCTURE AND FUNCTION
1. Structure of the CD4 Gene and that of the CD4 Polypeptide
a. Structure of the CD4 gene
CD4 is encoded by a single gene located on the short arm of human chromosome 12
(Isobe et al., 1986; Kozbor et al., 1986) and on mouse chromosome 6 (Field et al., 1987).
This region of chromosome 12 shows striking homology to the distal segment of mouse
chromosome 6. CD4 is located in a synentic group that contains a number of different
genes that are important for the function of the immune system. These genes include
LAG-3 (Triebel et al., 1990), CD27 (Loenen et al., 1992), HCP (Yi et al., 1992a; Yi et
al., 1992b), and TNFR, FGF-6, KRAS-2 (Elliott and Moore, 1992). The organization of
these genes to the same chromosomal locus may be significant for the control of their
expression.
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The genomic organization of the murine and human CD4 genes has been determined.
The mouse CD4 gene spans 26 kb of DNA and is composed of 10 exons (Gorman et ah,
1987; Littman and Gettner, 1987) (Figure 1). An unusual feature of the CD4 gene is the
presence of a first intron (8.6 kb) in the 5' untranslated region. Also, a large third intron
(6.4 kb) divides the sequence encoding the amino-terminal V-like domain into two exons
(exons III and IV) approximately half-way through the predicted protein domain
(Gorman et al., 1987; Littman and Gettner, 1987). The large introns separating these
exons were probably inserted during evolution and may be involved in regulation of CD4
gene expression in different tissues, which is also suggested by numerous T cell- and non
T-T cell-specific DNase I hypersensitive (DH) sites mapped to both introns (Maddon et
al., 1987; Sands and Nikolic, 1992; Siu et al., 1994). The human CD4 gene spans at least
33 kb of DNA and its gene structure is similar to that of the mouse (Maddon et al., 1987).
cDNA clones encoding human CD4 protein were isolated using gene transfer and
subtractive hybridization (Maddon et al., 1985). The murine homologue of CD4 cDNA
was subsequently isolated by screening mouse T cell cDNA libraries at low stringency
with the human cDNAs as probes (Littman and Gettner, 1987).
b. CD4 polypeptide and the structure of CD4 cDNA
The CD4 antigen was first identified by use of the W3/25 monoclonal antibodies
(mAb) in the rat (Williams et al., 1977). The human homologue of the W3/25 antigen
was identified with the mAb T4 (Reinherz et al., 1979) and later termed CD4. The CD
(clusters of differentiation) nomenclature was introduced to group mAbs that recognized
the same antigen at the surface of human leukocytes (Littman, 1996). CD4 protein is a
membrane glycoprotein of approximately 55 kDa, which immunoprecipitates as a single
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polypeptide chain (Classon et al., 1986; Dialynas et al., 1983). CD4, a member of the
immunoglobulin (Ig) superfamily, consists of 5 external domains, a hydrophobic
transmembrane domain, and a highly basic cytoplasmic tail (Littman and Gettner, 1987;
Maddon et al., 1985). Amino acid sequence comparisons of CD4 proteins from a number
of species demonstrate strong conservation within all domains of CD4 (Littman, 1987).
The mature CD4 polypeptide chain is preceded by a 23- or 26-amino acid signal peptide
in humans and in mice, respectively. The extracellular portion of CD4 consists of 374
amino acids in humans and 368 amino acids in mice. This is followed by a
transmembrane segment (26 amino acids in humans, 25 in mice) and a cytoplasmic tail
(38 amino acids in both species). There is species variation in CD4 N-linked
glycosylation with only one site in rabbit CD4, two in human CD4, three in rat and
mouse CD4, and four in chimpanzee CD4 (Fomsgaard et al., 1992). Each CD4 molecule
of the five species listed has six extracellular cysteine residues, which are conserved
between species and form three intrachain disulfide loops connecting adjacent cysteines
(Classon et al., 1986). The cytoplasmic tail is the most highly conserved domain of CD4
between mouse and other species, with 80% identical residues in humans, 98% identical
residues in rats. The strong conservation in the cytoplasmic domain of CD4 suggests that
it is essential for the function of the molecule. There is much greater divergence in the
other domains, with overall homologies of 55% between human and mouse and 74%
between rat and mouse (Littman, 1987).
The X-ray crystallography structures of the four extracellular domains of CD4
indicate that these domains are members of the Ig superfamily. Domains 1 and 3 are
similar to antibody variable region (V-set) domains, while domains 2 and 4 are closer to
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the size of C-domains but with patches of sequence similar to V-domains and this group
is termed C2-set domains (Williams and Barclay, 1988). In domains 1 and 3, the nine
strands form two P-sheets which can be termed ABED and GFCC'C" by analogy with
antibody V-domains (Ryu et ah, 1990; Wang et al., 1990). D2 and D4 are characterized
by a short connecting strand between the C and E strands, termed the C strand, which
hydrogen bonds to strand C rather than E as is observed for strand D in C domains
(Brady et al., 1993; Garrett et al., 1993). A linear arrangement of the four extracellular
domains of CD4 results in a structure about 120 angstroms (A) in length and 25 to 30
angstroms in width. This length also corresponds approximately with the expected
lenghs of the complex of MHC class II interacting with the T cell receptor (TCR) (Brady
et al., 1993; Ryu et al., 1990; Wang et al., 1990). The structures showed a unique
arrangement of D1 to D2 and D3 to D4 in which the last G strand of one domain
continues directly to form the first strand (A) of the next domain. Studies of different
crystal forms suggest the resulting rod-like structure behaves essentially as a rigid unit
allowing only limited flexibility between domains (Lange et al., 1994; Ryu et al., 1994).
2. Functions of the CD4 Proteins
a. Co-receptor function
The T cell surface glycoprotein CD4 is expressed on helper T cells that have a T cell
receptor (TCR) specific for antigens associated with class II MHC molecules. CD4
protein plays a role during antigen recognition by binding to a nonpolymorphic region of
MHC class II molecules (Doyle and Strominger, 1987; Julius et al., 1993). CD4 is not
merely an adhesion or accessory molecule, but also contributes to T cell activation by
acting as a co-receptor that helps form a multiprotein signaling assembly with the TCR
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and CD3/(^ complex (Janeway, 1992; Julius et al., 1993). The co-receptors contribute to
intracellular messenger generation by participating in antigen recognition and receptor
clustering and through their noncovalent association with the protein tyrosine kinase
p56Lck (Rudd et al., 1989; Veillette et al., 1989) (Figure 2).
Several experiments have directly indicated a close physical association between CD4
and TCR (Beyers et al., 1992; Gallagher et al., 1989; Janeway et al., 1989; Saizawa et al.,
1987). Evidence for the physiological relevance of the CD4/TCR interaction was
provided by the demonstration that non-polymorphic regions of MHC II molecules are
natural ligands for CD4 (Doyle and Strominger, 1987; Gay et al., 1987; Sleckman et al.,
1987). Doyle and Strominger (1987) have used the human CD4 cDNA to provide the
evidence for physical binding between CD4 and MHC class II molecules. The specificity
of this binding was confirmed by its complete inhibition by either anti-CD4 mAb or a
mixture of anti-class II mAbs. This study further indicates that the interaction between
CD4 and MHC class II molecules can take place in the absence of the TCR. Gay et al.
(1987) have drawn similar conclusions concerning the ability of human CD4 to enhance
responsiveness in the presence of class II MHC molecules using another xenogeneic
system. Their results indicate that CD4 interacts with class II MHC molecules and that
this interaction enhances the T cell activation. Similar conclusions regarding the function
of mouse CD4 have been obtained in a totally syngeneic system (Gay et al., 1987). To
explain the strict association of CD4 expression with class II restriction, the co-receptor
model was proposed for CD4 function (Janeway et al., 1989). This model postulates that,
aside from any adhesive function, CD4 plays a critical role as a component of the TCR
complex required for efficient and proper antigen-dependent signal transduction.

8

Figure 2. Schematic illustration of CD4 function. The function of CD4 molecule is two
fold. CD4 binds to the beta chain of MHC class II thereby strengthening the contact
between the T cell and the class II antigen-presenting cell. Also, the short cytoplasmic
tail contacts the protein tyrosine kinase p56Lck and this association cause the intracellular
signal transduction, which will lead to T cell activation. Adapted from Watson et al.
(1992).
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Site-directed mutagenesis and gene transfer techniques have yielded a substantial
understanding of the molecular basis for CD4-MHC class II molecule interactions. The
atomic resolution of the three-dimensional structure of crystals consisting of the two Nterminal domains (D1 and D2) of CD4 made it possible to relate the results of mutational
analyses to the strucutre of CD4 (Ryu et ah, 1990; Wang et ah, 1990). These mutational
analyses have identified multiple regions of CD4 that affect either direct binding to class
II MHC molecules or downstream functions dependent on interaction with class II
molecules. An extended region of functional significance is formed on one side of
domain 1 by residues in the A-strand, the A/B loop, the B-strand, the beginning of the
CDRl-like B/C loop, the CDR3-like F/G loop, and the D-strand, as well as residues in
the D/E-loop and at the end of the E-strand (Clayton et ah, 1989; Moebius et ah, 1993).
On the same side of CD4, residues in the A-strand, and the A/B and B/C-loops of domain
2 also contribute to the function. These data imply the existence of two extended regions
located on two spatially discrete faces of the CD4 molecule that are involved in MHC
class-II dependent CD4 function. The CD4 molecule is about 125 A long (Kwong et ah,
1990), whereas the height of a class II MHC molecule is about 73 A (Brown et ah, 1993)
and that of the TCR may be 60-70 A (considering that both the a and the p chains consist
of two immunoglobulin-like domains). Therefore, the D3 and D4 domains of CD4 would
be unlikely to reach beyond the TCR to contact class II MHC molecules. If so, how can
mutations in D3 and D4 affect CD4 function? One possibility is that the mutations may
induce structural changes in distant regions of CD4, indirectly disturbing interactions
with class II MHC and/or TCR/CD3 complexes (Fleury et ah, 1991). Alternatively, the
signaling function of CD4 may depend on protein-protein interactions, either between
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CD4 molecules or between CD4 and TCR/CD3 components, and this may involve the
membrane-proximal D3 and D4 domains (Vignali et ah, 1993).
In contrast to immunoglobulins that recognize a wide diversity of ligand structure, ccP
T cells participate in adaptive immune responses by recognizing short peptides bound to
a common framework consisting of the surrounding MHC class I or class II molecule
(Germain, 1994). A TCR must discriminate among thousands of subtly different peptides
bound to identical MHC molecules expressed on a single cell surface. High affinity
receptors discriminate well between diverse structures, but poorly between related
structures. Due to this feature of receptor-ligand interactions, a(3 TCR cannot be of very
high affinity, as this would reduce their specificity of recognition and their ability to
distinguish between MHC molecules occupied with peptides of similar structure (Weber
et al., 1992). Although modest TCR affinity aids in discriminatory recognition of similar
peptide-MHC molecule complexes, this feature also limits the sensitivity of the response
system. But the T cell activation system must be very sensitive to ensure effector
responses at the low concentrations of antigen available early after infection. The co
receptor system is the solution to the problem of maintaining high sensitivity and
specificity in the T cell recognition of peptide-MHC complexes. In effect, the CD4 co
receptor is an integral part of the TCR recognition unit, which allows high specificity as
the TCR scans through the many potential MHC ligands on a cell surface. At the same
time, the affinity of the receptor alone for MHC molecules is very low, preventing
interactions in the absence of TCR recognition (Gay et al., 1987; Janeway, 1992). Once
such specific recognition takes place, the ability of CD4 to simultaneously engage the
recognized peptide-MHC molecule and the attached TCR complex results in both a
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stabilization of co-receptor-MHC molecule binding and a major increase in the effective
affinity of the TCR. By occurring after the initial interaction of an a(3 TCR with a
suitable peptide-MHC complex, this affinity increase can happen without a loss of
specificity. This sequential, cooperative mechanism permits low numbers of specific
ligands on a cell surface to activate the TCR signal transduction machinery to stimulatory
levels (Demotz et al., 1990; Harding and Unanue, 1990).
b. CD4 protein and signal transduction
A series of observations suggested that CD4 protein could transduce intracellular
signals during T cell activation. Cross-linking CD4 with the TCR/CD3 complex caused
significantly more activation than cross-linking TCR/CD3 complex alone (Anderson et
al., 1987; Eichmann et al., 1987; Emmrich et al., 1987; Owens et al., 1987; Walker et al.,
1987). It was further demonstrated that the enhancement of T cell activation by ligation
of CD4 with MHC class II molecule was dependent on the cytoplasmic domain of CD4
and not merely on the extracellular domain (Sleckman et al., 1988; Sleckman et al.,
1991). CD4 protein associates noncovalently with the Src-related protein tyrosine kinase
Lck suggesting that CD4 signaling may be mediated by the activation of Lck (Barber et
al., 1989; Rudd et al., 1989; Veillette et al, 1988). Lck is a 56 kDa protein composed of
a unique N-terminal domain, a Src-homology 2 (SH2) domain, a Src-homology 3 (SH3)
domain and a kinase domain (Ravichandran et al., 1996). The CD4:Lck interaction
occurs between the cytoplasmic domain of CD4 and the N-terminal domain of Lck (Shaw
et al., 1989). Site-directed mutagenesis studies indicate that two closely positioned
cysteine residues 420 and 422 of CD4 and residues 20 and 23 of Lck are essential for this
CD4-p56Lck interaction (Turner et al., 1990). Expression of CD4 point mutants do not
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enhance antigen responsiveness and also fail to co-associate with the TCR/CD3 complex
during T cell stimulation, suggesting that CD4/Lck association is necessary for CD4 co
receptor function (Collins et ah, 1992).
Although CD4:p56Lck association is essential for CD4 co-receptor activity, the
tyrosine kinase activity of CD4-associated Lck appears to be dispensable for CD4
function. Models in which CD4 potentiates TCR signaling both by modulating the
protein kinase activity of p56Lck (Luo and Sefton, 1990) and by recruiting the activated
Lck molecules in the vicinity of the antigen receptor complex have been proposed
(Veillette and Davidson, 1992). The recruited p56Lckthen enhances TCR signals by
phosphorylating rate-limiting substrates such as CD3, TCR<^ chains and Zap-70 (<;associated protein). However, studies performed using chimeric CD4-p56Lck molecules
demonstrated that the CD4-associated p56Lck improves TCR signaling by a mechanism
unrelated to its tyrosine protein kinase activity but relying on its SH2 sequence (Xu and
Littman, 1993). The SH2 domain fulfills this function by recruiting other
phosphotyrosine-containing signaling molecules or by binding the tyrosine
phosphorylated CD3 and TCR<^ chains to stabilize the association between CD4 and TCR
(Xu and Littman, 1993). Data also show that p56Lck plays a central role in TCR-mediated
signal transduction independently of its association with CD4 (Abraham et al., 1991;
Haughn et al., 1992; Strauss.D.B. and Weiss, 1992). Therefore, p56Lck appears to have
two distinct functions in co-receptor-assisted T cell activation. One of these functions,
which may occur independently of its association with the co-receptor, involves
localization of enzymatically active p56Lck in close proximity to the TCR complex, where
it acts early in the signaling pathway (Anderson et al., 1994). The second function of
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p56Lck is to coordinate interaction of the TCR and corecptor with a single MHC molecule,
possibly by helping to stabilize CD4 in the antigen receptor complex in a kinaseindependent fashion (Collins et al., 1992).
One of the early signaling events following TCR triggering is the activation of Ras
proteins, which are small guanine nucleotide-binding proteins of 21 kDa. Guanosine
triphosphate (GTP)-bound Ras is active while guanosine diphosphate (GDP)-bound Ras
is inactive (Ravichandran et al., 1996). CD4/Lck may influence T cell receptor (TCR)mediated Ras activation in at least three different ways (Figure 3). The individual
contributions of adaptor proteins She, p36 or Vav to the overall formation of GTP-bound
Ras following TCR activation are currently unknown. She is one of the adaptor proteins,
composed of a single SH2 domain, a collagen-homology domain and a unique N-terminal
domain (Pelicci et al., 1992). Upon TCR activation She is tyrosine-phosphorylated and it
subsequently interacts with another adapter protein Grb2, which is composed of one SH2
domain and two SH3 domains (Ravichandran et al., 1995). Grb2, via its SH2 domain,
interacts with phosphorylated She and also interacts via its SH3 domains with mSOS, a
GTP/CDP exchange factor for Ras (Buday and Downward, 1993; Egan et al., 1993).
She, via its own SH2 domain, also interacts with the tyrosine-phosphorylated TCR(^
chains. Therefore, She and Grb2 act as adaptor proteins to bring mSOS to the membrane,
thereby leading to Ras activation. Another tyrosine-phosphorylated protein p36 has also
been shown to interact with Grb2 and mSOS upon T cell activation (Buday et al., 1994).
The third, the SH2 and SH3 domain-containing protein Vav is shown to be able to act as
a guanine nucleotide exchange factor for Ras following TCR activation (Gulbins et al.,
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1993) (Figure 3). It is possible that different mechanisms of Ras activation are used
under different conditions or at different stages of T cell maturation.
In addition to the two major functions discussed above, CD4 molecule appears to
have a number of other functions as well. CD4 partially inhibits the binding activities of
nuclear factors to down-regulate IL-2 transcription (Takahashi et al., 1992). CD4 either
binds or associates with a complex of proteins, which bind lymphocyte chemoattractant
factor (LCF) secreted by CD8+ T cells. The interaction of LCF with CD4 stimulates
migration of CD4+ lymphocytes, monocytes, and eosinophils, and stimulates the growth
of CD4+T cells (Center et al., 1995; Cruikshank et al., 1994). In addition, CD4/Lck can
associate with two lipid kinases: phosphoinositide-3 (PI-3) kinase and phosphoinositide-4
(PI-4) kinase and play a role in lipid messanger signaling (Prasad et al., 1993). The
association of PI-3 kinase with platelet-derived growth factor (PDGF) receptor is
essential for PDGF-mediated mitogenesis in fibroblasts (Valius and Kazlauskas, 1993).

C. THE DEVELOPMENTAL BIOLOGY OF THE T CELLS
1. T Cell Progenitors
All lymphoid cells originate from multipoietic stem cells (HSCs) found in the fetal
liver and then in the bone marrow of the adult (Shortman and Wu, 1996). The stem cell
population appears to be separable into subpopulations representing stages of
differentiation between the most primitive long-term reconstituting cells and the lineagecommitted progenitors (Uchida and Weissman, 1992). The surface markers for the
characterization of multipotent HSCs are Sca-l+Thyl.lloc-kit+ in the mouse and CD34+
in the human. CD34 protein is a heavily glycosylated 120 kDa molecule, which is
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Figure 3. The co-receptor function mediated via CD4 depends on its association with
Lck, a src-family tyrosine kinase. CD4/Lck association may influence T cell receptor
(TCR)-mediated Ras activation in at least three different ways: (1) Tyrosine
phosphorylation of adaptor protein She is augmented by cross-linking of CD4 with the
TCR and, in turn, the level of another adaptor protein Grb2 bound to She. Since the
interaction of phosphorylated She with Grb2 regulates the Grb2:mSOS association, this
may in turn lead to enhanced Ras activation; (2) Vav directly acts as a guanine exchange
factor for Ras and tyrosine phosphorylation of Vav (mediated by Lck) influences its
exchange activity toward Ras; and (3) Phosphorylation of the p36 protein leads to its
interaction with Grb2 and mSOS. Adapted from Ravichandran et al. (1996)
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expressed on pluripotent stem cells, and also on lineage-committed myeloid cells and B
progenitor cells (Spits, 1994). Another characteristic generally assumed to indicate T cell
commitment is the expression of CD3 components in the cytoplasm (Bercena et al.,
1993).
The first major event in the thymic development of T cells occurs when
hematopoietic stem cells seed the thymus. From the various sites of hematopoiesis, pre-T
cells travel to the thymus via the circulation (Savagner et al., 1986). What form of the
progenitor enters the thymus from the bloodstream? Within the embryonic mouse thymus
there are precursors capable of forming both B cells and macrophages as well as T cells
(Kimoto et al., 1993; Peault et al., 1994). Within the postnatal human thymus there are
CD34+ cells with myeloid as well as T cell-developmental capacity (Kurtzberg et al.,
1989; Marquez et al., 1995). Within the adult mouse thymus, early T-precursor
populations can form as well as T cells, B cells, NK cells, and DC (Matsuzaki et al.,
1993; Wu et al., 1991a). All this suggests that the thymus is seeded by some form of
multipotent stem cells (Spits, 1994). However, a T lineage-committed precursor
population has been identified in murine fetal blood. Prothymocytes reconstitute the ocp
T cell lineage in vivo but lack progenitor potential to reconstitute B lymphocyte, myeloid
and erythroid lineages. Fetal blood prothymocytes are likely to represent an intermediate
stage in the hematopoietic hierarchy located between multipotent stem cells and the
earliest thymocytes (Rodewald, 1995a).
CD4 is expressed at low levels on murine hematopoietic stem cells. The initial
characterization of a monoclonal antibody, GK1.5, showed that bone marrow-derived
cells expressed the CD4 molecule (Dialynas et al., 1983). Fredrickson and Basch
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provided additional evidence that CD4 was expressed on immature hematopoietic cells
and suggested that CD4 was transiently expressed by most, if not all, hematopoietic
precursors early in their maturation (Fredrickson and Basch, 1989). The earliest Tlineage precursors in the adult murine thymus express CD4 (Wu et al., 1991b). CD4l0
murine bone marrow cells can repopulate all hematopoietic lineages (Onishi et al., 1993;
Wineman et al., 1992).
2. Thymic Development
a. Early thymic differentiation
Thymic differentiation (Figure 4) begins between days 11 and 12 of fetal life when
hematopoietic stem cells initially arrive in the thymus from the yolk sac and/or fetal liver.
In the embryonic thymus, development proceeds in an ordered fashion after stem-cell
colonization, so that sequential stages occur at different days of fetal life. The
differentiation process is also recapitulated during adult life by bone marrow-derived
stem cells that continually migrate to the thymus (Zuniga-Pflucker and Lenardo, 1996).
Differentiation to a T cell phenotype depends on interactions of hematopoietic precursors
with thymic stroma cells derived from the third pharyngeal cleft (Owen and Jenkinson,
1984). Both epithelial and mesenchymal cells from the stroma are necessary (Anderson
et al., 1993). The architectural organization of the thymus dictates that early
differentiation occurs in the cortical circumference of the thymic lobe (Boyd et al., 1993).
Early thymopoiesis involves signals for survival as well as signals for differentiation. If
differentiation is blocked, the later stages are lost and the early progenitors remain limited
by programmed cell death (Zuniga-Pflucker and Lenardo, 1996).
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Figure 4. Schematic illustration of T cell development. Pre-thymic T cells are attracted
to and enter the thymic rudiment. They proliferate below the subcapsular region as
lymphoblasts, which replicate and give rise to a pool of cells entering the differentiation
pathway. Cells in this region first acquire CDS and then CD4 at low density. They also
rearrange their TCR genes and may express the products of these genes at low density on
the cell surface. Maturing cells move deeper into the cortex and adhere to cortical
epithelial cells. These epithelial cells are elongated and branched, and thus provide a
large surface area for contact with thymocytes. The TCRs on the thymocytes are exposed
to epithelial MHC molecules through these contacts. This leads to positive selection of
the thymocytes. Those cells which are not selected undergo apoptosis and are
phagocytosed by macrophages. There is an increased expression of CDS, TCR, CD4 and
CD8 during thymocyte migration from the subcapsular region to the deeper cortex.
Those TCRs with self reactivity are now deleted through negative selection. Following
this stage, cells expressing either CD4 or CDS appear and exit to periphery via
specialized vessels at the cortico-medullary junction. Adapted from Benjamini et al.
(1996).
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The search for early T cell precursors in the adult murine thymus began with a
subdivision of the 2-5% triple negative (TN, CD3'CD4'CD8 ) populations, which gives
rise to all other thymocyte subsets (Antica et ah, 1993; Ardavin et ah, 1993; Wu et ah,
1991b). These thymic lymphoid progenitors (TLPs) from adult mice characteristically
express low, but detectable, levels of CD4 (termed "CD4l0 progenitors"), whereas the
TLPs from fetal mice do not express CD4 (Shortman and Wu, 1996). No known function
has been attibuted to CD4 expression at the TLP stage, and also CD4 is not expressed in
the earliest progenitors found in the human thymus (Shortman and Wu, 1996).
Nonetheless, CD4 has served as a useful marker of adult TLPs in the mouse. TLPs
constitute a minute fraction (0.05%) of all thymocytes; in the day 14 fetal thymus, TLPs
comprise 3-4% of all cells (Shortman and Wu, 1996). TLPs express high levels of CD44
and GDI 17 (c-kit), low levels of Thy-1 and heat stable antigen (HAS), and none of the
later markers such as CD25 (IL-2 receptor a chain) (Zuniga-Pflucker and Lenardo,
1996). TLPs are the most immature thymocytes and are not yet committed exclusively to
the T cell lineage. Expression of CD25 and other 'activation' markers on TLPs defines
the pro-T cell stage. Commitment to the T cell lineage and proliferation take effect at
this stage (Moore and Zlotnik, 1995; Zuniga-Pflucker et al., 1995), but TCR
rearrangement has not yet been initiated (Dudley et al., 1994; Godfrey et al., 1994;
Hozumi et al., 1994). The loss of CD44 and GDI 17 expression together with the
expression of high levels of CD25, Thy-1, HAS and Sca-1/2 characterizes the early pre-T
cell stage (Shortman and Wu, 1996). Majority (60%) of TN thymocytes belong to early
pre-T cell stage, where TCR-p gene rearragement and expression of the pre-Ta gene are
initiated (Godfrey et al., 1994; Ungewiss et al., 1994). The molecular characterization of
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a pre-TCR complex has provided a fundamental insight into regulation at the pre-T cell
stage. The pre-TCR is an 80 kDa protein complex that consists of the TCR-(3 protein
covalently linked by a disulfide bond to a 33kDa glycoprotein (gp33), termed 'pre-Ta'
(Groettrup and von Boehmer, 1993; Ungewiss et ah, 1994). Pre-Ta is a transmembrane
protein that shares homology with TCR chains but contains only a single extracellular
immunoglobulin-like domain. The intracytoplasmic portion of the pre-Ta chain is longer
than that of TCR chains and contains potential signalling motifs (Ungewiss et ah, 1994).
The pre-Ta gene is expressed only in the precursors of ap T cells and not in the y5,
natural killer (NK), B cell or myeloid cell lineages (Bruno et ah, 1995). Most thymocytes
require TCR-(3 protein in association with the pre-Ta protein to receive a signal to
survive, proliferate and further differentiate (Fehling et ah, 1995). The assembly of the
pre-TCR therefore establishes a key checkpoint in early thymoyte differentiation which
has been termed 'P-selection' (Groettrup and von Boehmer, 1993; Levelt and Eichmann,
1995). The late pre-T cell stage is marked by the loss of CD25 expression and the onset
of renewed proliferation, resulting in an eight-fold expansion of thymocytes (ZunigaPflucker and Lenardo, 1996). TCR-p chain rearrangement and expression are
accomplished successfully (Dudley et ah, 1994; Godfrey et ah, 1994). During the late
pre-T cell stage, rearrangement and expression of the TCR-a loci begins. Newly
synthesized TCR-a chains appear to displace pre-Ta chains, and the ap TCR complex
supplants the pre-TCR complex (Shortman and Wu, 1996). After this event, expression
of the pre-Ta gene is turned off, and early, large-sized double positive (DP, CD4+CD8+)
thymocytes evolve into small resting DP thymocytes (Ungewiss et ah, 1994).
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During early thymocyte development, changes in the lineage-specific genes and
sequential rearrangement of TCR genes are controlled at the DNA level by certain
transcription factors, controlled in the cytoplasm by signal transduction molecules
including a number of tyrosine kinases, and controlled at the cell surface by receptors for
cell interaction molecules and cytokines (Shortman and Wu, 1996). Studies show that
stem cell factor (SCF) and IL-7 stimulate survival and proliferation of early thymocytes
(Moore and Zlotnik, 1995; Rodewald et ah, 1995b). Thymic lymphoid progenitors
exhibit a strong requirement for SCF whereas IL-7 augments growth but is not required.
In contrast, pro-T cells are completely dependent on IL-7, which causes enhanced
survival and proliferation at this stage (Moore and Zlotnik, 1995; Penit et al., 1995).
Recent data also implicates two cytokines, IL-la and TNF-oc, in the maturation of
thymocytes from the TLP to the pro-T cell stage (Zuniga-Pflucker et al., 1995). The
earliest known genetic block in the lymphoid lineage results from targeted disruption of
the Ikaros gene (Georgopoulos et al., 1994; Georgopoulos et al., 1992). Ikaros is a zincfinger, DNA-binding trans-activator that directly controls the expression of lymphoidrestricted genes, such as those coding CDS proteins (Georgopoulos et al., 1992). A
mutation in the DNA-binding domain of Ikaros arrests all lymphoid development
(Georgopoulos et al., 1994). Both aP and y5 T cells are absent. It is likely that the Ikaros
deficiency causes an intrinsic defect in an early bone marrow-derived progenitor. Other
genetic alterations that affect development at the TLP or pro-T stage includes those for
IL-7 (Von Freeden-Jeffry et al., 1995), and IL-7 receptor (IL-7R) (Peschon et al., 1994).
Targeted disruptions of the IL-7 and IL-7R genetic loci have a dramatic inhibitory effect
on early thymic subsets and bone marrow progenitors (Peschon et al., 1994). Progression
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beyond the pro-T cell stage is diminished by reduced cell survival. In contrast to intrinsic
thymocyte defects, the nude mutation alters the proper development of the thymic stroma
(Boehm et ah, 1995). Other genetic defects exist which arrest T cell development after
commitment to lineage. Disruptions of RAG-1 and RAG-2 (Mombaerts et al., 1992;
Shinkai et al., 1992) or the SCID DNA-dependent p350 kinase gene (Kirchgessner et al.,
1995), which are necessary for TCR rearrangement, prevent the arrangement of TCR-P
loci and the subsequent emergence of late pre-T cells.
b. Transition to CD4+CD8+(DP)
Signals transmitted through the pre-TCR complex on DN thymocytes not only cause
proliferation and expansion, but also induce TCRa gene rearrangement and the
expression of the CD4 and CDS co-receptors, and therefore progression to the DP stage,
which constitutes about 80 to 84 percent of thymocytes (Fowlkes et al., 1988). The
transition of DN cells into DP thymocytes occurs in such a way that either CDS is
expressed before CD4 (more common) ((Kisielow et al., 1984)) or in some mice CD4 is
expressed before CDS (Hugo and Petrie, 1992). These early single positive cells become
DP cells within hours upon culture in vitro or upon intrathymic injection (Kisielow and
von Boehmer, 1995). DP thymocytes express a highly diverse array of clonotypically
distinct TCRa|3 complexes, and numerous studies have indicated that most DP thymoytes
die within 3-4 days because their TCRaps cannot recognize self MHC-peptide
complexes on thymic stroma (Egerton et al., 1990; Huesmann et al., 1991). The
expression of TCRa and p appear to precede the expression of CD3, CD4, and CDS
(Petrie et al., 1992).
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The independent expression of CD4 and CDS can be attributed to the different signals
that are required to up-regulate their expression. CD4 requires a thymocyte-stromal cell
interaction (Brightman et al., 1989; Tatsumi et al., 1990), while the expression of CDS is
inducible by thymic stromal cell-derived cytokines such as TGF[3 and TNFcc (Suda and
Zlotnik, 1992; Tatsumi et al., 1990). Furthermore, the up-regulation of CD4 and CDS
appear to be signaled through the CD3/TCR(3 complex that is expressed on DN
thymocytes (Ardouin et al., 1998). This signaling appears to be through the p56 Lck
molecule since mice deficient for this tyrosine kinase is also blocked at the DN
thymocyte stage (Molina et al., 1992). Humans with a defect in the expression of the
CD3x subunit have a problem in maturing CD8+ T cells (Alarcon et al., 1990), while
humans with a defect in the expression of the CD3s subunit have defects in maturing
CD4+ T cells (Thoenes et al., 1992). Finally, IL-1 can induce CD4 and CDS on
thymocytes that have been selected by complement lysis using antibodies to CD4, CDS,
and CD3 (Zimecki and Wieczorek, 1989), but it is not clear if these cells are CD4'CD8'
or CD4loCD8l0.
c. Lineage commitment of DP thymocytes
The DP thymocytes are subjected to a selection process that shapes the T cell
repertoire (von Boehmer, 1994). DP cells bearing low densities of self-restricted TCRap
are positively selected to survive and differentiate into TCRhlCD4 or CDS single positive
(SP) T cells; DP cells with nonproductive rearrangements of their TCR-a genes or with
TCRs that do not interact with host MHC and undergo apoptosis, and this selection
process is called positive selection (Guidos, 1996; Marrack and Kappler, 1997).
Potentially self-reactive thymocytes, with receptors that react too vigorously with
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peptide/MHC complexes, are eliminated through activation of an apoptotic pathway, and
this selection process is called negative selection (Nossal, 1994). Positive and negative
selection ensures that only the rare DP cells that express a TCR complex able to
recognize self-MHC/peptide complexes with an appropriate avidity will develop into
mature SP thymocytes. The result of these selection processes are MHC class I restricted
CD4'CD8+ T cells and MHC class II restricted CD4+CD8‘ T cells (Marrack and Kappler,
1997).
While the specificity and affinity of the TCR play a crucial role in both positive and
negative selection, the CD4 and CDS molecules also contribute to these processes by
influencing both the avidity of TCR-MHC interaction and the signaling function of the
ligated TCR complex (Miceli and Fames, 1993; Zamoyska, 1998). Mice that lack
expression of CD4 (CD4nu11) (Rahemtulla et al., 1991) or CDS (CD8nu11) (Fung-Leung et
al., 1991) have severely impaired differentiation of MHC class II- and class I-restricted T
cells, respectively. If the endogenous molecules are replaced by CD4 or CDS mutants
that lack cytoplasmic domains, differentiation of the subpopulations is somewhat restored
although high levels of expression of such mutants are required (Fung-Leung et al., 1993;
Killeen and Littman, 1993). These results suggest that the Lck-binding function of the
co-receptors is not an absolute requirement for the function of these molecules during
differentiation. It is now clear that T-cell differentiation can occur in the absence of CD4
and CDS expression, implying that the co-receptors do not contribute a unique
differentiation signal (Jameson and Beverley, 1998). However, they provide a significant
contribution to the selection of a broad TCR repertoire on endogenous thymic MHCpeptide ligands and influence the fine specificity of a response (Zamoyska, 1998). For
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example, co-receptor negative T cells that were responsive to particular antigens could
broaden their recognition and acquire the ability to respond to related antigens once
transfected with the appropriate co-receptor (Blok et ah, 1992; Miceli and Fames, 1993).
The involvement of CD4 co-receptor in negative selection was initially suggested by
the fact that in vivo treatment with anti-CD4 antibodies inhibited the deletion of
precursors of CD4"CD8+ T cells, which express receptors specific for superantigen
(Fowlkes et ah, 1988; MacDonald et ah, 1988; Fowlkes et ah, 1988). However, the
requirement for CD4 co-receptor in negative selection is not absolute. It was shown that
deletion of some class II MHC-restricted superantigen-reactive thymocytes can occur in
the absence of CD4 (Wallace et ah, 1992).
The molecular mechanisms of lineage commitment during the development of DP
thymocytes into CD4 or CDS SP cells are not yet clear (Chan et ah, 1994; Davis and
Littman, 1994; von Boehmer, 1996; von Boehmer and Kisielow, 1993). One of the
critical questions is how CD4 or CDS expression and MHC protein specificity are
coordinated at the onset of positive selection. Four distinct CD4/CD8 lineage
commitment models have been proposed to explain this correlation (von Boehmer, 1996).
The instmctive model proposes that positive selection occurs at the double-positive stage
of thymocyte development. Coengagement of the a/p TCR and the CDS or CD4 co
receptor by either class I or class II MHC molecules would result in different signals that
would direct the differentiation into the CD4'CD8+ and CD4+CD8' lineages, respectively
(Kaye et ah, 1989; Sha et ah, 1988; Teh et ah, 1988). In contrast, the stochastic/selective
model proposes that thymocytes make a random choice about which gene to be
downregulated, and then coengagement of TCRs and co-receptors by either class I or
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class II MHC molecules result in rescue from programmed death of cells with matched
receptor molecules only (Corbella et al., 1994; Crump et ah, 1993; Davis et al., 1993). A
symmetry for the generation of CD4, CDS, or both cells is implied by either model.
However, studies by three groups demonstrated that TCR-MHC class I engagement is
required only for the generation of the CDS, but not the CD4 lineage (Lucas and
Germain, 1996; Lundberg et al., 1995; Suzuki et al., 1995). These results show that there
is an asymmetry in the commitment to the CDS versus the CD4 lineage. Based on these
results, the default/instructive model proposes that CD4+CD8' commitment occurs
regularly, even in the absence of classical MHC molecules, whereas commitment to the
CD4'CD8+ lineage requires an instructive signal delivered when TCR and CDS co
receptor bind to class I MHC molecules (Suzuki et al., 1995). According to this model,
differentiation into CD4+CD8" T cells might be a default pathway unless a signal from the
cytoplasmic tail of a MHC-engaged CDS is also received by the cells (Punt et al., 1996).
To complete the circle of CD4/CD8 lineage commiment models and experiments that are
consistent with them, Itano et al. (1996) report that a CD8a/CD4 chimeric transgene, in
which the CD4 cytoplasmic tail has been hooked into the CDScc extracellular and
transmembrane region, engages signifcantly more p56Lck than a CDScc transgene when
expressed together with a CDScc transgene. The same transgene causes an increase in
CD4+CD8' cells that express a class I MHC-restricted TCR. The instructive/selective
model proposes that quantitative differences in signaling induced by coengagement of
TCR and co-receptors by either class I or class II MHC molecules produce a bias in
lineage commitment such as a stronger signal favoring CD4+CD8' and a weaker signal
favoring CD4'CD8+ commitment. After receptor downregulation, a confirmatory step
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due to coengagement of TCRs and co-receptors ensures survival of those cells with
matched TCR and co-receptor expression, while others die (von Boehmer, 1996). Thus,
it may be premature to conclude that commitment to the CD4 and CDS lineages occurs
by distinct mechanisms.
Recent experiments indicate that overexpression of an activated form of the fate
determining protein Notch in thymocytes of transgenic mice favors the development of
CDS lineage cells, suggesting that the Notch signaling pathway is involved in instructing
the CDS lineage choice (Robey et al., 1996). This idea might give a new insight into the
controversy over how thymocytes decide whether to express CD4 or CDS. An alternative
and complementary approach to understanding this process is to focus on the changes in
gene expression that occur as cells differentiate into CD4+ or CD8+ lineage cells. Since
transcriptional regulation of the CD4 and CDS genes is tightly linked to the lineage
commitment, it is suggested that factors that positively and negatively regulate CD4 and
CDS expression in developing SP thymocytes are also involved in directing DP
thymocytes toward the helper or cytotoxic lineage (Baron et al., 1994; Chan et al., 1994).
By working on these factors, we should eventually understand how cell-surface signals
initiate the differentiation program.
3. Extra-thymic Development
While the thymus is the major organ where the development of most of the T
lymphocytes found in the peripheral lymphoid organs occurs (Rocha et al., 1995), T cell
differentiation also occurs extrathymically, in particular in the gut and in the liver, whose
epithelium is of endodermic origin as is the thymus (Guy-Grand et al., 1991a; Rocha et
al., 1992). Although extrathymic T cells are minor in numbers at a young age, they
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gradually become prominent with aging (liai et al., 1992; Ohteki et al, 1991; Ohteki et
al., 1992; Takimoto et al., 1992; Taylor et al., 1992).
T cells of extrathymic origin differ in phenotype and functional behavior from T
lymphocytes resulting from the main thymic differentiation pathway, and are rare in
peripheral lymphoid organs but abundant in sites such as the gut epithelium, where they
have an important role in local immune responses. T lymphocytes located between the
epithelial cells of the gut mucosa (intraepithelial lymphocytes, or lELs) have a
heterogeneous surface phenotype (Ibraghimov and Lynch, 1994). About half of the lELs
have a phenotype similar to that of peripheral T cells, which are TCRotP+ and Thyl+,
most being CD8ap+ and few being CD4+ (De Geus et al., 1990; Rocha et al., 1991).
These populations display the same levels of depletion of potentially autoreactive cells as
do all peripheral T cells and appear to belong to the major thymic pathway of
differentiation followed by most peripheral T cells (Rocha et al., 1994). The other half of
the lELs consist mostly of cells expressing CDSotoc homodimers (a small proportion are
CD4 CD8'); they are either Thy-1+ or Thy-L, and bear y8 or ctp TCRs (Banderia et al.,
1991; Deusch et al., 1991). The formation of these populations results from a
differentiation process entirely distinct from the main thymic pathway (Rocha et al.,
1994). Since these extrathymic T cells do not undergo negative selection for autoreactive
clones, they contain a proportion of autoreactive clones (Murosaki et al., 1991).
Almost all lELs bear the ocEp7 integrin (CD 103), whose ligand is the E-cadherin
borne by gut epithelial cells (Cepek et al., 1994). In all populations, a fraction of the cells
contains intracytoplasmic perforin and granzyme-containing granules, characteristics of
cytotoxic cells (Guy-Grand et al., 1991b). On the other hand, the few CD4CD8aoc+ lELs
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can be interpreted as belonging to the usual CD4+ peripheral T cell pool, with locally
induced additional co-expression of CD8aa homodimers (Guy-Grand and Vassalli,
1993). Unlike all thymus-derived peripheral T cells, gut thymus-independent lELs use
peculiar TCR/CD3 signal transmitting modules which resemble those on natural killer
(NK) cells (Guy-Grand et al., 1994; Ravetch, 1994).
In the mouse, the gut mucosa is a major site of extrathymic differentiation of T cells.
Several lines of evidence indicate that the liver is also a site of extrathymic differentiation
(Rocha et al., 1992). It contains double negative (CD4'CD8'), CD4+ and a few CD8+
cells that are TCRaP low and NK1.1+ with skewed Vp8 expression (Ohteki and
MacDonald, 1994). The lymphocytes are selected by MHC class I (a or P) molecules
(Ohteki and MacDonald, 1994) but have not undergone negative selection; they expand
during bacterial infections (Abo et al., 1991). It is possible that NKl.l+TCRap+ cells
develop independently at multiple site of hematopoiesis (Makino et al., 1993); however,
they are not found in significant amounts in gut.
Up to now, very little is known about the physiological function and specificity of
extrathymic ccp and y5 T cells. It is postulated that extrathymically-derived T cells play a
complementary role to thymus-derived T cells (Ohtsuka et al., 1994). They are activated
under conditions of infection (Hayashi et al., 1989), aging (Ohteki et al., 1992),
malignancies (liai et al., 1994; Ohmori et al., 1993), pregnancy (Okuyama et al., 1992),
and some autoimmune diseases (Masuda et al., 1991; Ohteki et al., 1990). Thus, the
activation of extrathymically derived cells may occur when the thymus becomes atrophic,
to compensate for the time when the intrathymic pathway is inactivated (Ohtsuka et al.,
1994).
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4. Post-thymic
a. T lymphocyte migration into tissue
One of the most characteristic features of the immune system is the continuous
recirculation of cells from blood to lymph. Small lymphocytes have the capacity to
migrate from the blood into secondary lymphoid tissues, such as peripheral and
mesenteric lymph nodes (PLN and MLN, respectively) and Peyer's patches (PP), by
extravasating through the endothelium of specialized post-capillary or high endothelial
venules (HEV) (Girard and Springer, 1995). Early studies indicated that lymphocyte
extravasation is a highly regulated process, consisting of two major pathways, generally
referred to as the peripheral and gut-mucosal pathways, within which lymphocyte subsets
preferentially recirculate (Cahill et al, 1977). Recent studies suggest that lymphocyte
extravasation is a multistep process that is regulated precisely by interactions of adhesion
molecules with their ligands/counter receptors on vascular endothelium (Bargatze et al.,
1995; Bradley et al., 1994; Engelhardt et al., 1995; Luscinskas et al., 1995; Santamaria et
al., 1995). Basically, extravation of cells through endothelium involves three sequential
but overlapping steps: primary adhesion, activation-dependent adhesion, and
transmigration (Bradley and Watson, 1998).
Naive CD4 cells represent the primary population to recirculate from blood to lymph
via HEV. Nai've cells uniformly express moderate-to-high levels of several adhesion
molecules, including the homing receptors for PLN, L-selectin and for gut mucosal
tissue, oc4p7 (Bradley and Watson, 1998). The critical importance of recirculation by
naive cells for the development of immune response has been demonstrated by functional
studies, which have shown that when the capacity of naive cells to enter PLN draining a
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site of antigen exposure is blocked by treatment with mAb specific for either L-selectin
or LFA-1, a primary response fails to develop (Bradley et al., 1994). Effector CD4 cells
can migrate through both normal and inflamed endothelium (Brezinschek et ah, 1995),
indicating that the capacity to enter non-lymphoid tissue reperesent an important
functional consequence of antigen-induced changes in adhesion molecule expression by
effector CD4 cells. Effector-cell recruitment to sites of inflammation is the result of a
dynamic interplay of T cells, endothelium, and underlying tissue. Recent studies have
characterized specific components that may regulate the selective recruitment of CD4
subsets (O'Garra and Murphy, 1994; Xu-Amano et al., 1993). T helper (Th)l cells which
provide defense against intracellular pathogens, secrete both TNF-cc and IFN-y in
addition to IL-2 and TNF-P (O'Garra and Murphy, 1994). These effectors induce
endothelial cell expression of E-selectin and production of RANTES (a chemokine
specific for activated or memory CD4 cells and monocytes) at the site of infection,
resulting in further recruitment of T cells (Ying et al., 1995). In gut mucosal tissues, the
predominant responses involve Th2 cells, which secrete IL-4, IL-5, IL-6 and IL-10 and
are effective in infections involving extracellular pathogens (Xu-Amano et al., 1993).
Resting memory CD4 cells that are also generated during the response largely retain the
surface phenotype and migratory characteristics of effector cells and are found
predominantly in the blood and spleen (Bradley and Watson, 1998).
b. T cell activation
Triggering of resting T cells involves interaction with cells bearing the appropriate
antigen in the context of MHC molecules (Altman et al., 1990; Janeway and Bottomly,
1994). The binding event initiates a cascade of biochemical changes and generates
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signals that are transmitted sequentially from the cell surface to the nucleus, where genes
are activated or inhibited. This gives rise to activated and differentiated T cells
displaying genetically determined effector functions, such as secretion of
immunoregulatory cytokines by T helper cells and specific lysis of target cells by T
cytotoxic cells.
Although the normal functions of CD4 require its expression at the plasma
membrane, the stimuli that lead to T cell activation also induce CD4 down-regulation
(Minami et al., 1987; Weyand et al., 1987). The cell surface expression of other T cell
antigens is also modulated under these conditions (Paillard et al., 1988). One function of
the modulation of surface components may be to facilitate release of T cells from antigen
presenting cells following activation (Rosenstein et al., 1990). Although CD4 function at
the cell surface may be down-regulated by ligand-mediated occlusion of crucial sites on
the molecule, the principal mechanism for regulating expression is the removal of cell
surface molecules through receptor-mediated endocytosis (Wang et al., 1992).
Endocytotic vesicles and vacuoles of different sizes and shapes contain CD4 after the T
cell is activated by IL-2. These vesicles are located near the cell membrane and deep in
the cell center. CD4 endocytosis is balanced by recycling back to the cell surface
(Pelchen-Matthews et al., 1992).
CD4 can be rapidly down-regulated from the surfaces of T cells by a variety of
stimuli such as exposure to an appropriate antigen (Rivas et al., 1988; Weyand et al.,
1987) or treatment with cross-linking antibodies against CD4 (Cole et al., 1989), the
CD3/TCR complex (Rivas et al., 1988) or CD2 (Blue et al., 1989). Most of these stimuli
operate through the activation of protein kinase C (PKC) and, accordingly, the most
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effective triggers for CD4 down-regulation are PKC-activating phorbol esters such as
phorbol myristate acetate (PMA) or phorbol dibutyrate (PDB) (Pelchen-Matthews et al.,
1993). In addition to the down-regulation induced by T cell activation and phorbol
esters, treatment of cells with certain gangliosides also down-regulate CD4 expression
(Saggioro et al., 1993).
Infection of CD4 positive cells by the HIVs and SIVs leads to the down-modulation
of cell surface CD4 on the infected cells (Hoxie et al., 1986; Stevenson et al., 1987). The
viruses use multiple mechanisms to control CD4 expression, indicating that cell surface
CD4 expression is an important regulator of viral replication and pathogenesis. CD4
down-modulation can render infected cells resistant to super-infection by HIV, and may
also facilitate the release of progeny viruses from infected cells (Stevenson et al., 1988).
In addition, CD4 down-modulation may suppress the responsiveness of infected cells and
contribute to the pathology of AIDS by limiting the cell's ability to interact with antigen
presenting cells and/or by coupling p56Lck (Marsh and Pelchen-Matthews, 1996). Factors
that may cause HIV-1 associated cell surface CD4 down-modulation include endocytosis
(Amadori et al., 1992; Cefai et al., 1992), reductions in transcript levels of CD4 (Hoxie et
al., 1986; Salmon et al., 1988), impaired translation of CD4 mRNA (Yuille et al., 1988),
intracellular retention of CD4 (Crise et al., 1990; Jabbar and Nayak, 1990), and CD4
degradation (Chen et al., 1993; Willey et al., 1992).
D. CD4 GENE EXPRESSION
The pattern of CD4 expression appears to be species-specific. In the mouse, CD4
protein has only been identified on thymocytes and mature T lymphocytes. In addition,
CD4 expression has been reported on some thymic stromal cells (Tucek and Boyd, 1990),
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but not on thymic dendritic or splenic dendritic cells (Ardavin and Shortman, 1992). Rat
CD4 has additionally been identified on macrophage (Jefferies et al., 1985), Langerhans
cells, and alveolar dendritic cells (Simecka et al., 1992). Human CD4 has been expressed
on thymocytes and mature T lymphocytes (Maddon et al., 1987), macrophages and
hepatic sinusoidal endthelial cells (Scoazec and Feldmann, 1990), monocytes and
Langerhans cells (Moscicki et al., 1983; Wood et al., 1983), eosinophils (Lucey et al.,
1989), neurons and glial cells in the brain (Funke et al., 1987), some colon epithelial cells
(Omary et al., 1991), megakaryocytes (Basch et al., 1990), dendritic cells, granulocytes,
and some B cells (Maddon et al., 1987). In the mouse, the lack of expression of CD4 in
macrophages appears to be due to a truncation in the 3' coding region of CD4 (Moore et
al., 1992). The physiological role of CD4 on non-T cells is unknown.
The cellular distribution of CD4 mRNA has been detected in both mouse and human
cells. Tourieille et al. (1986) identified a 3.7 kb mouse CD4 mRNA in thymus, spleen,
and lymph node and in T cell lines that express CD4 protein. Although expression of
CD4 protein has not been identified in the mouse brain, a smaller (2.7 kb) polyadenylated
CD4 mRNA species has been identified in this tissue (Tourieille et al., 1986). Using
Northern blotting and SI nuclease analysis, Gorman et al. (1987) demonstrated that this
mRNA contains sequences only from the 3' half of the mouse CD4-coding sequence and
the 3' untranslated region. The start site was mapped approximately to the sequence
encoding amino acid 200, which lies within the protein-coding sequence of exon XL The
sequence TATAA is located also within exon VI, 32 bp upstream of the predicted start
site, and may serve as a promoter that is specifically regulated in the brain (Gorman et al.,
1987). The truncated protein from this brain-specific transcript starts at the second
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membrane-proximal domain (E3) of CD4 and continues through the normal cytoplasmic
tail. It is not yet known if it is a functional brain-specific protein.
In contrast to the findings in the mouse, human brain tissue has been found to express
not only a smaller form of CD4 transcript, but also full-length CD4 mRNA that
comigrates with human CD4 transcripts (Maddon et al., 1986). The expression of CD4
mRNA in human brain is of intense interest as T helper cells are the primary targets for
the human immunodeficiency virus (HIV) and CD4 serves as the viral primary receptors
on these cells (Dalgleish et al., 1984; Klatzmann et al., 1984; Maddon et al., 1986).
Following the multimolecular interaction between CD4 and the oligomeric viral envelope
glycoprotein, gpl20, conformational changes occur in gpl20 allowing the V3 loop of
gpl20, the fusogenic peptide of gp41 or possibly other sites to make contact with
accessory factors on the surface of the cell, leading to fusion between cellular and viral
membranes (James et al., 1996). Central nervous system involvement occurs with high
frequency in patients with AIDS and it is most likely that receptors for HIV-1 in the
human brain result from translation of the full-length CD4 transcript (Fames, 1989).
Human macrophages are the predominant class of CD4+ cells infected by HIV in the
brain. Macrophage infection and neuronal dysfunction in the brain play a cmcial role in
the pathogenesis of HIV-related dementia complex (Gartner et al., 1986; Koenig et al.,
1986). However, HIV-1 has also been observed in some neuronal and glial cells in the
human brain (Funke et al, 1987), and on rare occasions HIV-1 was observed in
astrocytes in the brains of AIDS encephalopathy patients (Wiley et al., 1986). Tissue
macrophages are selective targets for HIV, as shown by infection of Langerhans cells of
the skin (Tschachler et al., 1987), reticuloendothelial cells in lymph nodes (Armstrong
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and Home, 1984), alveolar macrophages of the lung (Salahuddin et ah, 1986), and
Kupffer cells of the liver (Hoda et al, 1991). Infection of macrophage seems dependent
on the degree of expression of CD4 at the moment of infection (Asjo et ah, 1987; Kazazi
et al., 1989; Klatzmann et al., 1984; Potts et al., 1990). Studies have shown that blood
dendritic cells can be infected by HIV (Langhoff et al., 1991; Macatonia et al., 1990).
However, it is not clear whether this occurs at a high level in vivo (Cameron et al., 1992),
or whether it is dependent on CD4 expression (Chehimi et al., 1993). HIV-1 infection of
colon epithelial cells occurs independently of CD4 (Asumth et al., 1994; Omary et al.,
1991; Yahi et al., 1992). Instead, galactosylceramide (GalCer) is an alternate receptor in
these cells (Fantini et al., 1993; Yahi et al., 1992). GalCer is also abundant in the brain
and appears to mediate HIV-1 entry into some neural cells (Harouse et al., 1991). So far,
the role of CD4+ cells in AIDS pathogenesis is still not clear.
E. CD4 GENE REGULATION
The CD4 molecule is essential for normal T cell functions and plays a cmcial role in
T cell development and activation. During intrathymic development, expression of the
CD4 and CDS glycoproteins is regulated in an ordered fashion. Both molecules are
coordinately up-regulated on DP cells and are subsequently shut off on mature T cells in
the course of positive selection. Early studies suggested that regulation of mRNA
stability contributes significantly to the regulation of the CD4 gene expression (Paillard et
al., 1990; Takahama and Singer, 1992). Human T cells stimulated with PMA or antiCD3 antibodies resulted in a pronounced transient decrease in the half-life of CD4
mRNA without affecting the rate of CD4 transcription (Takahama and Singer, 1992). In
addition, incubation of T-lymphoma cell lines with protein synthesis inhibitors rapidly
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increases the steady state levels of CD4 mRNA (Wilkinson et al., 1991b). Therefore,
CD4 expression appears to be regulated at the post-transcriptional level, at least during
the early transition from DP to SP thymocytes. However, recent studies, using both
transfection assays and analyses of transgenic mice, indicate that the major mechanism of
CD4 expression in both immature thymocytes and mature T cells is regulated at the
transcriptional level (Sawada and Littman, 1991; Sawada et al., 1994; Siu et al., 1994).
These experiments identified multiple elements that are involved in both positive and
negative regulation of CD4 gene transcription. These results do not appear to conflict
with previous reports that post-transcriptional mechanisms play a role in the control of
CD4 expression (Takahama and Singer, 1992), since the earlier reports concerned cells
early in development. The following sections will describe what we know about the
regulation of CD4 gene expression.
1. CD4 Promoter
The DNA sequence and transcriptional start sites of the human (Salmon et al., 1993)
and murine (Siu et al., 1992) CD4 promoters have been determined. The minimal murine
CD4 promoter has been mapped within a 101 bp fragment immediately 5' from the
transcription initiation site by using transient transfection assays (Siu et al., 1992).
Sequence analysis revealed the presence of two Myb binding sites within the minimal
promoter, and both of them are required for full activity of the TATA box-less CD4
promoter (Nakayama et al., 1993; Siu et al., 1992). Using biochemical and mutagenesis
analyses, three additional cz's-acting elements required for full promoter function have
been identified, which are an initiator-like sequence (Inr) at the cap site, a Mycassociated zinc finger protein (MAZ) binding site, and an Ets protein consensus binding
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sequence (Duncan et al., 1995). The human CD4 promoter is similar to the murine CD4
promoter (Salmon et ah, 1993). The core promoter (positions -40 to +16) lacks a TATA
box or Inr at the cap site. Within this fragment, two Myb consensus sequences and one
Ets consensus sequence are completely conserved in the murine CD4 gene. Furthermore,
the human CD4 promoter is activated by Ets proteins (Salmon et al., 1993). In addition,
the human CD4 promoter has been shown to be sufficient to up-regulate CD4 expression
in mature murine T cells and macrophages in the absence of the T cell-specific enhancer
located 5' of the gene (Hanna et al., 1994; Salmon et al., 1993).
The murine CD4 promoter appears to be T cell-specific but the human CD4 promoter
does not appear to contain this specificity (Maddon et al., 1987). The CD4 promoter is
relatively T cell subclass-specific, as it has preferential activity in CD4+ T cell lines
compared with CD4'CD8+ cell lines (Salmon et al., 1993; Siu et al., 1992). However, the
findings of subclass-specificity in these studies is hard to reconcile with the observation
that a combiniation of CD4 enhancer and promoter directs reporter gene expression in
both CD4 SP and CDS SP cell lines (Sawada and Littman, 1991). Furthermore, recent
studies in transgenic mice indicate that, in the presence of the CD4 enhancer, the CD4
promoter is not sufficient for subclass-specific expression (Sawada et al., 1994; Siu et al.,
1994). One possible explanation for this discrepancy is that the CD4 promoter is
preferentially active in the CD4 subset, but its specificity is overridden by the presence of
the CD4 enhancer (Killeen and Littman, 1996). Alternatively, it is possible that the
discrepancy is caused by performing in vitro transactivation assays in cell lines that might
not properly reflect the transcriptional regulation and specificity observed in T cells in
vivo. Furthermore, the promoter activity is possibly regulated by the concentration of the
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somewhat ubiquitous T cell trans-^cimg factors that exist in higher concentration in
CD4+ T cells than in CD4" T cells. The concentration of such factors might cause the
subclass-specific expression of CD4 promoter. Indeed, the Ets protein is 10-20 times
higher in concentration in CD4+ T cells than in CD4" T cells (Salmon et al., 1993).
Recently, an intronic promoter was identified within the first intron of the human
CD4 gene (Rushton et al., 1997). The basal promoter has been localized to a 32 bp
fragment at 3' end of first intron of the human CD4 gene. This internal promoter
functions in T cell lines and is preferentially active in immature DP T cells, compared to
the activity detected using the 5' promoter (Rushton et al., 1997). This basal promoter
lacks potential binding domains for Myb and Ets, both of which have been shown to be
involved in the function of the 5' murine and human CD4 promoter. Sequence analysis
of the internal promoter indicates the potential transcription factor-binding sites for AP2,
LBP1, c-raas-DSl and CK-8-mer (Rushton et al., 1997). Transcriptional regulation by
multiple promoters has been reported for other genes (Campos et al., 1992; CourchesneSmith et al., 1992; Hu et al., 1997; Yamasaki et al., 1991). Basically, the use of multiple
promoters is associated with developmental and tissue-specific expression patterns. The
exact function of this internal promoter in the developmental regulation of CD4
expression needs to be further determined.
2. CD4 Enhancer
An enhancer is a DNA sequence that stimulates transcription from a promoter in an
orientation and position-independent fashion (Ernst and Smale, 1995). Enhancers have
been identified for the murine (Sawada and Littman, 1991; Wurster et al., 1994) and
human (Blum et al., 1993) CD4 genes. A proximal enhancer, which is located
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approximately 13 kb upstream of the cap site of the murine CD4 gene, is T cell-specific
but is not T cell subclass-specific (Sawada and Littman, 1991). By using transfection
assays, the enhancer was narrowed down to a 339 bp minimal fragment (Sawada and
Littman, 1991), and it is required for detectable expression of CD4 transgenes in mice
(Gillespie et al., 1993; Hanna et al., 1994; Killeen et al., 1993). The minimal enhancer
consists of three nuclear protein binding sites: CD4-1, CD4-2, and CD4-3 (Sawada and
Littman, 1993). The CD4-2 site represented a consensus binding sequence for the HMG
(high mobility group) family members TCRla/LEFl (Clevers and van de Wetering,
1997). However, binding of TCFlcc/LEFl was largely dispensible for activity in
transient transfection assays (Sawada and Littman, 1993). Both of CD4-1 and CD4-3
sites contained E-box motifs, which are recognized by bHLH (basic helix-loop-helix)
factors (Murre et al., 1989). The CD4-3 site contained two E-boxes and interacted with
bHLH factors HEB and E12-related protein (Sawada and Littman, 1993). The T cell
subclass-specificity of the proximal enhancer might be due to the preferential expression
of HEB in T cells (Hu et al., 1992) even though E12-related protein is ubiquitously
expressed (Murre et al., 1989).
A distal murine enhancer, located about 25 kb 5' of the CD4 promoter, has also been
identified (Wurster et al., 1994). An Ets family member, Elf-1, which is expressed at a
high level, was involved in regulation of this enhancer (Wurster et al., 1994). This
enhancer is not T cell-specific, since in transgenic mice a combination of the proximal
CD4 enhancer and this distal enhancer with other DNase I hypersensitivity (DH) sites 3'
to the CD4 gene resulted in expression of a reporter gene not only in T cells, but also in B
cells and macrophages (Siu et al., 1994). Furthermore, while the distant enhancer is
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capable of stimulating CD4 expression in transient transfection assays, whether the distal
enhancer can specifically up-regulate transcription in mature T cells in the absence of the
proximal CD4 enhancer has not been shown in a transgenic mouse system. It is more
likely that the distal eenhancer is relevant for the regulation of LAG-3, which lies
immediately 5' of the distal enhancer and encodes a CD4-related molecule (Bruniquel et
ah, 1998; Triebel et al., 1990).
The proximal human enhancer, which is located 6.5 kb upstream of the human CD4
gene, functions in a T cell-specific manner in vivo (Blum et al., 1993). Sequence
comparison between the human and murine proximal enhancers reveals that the CD4-3
site is the only conserved element of the three murine protein/DNA binding sites. The
human enhancer is homologous to regions outside the murine minimal enhancer. This
suggests that the DNA surrounding the murine minimal enhancer may also be important
to enhancer function.
Transgenes, in which either the human or murine proximal enhancer was linked to a
hCD4 minigene, directed expression of hCD4 on both peripheral T lymphocytes and
thymocytes in mice (Blum et al., 1993; Gillespie et al., 1993; Hanna et al., 1994; Killeen
et al., 1993). However, in the absence of the enhancer, low level subclass-specific
expression of hCD4 could be detected in mature CD4 SP T cells, but not in DP
thymocytes. The inclusion of the murine enhancer increased CD4 levels on mature T
cells and resulted in expression in DP thymocytes (Hanna et al., 1994). The function of
the enhancer was also confirmed using a murine transgene that contained a human CD2
cDNA as a reporter gene driven by the murine CD4 promoter (Sawada and Littman,
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1991). Taken together, these results suggest that the CD4 enhancer is required for high
level expression and for tissue-specificity of the transgenes in vivo.
3. CD4 Silencer
Silencers are cfs-acting regulatory elements that appear to down-regulate transcription
by influencing chromatin structure through an extended DNA region (Ernst and Smale,
1995). The presence of DH sites (DH9 and DH10) in the first intron of the murine gene
first suggested that this region was involved in subclass-specific expression (Sands and
Nikolic, 1992). Early studies in transgenic mice have also implicated the importance of
the first intron in controlling subclass-specific CD4 expression (Blum et al., 1993;
Gillespie et al., 1993; Hanna et al., 1994; Killeen et al., 1993). A large human CD4
transgenic construct containing the 5' murine enhancer and 3 kb of 5' and 8 kb of 3'
flanking sequence was expressed in CD4, and not CDS, SP cells of transgenic mice
(Killeen et al., 1993). Other constructs containing 5' human enhancer and first intron
were similarly expressed (Blum et al., 1993; Gillespie et al., 1993).
The murine CD4 intronic silencer was initially narrowed down to a 434 bp fragment
located approximately 2.5 kb 3' of the transcription start site (Sawada et al., 1994; Siu et
al., 1994). This element correponds to DH9 and correlates with the absence of CD4
expression in thymocytes and CDS SP T cells (Sands and Nikolic, 1992). The intronic
silencer functions in a position- and orientation-independent way (Sawada et al., 1994;
Siu et al., 1994), and it is active in combination with a heterologous enhancer and
promoter from the CD35 gene (Sawada et al., 1994). Transcriptional silencing by the
CD4 intronic enhancer has been reproduced in transient transfection assays, but only
when multiple copies of the element are included (Sawada et al., 1994).
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A subclass-specific silencer was also identified within a 484 bp Rsal fragment in the
first intron of the human CD4 gene by using transgenic mice (Donda et al., 1996). Its
sequence is 77% identical to that of the murine silencer. Further experiments have shown
that the 5' 190 bp of this fragment is sufficient to direct silencing in transgenic mice
(Donda et al., 1996).
By using DNase I footprint, three sites were identified within the 434 bp murine
silencer (Duncan et al., 1996). Deletion of any single site had no effect on silencer
activity in transgenic mice. However, multiple deletions of these sites indicated that
either site II alone or a combination of site I and III is required for silencer activity,
suggesting that there is an asymmetric redundancy in the mechanism of CD4 silencer
function (Duncan et al., 1996). In the human silencer, two protein-binding sites were
detected in the 190 bp fragment (Donda et al., 1996). Tested in transient transfection
assays, these two sites showed significant silencing activity restricted to the CDS SP T
cells. One of these corresponded precisely to site I in the murine silencer, whereas the
other did not correspond to any footprints in the murine silencer (Duncan et al., 1996).
Comparison of the results of the two studies suggests that there are different requirements
for human versus murine silencer function in transgenic mice (Donda et al., 1996;
Duncan et al., 1996).
The mechanism through which silencing is achieved is not yet understood. It may
involve locus inactivation through changes in the structure of adjacent chromatin,
possibly by influencing DNA methylation or the activity of histone deacetylases; or it
may be due to direct interaction of a silencing factor with the components involved in
initiating transcription of the CD4 gene (Killeen and Littman, 1996). Recently, a
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transcription factor in the linl 2/Notch signaling pathway, the Hairy/Enhancer of Split
homologue HES-1, has been reported to bind to an important functional site in the CD4
silencer (Kim and Siu, 1998). Overexpression of HES-1 leads to the silencer sitedependent repression of CD4 promoter and enhancer function as well as the downregulation of endogenous CD4 expression in CD4+CD8‘ T cells. These data are
consistent with the hypothesis that the linl 2/Notch signaling pathway is important in
thymic development and may indicate that Notch signaling induces transcriptional downregulation of CD4 in the CDS lineage via the HES-1 protein (Robey et al., 1996).
4. Other Transcriptional Control Elements
Although the combinations of the minimal enhancer, promoter, and silencer can
direct developmental expression of CD4 in transgenic mice in a manner that is
indistinguishable from that observed for endogenous CD4, several reports have suggested
that additional elements are involved (Adlam et al., 1997; Boyer et al., 1997; McCready
et al., 1997; Salmon et al., 1996; Uematsu et al., 1997). An intronless CD4 minigene, in
which the human CD4 cDNA is under the control of the human CD4 promoter and the
murine CD4 minimal proximal enhancer, directed expression of hCD4 in mature
peripheral T cells and some NK cells, but not in,immature DP thymocytes (Salmon et al.,
1996). These results suggest that additional control elements are necessary for CD4
expression in immature thymocytes and that CD4 expression is differentially regulated in
DP and SP thymocytes. Adlam et al. (1997) further indicate that the additional enhancer
element located in the 3' flanking region of the CD4 gene is required for CD4 expression
in immature DP thymocytes (Adlam et al., 1997). Interestingly, in another study,
deletion of most of the sequence of the first intron resulted in reduction of transgene
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expression in DP cells, suggesting that an additional enhancer is located in the first intron
of the CD4 gene (Uematsu et ah, 1997). The results of these studies need to be
interpreted in the context of the observation that a murine minigene, consisting of the
murine proximal enhancer, the promoter and part of first intron, directed expression of a
hCD2 reporter equally well in DP and SP thymocytes and in mature T cells (Sawada et
ah, 1994). A possible explanation for these apparently conflicting results is that
expression in DP cells is repressed by an element upstream of the 0.5 kb minimal
promoter used in constructs by Sawada et ah (1994). This negative control element is
antagonized by a positive element, which is present in the first intron of the CD4 gene but
could be replaced by regulatory sequences in the gene-rich region 3' of the CD4 gene
(Adlam et ah, 1997; Ansari-Lari et ah, 1996). This negative element is also suggested in
the work of Uematsu et ah (1997), in which they propose that an early silencer is active at
DN CDS’ thymocytes. Using transient transfection assay, McCready et ah (1997) also
suggested the existence of intronic enhancers and a silencer associated with the 5'
minimal promoter. All these experiments suggest that thymocytes control the CD4 gene
expression differently from mature T cells.
There is another silencer element located in the first intron of murine CD4 gene. Siu
et ah (1994) identified the silencer within a 6.0 kb region of the first intron. This
fragment encompasses the 428 bp fragment identified by Sawada et ah (1994), and
includes DH9 and DH10 (Sands and Nikolic, 1992). The 428 bp minimal silencer downregulates CD4 expression in DN and CD4 SP T cells, but does not appear to regulate
CD4 in non-T cells. In contrast, the 6.0 kb fragment down-regulated CD4 expression in
DN and CD4 SP T cells as well as non-T cells. These experiments suggest that a larger
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region of the first intron, involving DH9 and DH10, is necessary for proper expression.
Using transient transfection assay, McCready et al. (1997) located another intronic
silencer to a 1.6 kb XballXbai fragment.
Another element represses CD4 expression in mouse macrophages. In addition to its
expression in T cells, the CD4 glycoprotein is expressed in macrophages in humans
(Kazazi et al., 1989), but not in mice (Crocker et al., 1987). The species difference in
macrophage expression is dictated by differences within c/s-acting elements of CD4
genes in these species. Hanna et al. (1994) suggested that the endogenous mouse CD4
gene failed to be expressed in mouse macrophages because it lacks the required
macrophage-specific regulatory elements or contains a suppressor sequence which
inhibits transcription in macrophages. They suggest that these control sequences are
located within a 2.5 kb region 5' of the first exon.
In summary, the regulation of the CD4 gene is a complex, tightly controlled process.
There appears to be numerous elements in addition to the 5' enhancer and the intronic
silencer which control CD4 expression. These are located within the first intron, 3' of the
CD4 gene, and around the promoter. A more refined analysis leading to the identification
of the c/s-acting regulatory elements in the expression of the CD4 gene is necessary in
forming an overall picture of thymocyte development.
5. Insights Into CD4 Gene Regulation
Sands and Nikolic-Zugic (1992) analyzed 75 kb of chromatin associated with the
murine CD4 locus in different cell lines using DNase I hypersensitive (DH) site analysis
(Figure 5). Twenty-three DH sites were found in 75 kb of chromatin. Seven of these DH
sites are T cell-specific, which are located approximately 3 kb 5' of the first exon, 2.5 kb
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3' of the first exon, 4 kb 3' of the first exon, near the second and third exons, and 3' of the
gene. Two cell type-specific nuclear matrix attachment regions (MARs) are located 5' of
the first exon. Normally, DH sites include segments of protein-free DNA and represent
transcription active regions (Elgin, 1988). So far, each T cell-specific DH site has been
identified as being involved in the transcriptional regulation of the CD4 gene. DH site 8
was identified to be a T cell-specific promoter (Siu et al., 1992). DH sites 4 and 5
represent a T cell-specific enhancer (Sawada and Littman, 1991). The work of Gillespie
et al. (Gillespie et al., 1993) and Blum et al. (Blum et al., 1993) suggest that DH sites 711 are involved in controlling CD4 gene expression. DH 9 was further characterized to
be a T cell subclass-specific silencer (Sawada et al., 1994). The DH site 3' of the CD4
gene was identified as being important for CD4 expression during the immature
thymocyte stage (Adlam et al., 1997). However, all these control elements still cannot
fully explain the developmental regulation of CD4 gene expression. There appear to be
more control mechanisms involved in the tissue-specific expression of the CD4 gene.
Metaphase chromosome condensation is a dynamic process that must utilize cis
elements to form and maintain the final structure. Likewise, cis elements must regulate
the accessibility of chromatin domains to protein machines involved in processes such as
transcription. MARs are the only candidate cis elements identified to date that are
implicated in facilitating dynamic changes in chromatin states and in the structural
organization of chromosomes (Hart and Laemmli, 1998). MARs are very AT-rich
fragments several hundred base pairs in length and often associate with topoisomerases
which are involved in relieving the torsional stress created by DNA replication or
transcription (Cockerill and Garrard, 1986). MARs have been observed near enhancer
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and promoter regions of genes (Banan et al., 1997), and the participation of MARs in
regulating transcription of the immunoglobulin k light chain (Cockerill and Garrard,
1986), p heavy chain (Forrester et ah, 1994), and the mouse CD8a genes (Banan et al.,
1997) has been described. Cell type-specific MAR-binding protein (SATB1) could
modulate the association of specific MAR sequences and their adjacent genes with the
nuclear matrix and thereby repress or activate those genes (Dickinson et al., 1992;
Nakagomi et al., 1994). DH site analysis of the murine CD4 gene showed the presence
of two MARs located 5' of the murine CD4 gene (Sands and Nikolic, 1992). Wilkinson
et al. (1991) indicated that SATB1 protein increases in concentration at the transition
from the double negative of thymocyte development to the double positive stage of
thymocyte development (Wilkinson et al., 1991a). The above data suggests that the
interaction of this stage-specific SATB1 protein at the MARs located 5' of the CD4 gene
may be an important regulator involved in the transition from the double negative stage to
the double positive stage of thymocyte development. The function of this stage-specific
MAR/protein interaction could be to alter the chromatin at the CD4 locus and to favor
transcription of the CD4 gene, possibly by enhancing or altering its association with the
nuclear matrix (Forrester et al., 1994).
Chromatin structure is generally repressive to interaction of sequence-specific
binding proteins with DNA, and thus, nucleosomes must be remodeled in promoter
regions during gene activation. Covalent modifications of core histones have been
correlated with changes in chromatin that occur during transcription and replication
(Berger, 1999). Nucleosomal condensation induced by histone deacetylase (HDAC)
results in limited access of transcriptional activators to DNA. In addition, HDACs form
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part of corepressor complexes which directly counteract transcription of multiple cellular
genes (Dangond and Gullans, 1998). Recently, two microbial metabolites, trichostatin A
and trapoxin, were found to be potent inhibitors of HDACs (Yoshida et al., 1990). They
induce hyperacetylation of core histones at very low concentrations, which is
accompanied by characteristic blockage of the cell cycle as well as by various cellular
phenotypic changes (Yoshida et al., 1995). These agents are useful in analyzing the role
of histone acetylation in chromatin structure and function as well as in determining the
genes whose activities are regulated by histone acetylation. As we discussed above, the
mechanism through which silencing is achieved is not yet understood. It may involve
locus inactivation through changes in the structure of adjacent chromatin, possibly by
influencing DNA methylation or the activity of histone deacetylases (Killeen and
Littman, 1996). Therefore, to investigate the role of histone acetylation by trichostatin A
on CD4 gene expression will be helpful to understand the regulation of CD4 gene
expression.
The methylation status of the gene can also be used as a relative indicator of the
activation state of the gene (Cedar, 1988). DNA methylation could control gene activity
either at a local level through effects at a single promoter and enhancer, or through global
mechanisms that influence many genes within an entire chromosome or genome (Kass et
al., 1997). Demethylation of several lymphoid-related genes, including the
immunoglobulin k gene (Kelley et al., 1988), the interferon-y gene (Young et al., 1994),
the T cell receptor p gene (Sakamoto et al., 1988), the murine CDS gene (Carbone et al.,
1988), and the human CD4 gene (Richardson et al., 1986), has been shown to be
correlated with gene activation and expression. Data suggest that the expression of CD4
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is repressed by methylation of the CD4 gene, or that a positive regulator of CD4 is
repressed by methylation of its gene (Richardson et al., 1986). A methylation site is
further reported to be in the first intron of the CD4 gene, which appears to be CD4specific and becomes progressively demethylated upon differentiation of T lymphocytes
to CD4 single-positive mature peripheral T lymphocytes (Tutt et al., 1997). This
methylation site is located approximately 250 bp 3' of the CD4 promoter and
approximately 1.7 kb 5' of the CD4 silencer. Its relative proximity to both the CD4
promoter and silencer elements makes it possible to hypothesize a mechanism of action
involving either one of these elements. For example, demethylation at this site could
result in altered chromatin structure providing transcription factors easier access to the
promoter region. Conversely, this altered chromatin structure could permit the binding of
other regulatory factors capable of interfering with silencer function (Tutt et al., 1997).
Another regulatory mechanism that needs to be addressed is the location of the locus
control region (LCR) for the CD4 gene. LCRs are gene regulatory elements that are ex
acting to ensure that active transcriptional units are established in all cells of a given cell
lineage (Fraser and Grosveld, 1998; Kioussis and Festenstein, 1997). LCRs can direct
tissue-specific expression at a high level irrespective of the chromosomal site of
transgene integration and this may be achieved by establishing an open chromatin domain
(Grosveld et al., 1987). The work of Boyer et al (1997) indicated that the proportion of
transgene-expressing CD4+ T cells was constant within a given transgenic line, but varied
greatly from one line to another due to integration of the transgene within or in the
vicinity of centromeric heterochromatin (Boyer et al., 1997). This position-effect
variation suggested that the CD4 gene might contain an unidentified LCR.
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F. OBJECTIVES OF PRESENT STUDIES
In this laboratory, we have attempted to understand the transcriptional regulation of
murine CD4 gene expression. The previous work by Dr. Sands (1992) involved an
extensive analysis of the CD4 locus that identified possible transcriptional control
elements. A summary of those results is presented in Figure 5. DH sites 7 through 11,
17, and 18 are T cell-specific. Each T cell-specific site has associated with it a T cellspecific protein/DNA interaction. The previous work by McCready et al. (1997) further
indicated that there are multiple negative and positive c/s-acting elements controlling the
expression of the murine CD4 gene. These include a negative element associated with
the 5' enhancer, a negative element associated with the 5' promoter, an additional
negative element located within the first intron, and positive elements located within the
flanking sequences of the first intron. Furthermore the 5' MARs appear to be involved in
the up-regulation of the CD4 gene when the thymocyte transitions from the DN stage to
the DP stage of thymocyte development. In addition, there appear to be more control
mechanisms involved in the regulation of CD4 gene expression.
Therefore, the long-term objective of this study is to define the transcriptional control
elements responsible for the regulation of CD4 gene expression during T cell
development. The following specific aims are designed to achieve this objective:
1. The first aim is to identify and characterize the positive cA-acting elements
(enhancers) within the first intron of the murine CD4 gene.
2. The second aim is to identify the possible internal promoter within the first intron
of the murine CD4 gene.
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3. The third aim is to identify the negative c/s-acting elements associated with the 5'
CD4 promoter.
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CHAPTER TWO
II.

MATERIALS AND METHODS

A. MATERIALS
1. Reagents
Dulbecco’s RPMI-1640, L-glutamine, Penicillin-streptomycin solution (100X
containing 10,000 units of penicillin and 10 mg of streptomycin per ml of 0.9 % NaCl
solution) (PenStrep), and newborn bovine serum (NBS) were purchased from Gibco-BRL
(Grand Island, NY) and Promega Corp. (Madison, WI).
Bovine serum albumin (BSA), 0.4% trypan blue solution, and Percoll were purchased
from Sigma Chemical Company (St. Louis, MO).
Acrylamide, bis-acrylamide, ammonium persulfate, TEMED, Coomassie Brilliant
Blue and Bradford Protein Determination Reagent were purchased from Bio-Rad
Laboratories (Richmond, CA). Molecular biology grade agarose was from Promega
Corp. (Madison, WI). Electrophoresis grade ethidium bromide for staining gels was from
Fisher Scientific (Fair Lawn, NJ). A VectaStain ABC (avidimbiotinylated enzyme
complex) Kit was purchased from Vector Laboratories (Burlingame, CA).
PSL1180 was from Pharmacia LKB Biotechnology Inc. (Piscataway, NJ), Bluescript
II pKS+was from Stratagene (La Jolla, CA), and pUC 19, pCAT basic, pCAT promoter,
and pCAT control were from Promega Corp. (Madison, WI).
Radiolabeled -[32P]-dCTP (3000 Ci/mmol), cytoscint scintillation fluid, 14Cchloramphenicol, and y-[ P]-ATP (7000 Ci/mmol) were purchased from ICN
Biomedicals Inc. (Irvine, CA). Trichloroacetic acid (TCA) was purchased from USB
(Cleveland, OH).
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All restriction enzymes, T4 nucleotide kinase, T4 polymerase and T4 ligase were
purchased from New England BioLabs (Beverly, MA) and Promega Corp. (Madison,
WI). Deoxyribonuclease I was purchased from Sigma Chemical Company (St. Louis,
MO). Bacto-tryptone, Bacto-yeast extract and Bacto-agar were purchased from Difco,
Inc. (Livonia, MI). Ampicillin was from Boeringher Mannheim (Indianapolis, IN).
Qiagen Plasmid Maxi Kit was obtained from Qiagen Inc. (Chatsworth, CA).
Monoclonal anti-mouse CD4, CD2a FITC conjugate and anti-mouse CD8a, CD2a Rphycoerythrin conjugate were purchased from Sigma Chemical Company (St. Louis,
MO).
Culture flasks, polypropylene tubes, polystyrene pipettes, nylon disposable filter
systems, and cryogenic vials were obtained from Coming Glass Works (Coming, NY).
Pipetman tips were from VWR Scientific (West Chester, PA) and microcentrifuge tubes
were from USA Scientific Plastics (Ocala, FL). Disposable syringes and needles were
from Becton Dickinson Company (Franklin Lakes, NJ).
All other reagents were obtained from Sigma Chemical Company (St. Louis, MO),
VWR (Brisbane, CA) and Fisher Scientific (Tustin, CA).
2. Cell Lines
Thymoma cell lines SAKRTLS12.1 (CD4+CD8 ), TB2.1 (CD4'CD8+), and
AKR1.G.1 (CD4+ CD8+) were originally obtained from Dr. R. Hyman (Salk Institute, La
Jolla, CA).
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B. METHODS
1. Cells and Cell Lines
a. Cell growth and maintenance
The thymoma cell lines SAKRTLS12.1 (CD4+CD8 ), TB2.1 (CD4 CD8+), and
AKR1.G.1 (CD4+ CD8 ) were grown in complete RPMI media (RPMI supplemented
with 10% newborn calf serum, 2 mM L-glutamine, 100 U of penicillin per ml, and 100
pg of streptomycin per ml). The cells were cultured at 37 °C in a water-saturated
atmosphere of 5% CO2.
b. Preparation of culture media
Supplements were added to the RPMI media prior to use. Complete RPMI media
were prepared in 500 milliliters bottles and stored at 4 °C. Serum was purchased in 500
ml bottles which were heat inactivated at 50 °C for 1 hour. This serum was then either
used directly or frozen at -20 °C in 50 ml aliquots. Other media components were
purchased in 100 ml bottles which were thawed in a water-bath at 37 °C and frozen at -20
°C in 10 ml aliquots.
c. Freezing and thawing cells
Freezing media (for cells grown in newborn calf serum, 10% newborn calf serum,
10% DMSO, 80% RPMI) was made in advance and stored at -20 °C until use. Cells
were counted using a hemocytometer, then transferred to a sterile 50 ml tube and
centrifuged at 3,000 rpm for 5 minutes at 24 °C in a Beckman table-top centrifuge. The
cell pellet was resuspended in freezing media to a cell concentration of 5 x 106
cells/milliliter. One milliliter quantities were transferred to plastic cryogenic vials and
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frozen at -70 °C. Half of the vials were later transferred to liquid nitrogen for long term
storage at -196 °C.
To thaw the cells, a tube was removed from -70 °C and thawed rapidly at 37 °C. The
freezing mixture was diluted out slowly by adding warm complete media dropwise over 1
to 2 minutes for a total volume of 15 ml, thereby preventing osmotic damage to the cells.
The cell suspension was then transferred to a sterile 15 ml tube and centrifuged at 3,000
rpm for 5 minutes at room temperature in a Beckman table-top centrifuge. The cell pellet
was resuspended in 10 ml of complete media and transferred to a small flask for growth
overnight. The following day, cell viability was determined using a hemocytometer, and
the cells diluted for 3 days of growth.
d. Determining cell count and viability
Total cell count and determination of viability was done using a Neubauer
hemocytometer (Fisher Scientific Co.) and a PhotoZoom Inverted Microscope
(Cambridge Instruments). For total cell count, 10 pi of the cells from a culture flask were
loaded onto the hemocytometer. The cells were counted for each of 5 grids and the total
number of cells/ml (N) calculated as: N = (Total number of cells in 5 grids/5) x 104.
Viability counts were done in a similar manner using the dye exclusion test. Ten pi of
cells was added to an equal volume of trypan blue (0.4% in dH20, filtered through
0.45pm filter), mixed, and left for 1 to 2 minutes. The cells were introduced into the
hemocytometer and the total numbers of cells unstained and stained were counted. The
total number of cells/ml (T) was calculated as: T = (Total number of cells in 5 grids/5) x
2 x 104. Percent viability (V) was calculated as: V = (Number of cells unstained/Total
number of cells) x 100.
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2. Construction of Expression Vectors
a. Construction of the intronic enhancer series
The 900 bp Pstl/Xhol CD4 promoter fragment was ligated into the PstHSaH sites of
the pCAT basic vector (Promega Corp., Madison, WI) resulting in p900. The T cellspecific enhancer, isolated as a 339 bp BstXHAvail fragment, was blunted with T4 DNA
polymerase and ligated into the blunted Sphl site of p900 resulting in pEPCl (McCready
et al., 1997).
The recombinant DNA constructs to test the intronic elements were constructed using
the p900 and pEPCl vectors. The preliminary data in our lab showed the presence of
positive control elements within the first intron of the murine CD4 gene. The pAC4d
construct deletes 8.15 kb of the first intron, leaving only the 611 bp XhoPPstl fragment of
the most 5' end of the first intron including the splice donor and the 174 bp PstHSaB
fragment of the most 3' end of the first intron with the splice acceptor. PAC4d expresses
16 fold better in the CAT assay than the pAC4e construct, indicating that the small
amount of intronic sequence left confers a positive activity when compared to the absnce
of intronic sequences (McCready et al., 1997). Transient transfection with deletion
constructs located the positive activity to a 359 bp XhollPvull fragment (Figure 6).
Further analysis using a deletion gel-shift assay indicated that the principal protein-DNA
interaction sites of the 611 bp Xhol/Pstl fragment were located in the 124 bp Alul/Alul
fragment (Figure 7). Therefore, the 124 bp Alul/Alul fragment (named El) and the 174
bp Pstl/Sall fragment (named E2) were subcloned into the Smal site and Psil/SaR sites of
pUC19, respectively. These two intronic elements were purified through EcoRPHindlll
double digestion of the pUC19 vectors. The resulting EcoPA!Hindlll fragments
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Figure 6. Effect of the 5' intronic fragment on the 900 bp promoter. Equi-molar
amounts of each construct were transiently transfected into SAKRTLS12.1. One copy of
the 360 bp Xhol-Pvull fragment (BP) and the 251 bp Pvul\-Pst\ fragment (HP) were
added to the Pst\ site of p900 in forward orientation (p900PBP and p900PHP separately).
For each construct, three to nine experiments with at least two preparations of DNA were
performed. Each result represents the mean; the error bars show the standard error of the
mean (^S.E.M.) for 3-9 separate determinations (n = 3-9).
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I

p900PHP

Figure 7. Gel shift mapping using enhancer deletions to locate the protein-DNA
interaction within the 360 bp Xho\-Pvu\\ fragment (BP). The purified BP fragment was
end-labeled using T4 nucleotide kinase and [y-32?] ATP. The labeled probe was further
cut by Spe\ or Sad, resulting separately in 5' end-labeled and 3' end-labeled probe. The
3' probe was further digested separately by HaelW, Hpall or Saul PA, and the 5' probe was
further digested separately by Ddel, Alul or Hpall. GMSAs were performed using the
above digestion products as probes. The protein-DNA interactions were mapped to the
region within the Xhol-Pvull fragment.
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PvuU(359)

containing either El or E2 were blunted by T4 polymerase and placed into the blunted
Hindlll or BamHl sites of p900 and the blunted Hindlll or Ascl sites of pEPCl. This
produced constructs with 1 copy of the insert either in front of 900 bp Pstl/Xhol CD4
promoter or behind the CAT gene. Eight different vector constructs were named as
follows: p900HEl, p900BEl, pEPCIHEl, pEPCIAEl, p900HE2, p900BE2,
pEPClHE2, and pEPCl AE2.
b. Construction of the intronic promoter deletion series
To test the promoter activity of the first intron, reporter constructs containing
different regions of the first intron were made. The pBCl construct contains the first
exon, the full first intron, the first intron splice donor and acceptor and a large portion of
the 5' UT but does not contain the translational start codon of the CD4 gene. The pCAT
basic vector was digested with BamHl, filled in with T4 DNA polymerase, and an Ascl
linker ligated to the filled-in site. The CAT gene was removed from this altered pCAT
basic vector as a Sail/Ascl restriction fragment and subcloned into the SaWAscl sites of
pBCl to make pBCl.O (McCready et al., 1997), which was further double-digested
seperately by Xhol/Xbal, Xhol!Hindlll, and XhollBamlAl. The digestion reactions were
filled in with T4 DNA polymerase and religated to themselves to delete Xhol/Xbal,
Xhol/Hindlll fragments and the whole region of first intron separately. The constructs
containing 4660 bp and 1710 bp 3' of the first intron were selected and named pBC Xbal
and pBC Hindlll, respectively. The construct containing no first intronic element was
named pBCA.
To locate the basal promoter in the first intron of the murine CD4 gene, deletion
series were constructed from pBC Hindlll using the Delete-A-Base system (Promega,
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Madison, WI). Basically, 10 jag of pBC HindiW was digested with Kpn\ and HindiW to
generate a linear plasmid with 3' and 5' overhang, respectively. The linear plasmid was
then deleted incrementally from the 5' overhang with Exonuclease III digestion, which
proceeds at about 80 bases/minute at room temperature. Samples were removed into the
tubes containing the nuclease SI at 30 second intervals. Various constructs with
incrementally deleted internal promoter were blunted with nuclease SI, ligated and then
transformed into DH5cc competent cells. A number of subclones from each time point
were screened to select appropriate intervals between deletions. Colonies with plasmids
containing the desired, differentially deleted promoter fragment were confirmed by
restriction enzyme analysis following minipreps. The sequence of intronic elements in
these plasmids was confirmed by automatic DNA sequencing using the PRISM Ready
Reaction DyeDeoxy Terminator Cycle Sequencing Kit (Applied Biosystems, Inc.). A
number of promoter deletion series were generated.
c. Construction of a 5' silencer reporter series
Preliminary data in our laboratory showed that three DH sites associated with the 5'
minimal CD4 promoter might contain negative transcriptional control elements. These
three DH sites were subcloned into pUC19 on three fragments: a 250 bp HindllVPstl
fragment, a 250 bp HaeWUHaelll fragment, and a 274 bp Hincll/Xhol fragment, which
were named as 7B6, 8B2, and B7, respectively.
The recombinant DNA constructs to test the 5' silencer elements were constructed
using the p900 and pEPCl vectors. These fragments were purified through EcoRI/
Hindlll double digestion, blunted by T4 polymerase, and ligated into blunted Hindlll or
BamUl sites of p900 and the blunted Hindlll or Ascl sites of pEPCl. This produced
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constructs with 1 or 2 copies of the sense or antisense insert either in front of the 900 bp
PsiUXhol CD4 promoter or behind the CAT gene. Numerous vector constructs were
generated and named according to the orientation, position, and number of copies of the
inserts.
3. Preparation and Transformation of Competent E.coli Cells
a. Preparation of frozen competent E. coli cells
i.

Preparation using calcium chloride

Competent E. coli cells were prepared using calcium chloride as described (Cohen et
al., 1972). Bacterial cells (DH5a, XL1 Blue) (Maniatis et al., 1989) were used to
inoculate 100 ml of LB (1% tryptone, 0.5% yeast extract, 1% NaCl, pH 7.4) and grown at
37 °C with vigorous shaking until the OD590 reached 0.2-0.4. The cells were transferred
to sterile 50 ml tubes and centrifuged at 3,000 rpm for 10 minutes at 4 °C. The bacterial
pellet was resuspended in 50 ml of cold 100 mM CaCL and incubated on ice for 30
minutes. This was followed by centrifugation at 3,000 rpm for 10 minutes at 4 °C. The
pellet was then resuspended in 5 ml of cold 100 mM CaCL and 25% glycerol. Aliquots
50 pi of the cells were frozen immediately in liquid nitrogen and stored at -70 °C or used
directly for transformation.
ii.

Preparation using "simple and efficient method" (SEM)

This method was used to prepare the competent cells with an extremely high
transformation frequency (Inoue et al., 1990). Basically, DH5a cells were inoculated
into 250 ml of SOB medium (2% Bacto tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5
mM KC1, 10 mM MgCL, 10 mM MgS04) in a two liter flask and grown until A600 = 0.6
at room temperature with vigorous shaking. The flask was placed on ice for 10 minutes.
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The cultured cells were then transferred to a 500 ml centrifugation tube and centrifuged at
2,500 g for 10 minutes at 4 °C in a Sorvall SS-34 rotor (Dupont Co.). The pellet was
resuspended in 80 ml of ice cold TB buffer (10 mM Pipes, 55 mM MnCb, 15 mM CaCl2,
250 mM KC1, adjust pH to 6.7 with KOH, sterilized by filtration through prerinsed 0.45
pm filter unit at 4 °C) and was placed in an ice bath for 10 minutes. This was followed by
centrifugation at 2,500 g for 10 minutes at 4 °C. The pellet was then resuspended gently
in 20 ml of cold TB. DMSO (filtered) was added slowly with gentle swirling to a final
concentration of 7%. The cell suspension was placed in an ice bath for 10 minutes.
Aliquots 100 pi of the cells were frozen immediately in liquid nitrogen and stored at -70
°C or used directly for transformation.
b. Transformation of competent cells using the calcium chloride method
This method was used to introduce DNA into bacterial cells through heat shock
(Maniatis et al., 1989). All vectors were initially transformed into DH5a competent cells
using this method. An aliquot of plasmid DNA (100 to 250 ng) was added to 50 pi of
DH5oc competent cells in 0.1 M CaC^ solution and placed on ice for 30 minutes. The
mixture was then placed into a 42 °C water bath for 90 seconds, followed immediately on
ice for 1-2 minutes. To each reaction mixture, 400 pi of LB medium (with no antibiotic)
was added. The culture was then placed in a 37 °C water bath for 1 hour to allow the
bacteria to recover and express (3-lactamase containing resistance to ampicillin (AmpR).
(3-lactamase is encoded by the various plasmids. Aliquots of the culture (50 to 200 pi)
were then spread onto ampicillin agar plates (100 pg Amp/ml LB). The plates were
inverted and incubated at 37 °C overnight.
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4. Identification of Bacterial Colonies That Contain Recombinant Plasmids
a. Testing bacteria for a-complementation
This method was designed to test whether the plasmid contained insertion of an
particular DNA fragment (Maniatis et al., 1989). First, 40 pi of a stock solution of X-gal
(20 mg/ml in dimethylformamide) and 4 pi of isopropylthio-p-D-galactoside (IPTG)
(200mg/ml) were added to a LB agar plate containing ampicillin. Then, the solution was
spread over the entire surface of the plate using a sterile glass spreader. The plate was
incubated at 37 °C until the liquid median disappeared. A 100 pi sample of the
transformed bacteria was spread over the surface of the agar medium. After the inoculum
was absorbed, the plate was incubated in an inverted position for 12 to 16 hours at 37 °C.
The plate was stored at 4 °C for several hours to allow the blue color to develop
completely. Bacteria carrying recombinant plasmids form white colonies. The structure
of these plasmids was then verified by restriction analysis.
b. Screening by hybridization
This method was used to screen many colonies simultaneously and performed as
described (Maniatis et al., 1989). The bacterial suspension was plated on the surfaces of
LB agar plates containing the appropriate antibiotic. The plates were incubated in an
inverted position for 12 to 14 hours at 37 °C and then chilled for 30 to 60 minutes at 4 °C.
Nitrocellulose filters were numbered and placed on the surface of the LB agar
medium with numbered side down. The filter and the underlying medium were marked
in three locations by stabbing through the filter with an 18-gauge needle attached to a
syringe containing waterproof ink. The filters were peeled off and were ready to be
lysed. The master plates were incubated for 5 to 7 hours at 37 °C and stored at 4 °C.
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Four pieces of Whatman 3MM paper were saturated seperately with one of the following
solutions: 10% SDS; denaturing solution (0.5 N NaOH, 1.5 M NaCl); neutralizing
solution (1.5 M NaCl, 0.5 M Tris-HCl, pH 7.4); 2 X SSC. Each filter was placed, colony
side up, on the SDS-saturated paper for 3 minutes. Then, the filter was exposed to the
denaturing solution for 5 minutes and saturated with neutralizing solution for another 5
minutes. Finally, the filter was transferred to the SSC-saturated paper and saturated for 5
minutes. The filters containing lysed bacteria were dried on a surface of dry 3MM paper
at room temperature for at least 30 minutes. The dried filters were sandwiched between
two sheets of dry 3MM paper and baked for 1-2 hours at 80 °C in a vacuum oven to fix
the DNA to the filters.
The baked filters were saturated with 2 X SSC for 5 minutes. The filters were then
incubated in 200 ml of prewashing solution (5 X SSC, 0.5% SDS, 1 mM EDTA, pH 8.0)
for 30 minutes at 50 °C. The bacterial debris was scraped gently from the surfaces of the
filters using Kimwipes soaked in prewashing solution. The filters were transferred to 150
ml of prehybridization solution (6 X SSC, 0.05 X BLOTTO) in a glass crystallizing dish
and incubated for 1 to 2 hours at 68 °C. 32P-labeled double-stranded DNA probe was
denatured by heating for 5 minutes to 100 °C and added to the prehybridization solution
covering the filters to the final concentration of 1 X 106 cpm/per ml of prehybridization
solution. The hybridization was incubated at 68 °C overnight. When the hybridization
was completed, the filters were washed in a large volume (300 to 500 ml) of 2 X SSC and
0.1% SDS at room temperature for 5 minutes. The washing procedure was repeated
twice more. The filters were then washed twice for 1 h in 300 to 500 ml of a solution of
1 X SSC and 0.1% SDS at 68 °C. This was followed by drying the filters at room
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temperature on paper towels and arranging the filters on a sheet of Saran Wrap. Dot
labels marked with radioactive ink were applied to several asymmetric locations on the
Saran Wrap. The filters were then exposed to Fuji AIF RX X-ray film (Fisher Scientific,
Tustin, CA) for several days at -70 °C with an intensifying screen. The film was
developed later and aligned with the filters using the marks left by the radioactive ink.
The positive colonies were identified by aligning the dots on the film with those on the
agar plate and verified by restriction analysis.
5. Extraction of Plasmid DNA
a. Minipreps of plasmid DNA
The alkali lysis method was used to isolate small amounts of plasmid DNA from
bacterial cells for the purpose of screening large amount of colonies for a desired clone
(Maniatis et al., 1989). Tubes, with 2 ml of LB containing ampicillin, were inoculated
with single colonies from agar plates of the transformed DH5a. The inoculated tubes
were shaken at 200 rpm and 37 °C for 14-16 hours. Approximately 1.5 ml of the culture
was poured into a labeled Eppendorf tube, and centrifuged at 13,000 rpm for 1 minutes at
room temperature in a Baxter Biofuge 13 microcentrifuge (Baxter Diagnostics Inc.
Specific Products Division, McGraw Park, IL). The medium was removed by aspiration,
and the bacterial pellet was resuspended in 100 pi of Solution I (25 mM Tris-HCl, pH
8.0, 10 mM EDTA, 50 mM glucose, and 100 pg/ml of RNase) by vigorous vortexing.
Next, 200 pi of Solution II (0.2 N NaOH and 1% SDS) was added to lyse the bacteria.
The solutions were mixed by rapidly inverting the Eppendorf tubes five times. The tubes
were then placed on ice. Then, 150 pi of ice-cold Solution III (3M potassium acetate and
2 M glacial acetic acid) was added and mixed by gently inverting the tubes five times.
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The tubes were placed on ice for 3-5 minutes and then centrifuged at 13,000 rpm for 5
minutes at 4 °C in a Biofuge 13 microcentrifuge. The supernatants containing the
plasmid DNA were transferred to fresh Eppendorf tubes. Two volumes of ethanol at
room temperature were added to each tube to precipitate the DNA. After 5 minutes at
room temperature, the mixture was centrifuged at 13,000 rpm for 5 minute at 4 °C in a
Biofuge 13 microcentrifuge. The pelleted plasmid DNA was then washed with 1 ml icecold 70% ethanol, recentrifuged, and air-dried. Final plasmid DNA pellets were
dissolved in 50 pi of TE buffer containing no RNase A. Two pi of DNA was then
digested with the appropriate restriction enzymes and run on a gel to check whether they
were the correct plasmids.
b. Maxipreps of plasmid DNA
To obtain large quantities of plasmid DNA, maxipreps (a procedure for purifying
large quantities of plasmids from bacterial cells) were performed using the Qiagen
MaxiPrep kit (Qiagen, Chatsworth, CA) and the Qiagen manufacturer protocol for
extraction of plasmid DNA. Basically, transformed DH5a colonies, containing right
plasmid as determined via restriction enzyme analysis of plasmid DNA, were grown in
500 ml of LB medium and allowed to grow for 14-16 hours at 37 °C. The cells were
harvested by centrifugation at 4 °C for 15 minutes at 6,000 rpm in a Sorvall GSA rotor
(Dupont Co.). The pellet was resuspended in 10 ml of buffer PI (100 pg RNase A per
ml, 50 mM Tris/HCl, 10 mM EDTA, ph 8.0). This was followed by the addition of 10 ml
of buffer P2 (200 mM NaOH, 1% SDS). The suspension was mixed gently by inversion
5 times and incubated at room temperature for 5 minutes, after which 10 ml of chilled
buffer P3 (3.0 M KOAc, pH 5.5) was added. The solution was mixed immediately but
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gently by inversion 5 times. After incubation on ice for 20 minutes, the sample was
centrifuged at 4 °C for 30 minutes at 16,000 rpm in a Sorvall SS-34 rotor (Dupont Co.).
The supernatant was passed through a Qiagen plasmid binding column (Qiagen,
Chatsworth, CA). After washing the plasmid DNA from the column, the solution was
then precipitated with 0.7 volumes of isopropanol, and centrifuged at 4 °C to 9,500 rpm
in a Sorvall SS-34 rotor for 30 minutes. The precipitated plasmid DNA was then washed
with 70% ethanol. The DNA pellets were air dried, and resuspended in 1 ml of TE
buffer. Absorbance at 260 nm and 280 nm was read to determine DNA concentration.
6. Dephosphorylation and Labeling DNA Fragments
The procedure used for labeling the 5' end of fragments for use in the electrophoretic
mobility shift assay (EMSA), primer extension analysis, Northern blot, and DNase I
footprint assay was performed as described (Maniatis et al., 1989).
a. Dephosphorylation of the primers
This reaction was set up to remove the 5' terminal phosphate from DNA fragments
prior to labeling with [y- P]ATP and T4 polynucleotide kinase. The following was
added to 1 to 20 pmol of DNA termini: 1 pi calf intestine phosphatase (1,000 U/ml), 2 pi
10 X phosphate buffer (1 X concentration: 50 mM Tris-HCl, pH 9.3, ImM MgCb, 0.1
mM ZnCb, 1 mM spermidine), and sterile dH20 for a final volume of 20 pi. The
reaction mixture was incubated at 37 °C for 2 hours and stopped by extracting twice with
equal volumes of phenol and chloroform. This was followed by extracting once with an
equal volume of chloroform and precipitating the dephosphorylated DNA with 1/10
volume NaOAc and 2 volumes of 95% ethanol overnight at -20 °C. The sample was
centrifuged for 15 minutes at 13,000 rpm, washed twice with 70% ethanol, and
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resuspended in 20 pi of df^O. Absorbance at 260 nm and 280 nm was read to determine
DNA concentration.
b. Labeling the 51 ends of the primers
The dephosphorylated DNA was labeled using [y- P] ATP and T4 polynucleotide
kinase in the following reaction: 2 pi DNA (50 ng/pl), 1 pi T4 polynucleotide kinase (10
U/pl), 3 pi 10 X kinase buffer (IX concentration: 70 mM Tris-HCl, pH 7.6, 10 mM
MgCb, 5 mM DTT), 1 pi [y-32P]ATP (160 mCi/ml), and sterile dH20 for a final volume
of 30 pi. The reaction mixture was incubated at 37 °C for 1 hour and stopped by adding
2 pi of 0.5 M EDTA. This was followed by an extraction using equal volumes of
phenol:chloroform (1:1) mixture, followed by another extraction with an equal volume of
chloroform. The sample was then precipitated using 1 pi tRNA (20 mg/ml), 1 ml 5 M
NaCl, and 125 ml cold 95% ethanol at -20 °C overnight.
c. Labeling primers
The primers used in the primer extension analysis were labeled using [y-32P]ATP and
T4 polynucleotide kinase in the following reaction: 2 pi primer (5 pmol/pl), 1 pi T4
polynucleotide kinase (10 U/pl), 1 pi 10 X kinase buffer (IX concentration: 70 mM
Tris-HCl, pH 7.6, 10 mM MgCl2, 5 mM DTT), 1.3 pi [y-32P]ATP (7,000 Ci/mmol), and
sterile dH20 for a final volume of 10 pi. The reaction was incubated at 37 °C for 10
minutes and then heated to 90 °C for 2 minutes to inactivate the T4 polynucleotide
kinase. The final concentration of the primer was regulated to 100 ffnol/pl by adding 90
pi of Nuclease-free water. The labeled primers were stored at -20 °C. The formula to
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calculate the concentration of primers was as followings: ng of primer = pmol of primer x
0.33 x N, where N = length of primer in bases.
d. End labeling
The 122bp El and 174 bp E2 fragment were generated by EcoRl/HindVll double
digestion of the pUC19 vector containing it and purified from acrylamide gel by the
"crush and soak" method. This purified fragment was dephosphorylated by calf intestine
phosphatase and labeled at both ends using [y-32P] ATP and T4 polynucleotide kinase as
described above. Since the El and E2 fragments were subcloned into polylinker sites of
pUC19 vector, a 5' singly end-labeled probe was then generated by digesting the label off
the 3' end with Sphl. Alternatively, a 3' singly end-labeled probe was generated by
digesting the label off the 5' end with Sad. These two probes representing the top and
bottom strands of either El or E2 were then used in the DNase I footprint analysis.
e. Labeling DNA probes using random primers
This method was used to prepare the probes used in the screening by hybridization
and the procedures were described by Maniatis et al. (1989). Basically, 10 pi of gelpurified fragment (50 ng) was denatured by heating for 5 minutes in a boiling water bath
and then cooled immediately on ice. The probes were labeled using [cc-32P] dCTP and
Klenow fragment in the following reaction: 10 pi probe, 10 pi 10 X Klenow buffer, 10
pi random primers, 10 pi [a-32P] dCTP (3000 Ci/mmol), 3 pi Klenow fragment, 3 pi
dATP, 3 pi dGTP, 3 pi dTTP, and sterile water to a final volume of 100 pi. The reaction
was mixed well and incubated at room temperature for 2 hours. Afterwards, a G-25
sephadex column was used to purify the labeled probe as described below.
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7. Purification of DNA Fragments
a. G-25 sephadex column
DNA fragments labeled for use in the EMSA were purified with a G-25 sephadex
column. The column was prepared by plugging the bottom of a 1 ml syringe with glass
wool, and adding TE-saturated G-25 sephadex to the column until full. The prepared
column was centrifuged in a swinging bucket rotor at 800 rpm for 2 minutes at room
temperature. The sample was carefully applied to the top of the column and centrifuged
again at 800 rpm for 2 minutes. This was followed by elution of the labeled fragment
using 100 pi of TE and recentrifuging. One pi of each elution was counted in a
scintillation counter and run on a 8% acrylamide gel to assess labeling efficiency and
purity.
b. Spin column
DNA fragments labeled for use in the EMSA were also purified through
ProbeQuant™ G-50 Micro Columns (Amersham Pharmacia, Piscataway, NJ). The resin
in the column was resuspended by vortexing gently. The column was placed in a 1.5 ml
screw-cap microcentrifuge tube and centrifuged for 1 minute at 735 x g (3000 rpm) in a
microfuge. The samples were applied to the center of the angled surface of the
compacted resin bed and collected by centrifugation for 2 minutes at 735 x g. One pi of
each elution was counted in a scintillation counter and run on a 8% acrylamide gel to
assess labeling efficiency and purity.
c. Electroelution of DNA from agarose gel
DNA fragments of a specific size were seperated from fragments of other sizes by
agarose gel electrophoresis as described (Maniatis et al., 1989). The agarose band was
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excised and placed in a sealed dialysis bag filled with 0.1 X TBE. The DNA was
electroeluted for 4-5 hours at 350 to 500 V using a horizontal gel electrophoresis
apparatus. After electroelution was complete, the polarity of the electrodes was reversed
for 20 to 30 seconds. The bag was opened and the TBE buffer was transferred into a 15
ml disposable tube. The bag was then rinsed with 500 pi of 0.1 M NaCl, which was also
placed in the 15 ml tube. The DNA was concentrated to about 500 pi using several times
of butanol extractions, and precipitated with 2 volumes of ethanol at -20 °C overnight.
The DNA was collected by centrifugation at 13,000 rpm for 10 minutes at 4 °C in a
Biofuge 13 microcentrifuge. The pellet was resuspended with 100 pi TE.
d. The ” Crush and soak" method from acrylamide gel
This technique was used to isolate small DNA fragments from acrylamide gel
(Maniatis et al., 1989). The gel slice containing the DNA of interest was excised and
placed into a microfuge tube. The gel slice was weighed and crushed using a disposable
pippette tip. Two volumes of elution buffer (0.5 M ammonium acetate, 10 mM
magnesium acetate, 1 mM EDTA, pH 8.0, 0.1% SDS) was added to the tube. This was
followed by incubation at 37 °C on a rotary platform for 4 to 6 hours. The sample was
then centrifuged at 13,000 rpm for 1 minutes at 4 °C in a Biofuge 13 microcentrifuge.
The supernatant was transferred to a fresh micro fuge tube. The pellet of polyacrylamide
was added an additional 0.5 volume of elution buffer, vortexed briefly, and recentrifuged.
The two supernatants were conbined and passed through a syringe barrel containing
packed siliconized glass wool. The DNA was precipitated with 2 volumes of cold
ethanol on ice for 30 minutes. The DNA was recovered by centrifugation at 13,000 rpm
for 10 minutes at 4 °C in a Biofuge 13 microcentrifuge. The pellet was redissolved in
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200 [i\ of TE (pH 7.6), and reprecipitated with 25 ml of 3 M sodium acetate (pH 5.2) and
2 volumes of ethanol on ice for another 30 minutes. The DNA was collected by
centrifugation at 13,000 rpm for 10 minutes at 4 °C in a Biofuge 13 microcentrifuge and
washed once with 70% ethanol. The DNA was resuspended in 10 pi TE (pH 7.6). The
amount and quality of the fragment were checked by polyacrylamide gel electrophoresis.
8. Transient Transfection and CAT assays
The cells were fed 24 hours prior to transfection so they were in the log phase of
•
growth. The transfections were then performed by harvesting
4X107 cells and

resuspending them in 1 ml of RPMI without additives. An aliquot of 100 pi of these
cells, 4 X 106 cells, was incubated on ice with 7 X 10 ^2 moles of supercoiled plasmid
DNA for 5 minutes. The cells were electroporated using a Gene Pulser (BioRad
Laboratories) set at 230 volts and a Capacitance Extender (BioRad Laboratories) set at
500 pF. The pulse was followed by incubation on ice for another 5 minutes. The cells
were then transferred to 3 ml of complete RPMI medium and incubated at 37 °C in a CO2
incubator for 48 hours.
After the 48 hour incubation, the cells were harvested and resuspended in 100 pi of 1
X Reporter Lysis Buffer. Cells were incubated for 15 minutes at 4 °C, and the soluble
cellular extract was removed from the cellular debris by centrifugation at 3,000 rpm for 5
minutes. The supernatant was transferred to a new tube and heat inactivated at 60 °C for
10 minutes to inactivate endogenous deacetylase activity. Chloramphenicol
acetyltransferase (CAT) assays were performed as described (Promega Corporation,
1994). A constant amount (15 pg) of the cellular extract was combined with 5 pi nbutyryl coenzyme A (5 mg/ml), 1.5 pi 14C-chloramphenicol (0.1 mCi/ml), and 0.25 M
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Tris-HCl (pH 8.0) to a final volume of 125 pi. The reaction mixture was incubated at 37
°C for 20 hours. The reaction products were extracted once using 300 pi xylene and
back-extracted twice with 100 pi 0.25 M Tris-HCl (pH 8.0). A constant amount of final
sample (180 pi) was mixed with 10 ml scintillation cocktail, and the radioactivity was
counted using a Beckman LS3801 Liquid Scintillation System (Beckman Instruments,
Inc.). Background activity for each cell line used was determined by transfecting cells
with pCAT basic vector (Promega Corp., Madison, WI). The relative activity of each
CD4 construct reflects the average of at least three transfections.
9. Preparation of Primers and Probes
The primers were generated according to the analysis in the Seqstore
(http://www.gcg.com/seqstore-bio). The designed oligonucleotides were synthesized
either by Integrated DNA Technologies, Inc. (IDT, Coralville, IA) or by the Molecular
Biology and Gene Therapy Center (Loma Linda University). They were purified by
PAGE. An oligomer for primer extension was generated from the second exon of the
CD4 cDNA and its sequence is 5’- CTC GGC ACA TGG TGG TCT CCT TGA GCT C 3'. This oligomer was also used as a probe to detect the CD4 message in the Northern
blotting. Another oligomer for primer extension was generated from the CAT cDNA
(from nt 2 to nt 42) and its sequence is 5'- GGA TAT ATC AAC GGT GGT ATA TCC
AGT GAT TTT TTT CTC C -3'. Two primers for RT-PCR were generated from the
CAT cDNA. The sequence for the forward primer is 5'- TCC GGC CTT TAT TCA CAT
TC -3', and the sequence for the reverse primer is 5'- AGG TTT TCA CCG TAA CAA
GC -3'. The primer for sequencing the promoter deletion constructs was from Bluescript
II KS +/- and its sequence is 5'- GGA AAC AGC TAT GAC CAT G -3'.
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The probes for EMSA on intronic enhancers El and E2 were prepared by digesting
20 pg plasmid DNA with restriction enzymes recognizing a polylinker site outside of the
El and E2 fragments (normally using EcoRA-HindiW double digestion). The same probes
were used for DNase I footprint analysis and screening the enhancer constructs by
hybridization. The probe for the basal promoter element was prepared by digesting 20
pg of promoter construct D12 with Sail digestion, which yields the 138 bp basal
promoter element. The probe for 8B2 was prepared by digesting 20 pg of 8B2 plasmid
with EccRA-HindWl double digestion, which yields the 250 bp 8B2 fragment.
10. Bacterial Genomic DNA Extraction
Bacterial genomic DNA was used in the binding assay for nuclear matrices.
Overnight bacteria cell culture (500 ml) was collected by centrifugation at 6,000 rpm in a
GS3 rotor. The cells were resuspended in 10 ml of extraction buffer (50 mM Tris-HCl
pH 8.0, 50 mM EDTA). The cell suspension was frozen at -20 °C for at least 30 minutes.
When just thawed, the cells were added to 1 ml lysozyme (10 mg/ml) and placed on ice
for 45 minutes. This was followed by adding 250 pi of Proteinase K (10 mg/ml) and
incubation at 37 °C overnight. The reaction was extracted twice with 20 ml
phenol/chloroform/ isoamyl alcohol (25:24:1) and extracted once with 20 ml
chloroform/isoamyl alcohol (24:1). The lower phase was discarded after each extraction.
The genomic DNA was collected by precipitation with 1/25 volume of 5 M NaCl and 2
volumes of cold ethanol and spooled out. The genomic DNA was resuspended in 100 pi
TE buffer. Absorbance at 260 nm and 280 nm was read to determine DNA concentration.
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11. Fluorescence-Activated Cell Sorter (FACS)
Cells were collected by centrifugation for 5 min at 2000 rpm and washed once with
cold IX PBS. The cell suspension was adjusted to 1 X 107 cells/ml in diluent (0.01M
PBS, pH 7.4, 1% BSA, 0.1% NaN3). Cell suspension (100 pi) was added into three 15
ml tubes followed by adding 8 pi diluent, 4 pi anti-CD4 and 4 pi anti-CD8 antibody, and
4 pi anti-CD2a (FITC) and 4 pi anti-CD2a (PE) nonspecific antibody into each of the
tubes containing the cells. The cells were incubated on ice for 30 minutes. This was
followed by washing the cells with 2 ml of cold diluent and pelleting the cells by
centrifugation at 1200 rpm for 10 minutes. This washing procedure was repeated twice
more. The cells were then resuspended in 0.5 ml diluent for FACS analyzsis using a
BECTON/ DICKINSON Lysis II Ver 1.1 instrument. The experiment involving these
conjugated antibodies was performed in subdued light, and the tubes containing the
solutions were covered with aluminium foil.
12. Nuclear Extract Preparation
Nuclear extracts from cultured thymocytes were prepared as described previously
(Dignam et al., 1983). Around 1 X 109 cells were harvested at the end of the log phase of
growth. They were washed once with 5 volumes of cold PBS and once with 5 volumes
of cold Buffer A (10 mM HEPES pH 7.9, 1.5 mM MgCl2, 10 mM KC1, 0.5 mM DTT) by
spinning at 1,000 rpm for 5 mins at 4 °C. The cells were resuspend in 2 volumes of cold
buffer A and lysed using 10 strokes of a glass B-type pipette pestle and a Dounce
homogenizer (Coming Glass Works) to break open the cell membranes but not the nuclei.
The nuclei were pelleted at 3300-4000 rpm for 10 minutes at 4 °C and resuspended in 3
ml of Buffer C (20 mM HEPES pH 7.9, 25% glycerol, 0.42 M KC1, 1.5 mM MgCl2, 0.2
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mM EDTA, 0.5 mM PMSF, 0.5 mM DTT). Salt concentration was adjusted to 0.4 M
KC1 by the addition of 2.5 M KC1 and the nuclei were lysed using 10 strokes of a glass
A-type pipette pestle with the Bounce homogenizer to break open the nuclei. The broken
nuclei were transferred to a hard plastic ultracentrifuge tube and placed on a rocker for 30
mins at 4 °C, followed by ultra-centrifugation at 17,000 g (15,000 rpm) for 30 mins in a
90 Ti (cold) rotor (Beckman Instrument, Inc.). The supernatant was dialyzed against 2
changes of 50 volumes of buffer D (20 mM HEPES pH 7.9, 20% glycerol, 0.1 MKC1, 0.2
mM EDTA, 0.5 mM PMSF, 0.5 mM DTT) for 5 hours at 4 °C. The dialyzed nuclear
extracts were then centrifuged at 20,000 rpm for 30 minutes at 4 °C in a 90 Ti (cold) rotor
(Beckman Instrument, Inc.). Aliquots of nuclear proteins were immersed into dewar
flask of liquid nitrogen immediately and stored at -70 °C. Protein concentration was
obtained with the Bradford method and reagent (BioRad Laboratories, Richmond, CA)
13. Electrophoretic Mobility Shift Assay (EMSA)
The gel shift assay was performed as described (Singh et al., 1986). Briefly, 1 pi of 1
mg/ml poly dl-dC and 20 pi 1 X AS buffer (10% glycerol, 0.5 mM EDTA, 1 mM DTT,
20 mM HEPES pH 7.9, 50 mM KC1, 2 mM MgCh) were added to tubes containing 300
ng of nuclear protein and incubated on ice for 10 minutes. One pi of 32P-labeled doublestranded oligonucleotide probe (20,000 cpm/pl) was added to this tube and the reaction
mixture was incubated at room temperature for 20 minutes. The reaction was
electrophoresed on a 4% low-ionic-strength acrylamide gel at 120 volts for 3 hours at
room temperature. The gel was dried at 80 °C for 40 minutes and was autoradiographed
at -80 °C for 16 to 24 hours with Fuji RX X-ray film (Fisher Scientific, Tustin, CA).
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For competition experiments, specific and nonspecific competitor DNAs (50 to 200
pmol excess) were incubated in the mixture prior to addition of the nuclear extracts.
14. DNase I Footprint Analysis
The Core Footprint system (Promega, Madison, WI) was used to identify
transcription factor binding sites. Briefly, singly 32P end-labeled DNA probe was
generated as described above. One pi 32P-labeled DNA probe (15,000 cpm/pl) was
mixed well with 180 pi binding buffer (10% glycerol, 10 mM HEPES-NaOH, pH 7.9, 4
mM Tris-HCl, pH 7.9, 40 mM NaCl, 1 mM EDTA, 1 mM DTT, 300 pg BSA/ml). This
was followed by adding 1.5 pi of poly (dl-dC) (1 mg/ml) and 100 pg of dialyzed nuclear
extract into the binding buffer. The reaction was mixed well and incubated at room
temperature for 30 minutes. Fifty pi of the cofactor solution (10 mM MgCli, 5 mM
CaCb) was added into the reaction mixture and incubated at room temperature for one
minute. Five pi of the appropriate DNase I dilutions was added to a reaction every 15 s
(0.0005-0.005 Kunitz U/pl stocks for naked DNA, 0.002-0.08 Kunitz U/pl stocks for
DNA + proteins). After 2 minutes digestion, each reaction was stopped by the addition
of 100 pi of the stop solution (1% SDS, 200 mM NaCl, 20 mM EDTA, pH 8.0, 40 pg/ml
tRNA). After all the reactions have been processed, each reaction was extracted once
with phenol-chloroform (1:1) by vortexing followed by centrifugation at 13,000 rpm for
10 minutes in a microfuge. The DNA in the top phase was precipitated with 2 volumes
of ethanol in the presence of carrier RNA (2 pg) at -20 °C overnight. The pellet was
collected by centrifugation at 13,000 rpm for 15 minutes at 4 °C and washed once with
80 % ethanol (-20 °C). The DNA pellet was then dried under speed vacuum and
resuspended in 2 pi loading buffer. The sample was heated at 95 °C for 2 minutes and
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loaded onto a 6% polyacrylamide sequencing gel. The gel was run at 1500 V, 60 watts in
TBE 1 X buffer until the bromophenol blue was at the bottom. The gel was dried at 80 °C
for 1 hour and was autoradiographed at -80 °C for 5 to 7 days with Fuji RX X-ray film
(Fisher Scientific, Tustin, CA).
A sequence ladder (G+A) was prepared as described (Maniatis et al., 1989).
Basically, 2 pi of 1M pyridine formate (pH 2.0) was mixed with 30 pi singly end-labeled
DNA (200,000 cpm) and the solution was incubated at 37°C for 15 min. This was
followed by adding 150 pi of 1M piperidine and incubation at 90 °C for 30 min in a
thermal cycler. The DNA was precipitated twice with 20 pi of 3 M sodium acetate and
500 pi of ethanol at -80°C for 20 minutes. The precipitated DNA fraction was then
collected by centrifugation at 13,000 rpm for 10 minutes at 4 °C and resuspended in an
appropriate amount of loading buffer (5,000 cpm/pl). Four pi of sample was heated at 95
°C for 2 minutes and loaded onto a 6% polyacrylamide sequencing gel.
15. Preparation of Total RNA
Total cellular RNA was extracted using the single step of acid guanidiniumthiocyanate phenol-chloroform as described by Chomczynski et al. (1987). Briefly, the
cells were collected by centrifugation and washed once with cold PBS and extracted with
5 ml of Solution D (4 M guanidinium thiocyanate, 25 mM sodium citrate and 0.5%
sarcosyl). For RNA purification from total cell extract, 0.1 volume of 2 M sodium
acetate (pH 4.0), 1 volume of DEPC water-saturated phenol and 0.2 volume of DEPC
water saturated-chloroform/IAA (49:1 volume ratio) were added to the cell extracts
sequentially with complete mixing. The extraction mix was vortexed vigorously and
incubated on ice for 20 minutes and then centrifuged at 10,000 X g for 30 minutes at
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4°C. The upper aqueous layer containing the total RNA was transferred to a new 50 ml
tube and the RNA was precipitated by adding one volume of cold isopropanol and stored
at -20 °C overnight. The RNA fraction was precipitated by centrifugation at 10,000 X g
for 30 minutes at 4°C. The RNA pellet was redissolved in 500 pi of Solution D and
precipitated again by adding an equal volume of isopropanol and stored at -20 °C
overnight.
The final RNA purification step was done by centrifugation of RNA at 14,000 X g for
10 minutes and washing the RNA pellet twice with ice-cold 80% ethanol. The RNA
pellet was dissolved in 200 pi of TE/0.1% SDS solution (10 mM Tris-HCl, pH 8.0, 1 mM
EDTA and 0.1% SDS) and the concentration was measured by reading the absorbance
value at 260 nm and 280 nm. The purity of RNA was estimated by calculating the
A260/A280 ratio and only the samples which had a ratio greater than 1.7 were used for
primer extension and Northern blot analysis. Aliquots of RNA (containing 100 pg for
primer extension, 5 pg for RT-PCR, and 40 pg for Northern blotting) were then prepared
for primer extension, RT-PCR and Northern blotting.
16. Northern Blot Analysis
For Northern blotting, RNA samples were fractionated in a 1.5% agarose gel
containing 2.2 mM formaldehyde and MOPS buffer (IX). The separated RNA was
transferred from the gel to Magnagraph nylon (Micro Separations Inc., Westborough,
MA) overnight with 20X SSC (Maniatis et al., 1982). The membrane was cross linked
using a Stratalinker® 1800 UV crosslinker (Stratagene, La Jolla, CA) at autocrosslink
setting (120,000 pJ for 30 seconds), air dried, then vacuum baked at 80°C for 2 hours.
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Northern blots were hybridized following the protocols supplied by StrataGene.
Hybridization was performed overnight at 42°C in hybridization buffer (50% deionized
formamide, 10% dextran sulfate, 1 M NaCl, 100 pg/ml denatured salmon sperm DNA)
containing 1% SDS and 106 cpm/ml 32P labeled CD4 cDNA probe or 106 cpm/ml 32P
labeled oligomer probe. After hybridization, the filters hybridized with cDNA probe
were washed sequentially with 1 X SSC/0.1% SDS once at 37°C for 10 minutes, and 0.1
X SSC/0.1% SDS three times at 55 °C for 15 minutes. The filters hybridized with
oligomer probe were washed sequentially with 6 X SSC/0.1% SDS once at 37 °C for 10
minutes, 6 X SSC/0.1% SDS twice at 55 °C for 15 minutes, and 6 X SSC/0.1% SDS
twice at 65 °C for 15 minutes. Blots were autoradiographed at -80°C for 3-10 days with
Fuji AIF RX X-ray film (Fisher Scientific, Tustin, CA) without a phosphorous screen.
17. The Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) Analysis
RT-PCR was used to detect the message of CAT gene expression in the cell lines
transfected with intronic promoter deletion constructs and confirm the presence of the
message of the CD4 gene in the T cell lines. The first strand cDNA was synthesized as
described in the following procedures. Basically, 5 pg of total RNA, 1 pi Oligo (dT)1218 (500 pg/ml), and dH20 to a final volume of 12 pi were added to a nuclease-free
microcentrifuge tube. The mixture was heated at 70 °C for 10 minutes and 4 pi 5X First
Strand Buffer (250 mM Tris-Cl, pH 8.3, 375 mM KC1, 15 mM MgCl2), 2 pi 0.1 M DTT,
and 1 pi 10 mM dNTP Mix (10 mM each dATP, dGTP, dCTP and dTTP at neutral pH)
are added. This mixture was incubated at 42 °C for 2 minutes and 1 pi (200 units) of
SUPERSCRIPT II was added. The reaction was incubated at 42 °C for 50 minutes. This
was followed by inactivating the reaction at 70 °C for 15 minutes. The RNA
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complementary to the cDNA were removed by adding 1 pi (2 units) of E. coli RNase H
and incubation at 37 °C for 20 minutes.
Tenn percent of the first strand reaction was used in the following PCR reaction: 2.5
pi 10X PCR Buffer [200 mM Tris-HCl (pH 8.4), 500 mM KC1], 0.75 pi 50 mM MgCl2,
0.5 pi 10 mM dNTP Mix, 0.5 pi Amplification Primer 1 (Forward primer) (100 pg/ml),
0.5 pi Amplification Primer 2 (Reverse primer) (100 pg/ml), 2 pi cDNA from the first
strand reaction, and distilled water to a final volume of 24.5 pi. The reaction was mixed
gently and 1 drop (~50 pi) of silicone oil was layered over its top. The following cycles
of PCR were performed. The reaction was incubated in a PCR machine at 95 °C for 1
minute to denature primers and templates. Then, it was cooled to 80 °C and 0.5 pi (5 U)
Taq polymerase was added. The PCR reaction was performed in 18 cycles of 1 minute at
95 °C and 3 minute at 72 °C. This was followed by a final extension of 10 minute at 72
°C. The reaction was then cooled to 4 °C. A gel analysis was performed to check the size
of PCR product.
18. Primer Extension Analysis
Primer extension analysis was used to determine the location of transcription start
sites of the intronic promoter and was performed as described (Maniatis et al., 1989).
Basically, a Primer Extension System (Promega Corp., Madison, WI) was utilized to
perform the analysis. A single-stranded end-labeled CD4 intronic probe was generated
by using a synthetic oligonucleotide whose sequence is the complement to part of the
second exon of the CD4 cDNA. This oligonucleotide was labeled with 32P by using T4
polynucleotide kinase as described above. One pi of the labeled primer was mixed with
100 pg of the sample RNA. The mixture was precipitated with 0.1 volume of 3 M
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sodium acetate (pH 5.2) and 2.5 volumes of ethanol at -20°C for 30 mins, and then the
RNA was recovered by centrifugation at 12,000 x g for 10 mins at 4°C in a microfuge.
The pellet was washed with 70% ethanol and redissolved in 30 pi of hybridization buffer
(40 mM PIPES, pH 6.4, 1 mM EDIA, pH 8.0, 0.4 M NaCl, 80% deionized formamide).
The hybridization mixture was incubated at 85°C for 10 minutes to denature the nucleic
acids and transferred quickly to a water bath set at the annealing temperature, which was
68 °C for the primer. The mixture was then incubated for 8-12 hours, and followed by
mixing with 170 pi of water and 400 pi of ethanol at 0°C for 1 hour. The nucleic acids
were collected by centrifugation at 12,000 x g for 15minutes at 0°C in a microfuge and
washed once with 500pl of 70% ethanol. The primer:RNA hybrids were redissolved in 5
pi of the AMY Primer Extension 2X Buffer (Promega, Madison, WI) and 6 pi water and
mixed with 9 pi master reverse transcriptase extension mix (5 pi AMY Primer Extension
2X Buffer, 1.4 pi 40 mM sodium pyrophosphate, 1 u AMY reverse transcriptase, 1.6 pi
dH20). The reaction was incubated in a water-bath set at 410-42°C for 30 minutes. This
was followed by adding 20 pi of loading dye to each reaction. The sample was heated at
90°C for 10 minutes and loaded directly onto a 6% acrylamide/denaturing gel. The gel
was dried at 80 °C for 1 hour and was autoradiographed at -80 °C for 5 to 7 days with
Fuji RX X-ray film (Fisher Scientific, Tustin, CA).
19. Sequence Analysis
Sequence alignments and homology and motifs searches were performed with
TRANSFAC (http://transfac.gbf.de/TRANSFAC), TRRD (http://www.bionet.nsc.ru), Sequencher

2.1 from Gene Codes Corporation (Ann Arbor, MI), and MacVector 4.5 from
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International Biotechnologies, Inc. (New Haven, CT). The TRANSFAC database gives
information about the transcription factors and their binding sites and binding profiles
(Heinemeyer et ah, 1998). The TRRD database describes the structure of eukaryotic
transcription regulatory regions (promoters, enhancers) and specific patterns of gene
expression (Heinemeyer et al, 1998). Sequencher 2.1 was used to identify and remove
vector sequences, create contiguous sequences, edit contigs based on computer-generated
chromatograms, and create a consensus sequence. MacVector 4.5 was used to locate
restriction enzyme cut sites and to scan for known consensus sequences and motifs.
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CHAPTER THREE

I.

IDENTIFICATION AND CHARACTERIZATION OF THE POSITIVE cisELEMENTS (ENHANCERS) WITHIN THE FIRST INTRON OF MURINE
CD4 GENE.

A. RESULTS
1. Explanation of Constructs
The pAC4d construct shows the deleted 8.15 kb of the first intron, leaving only the
61 Ibp Xhol-Pst\ fragment of the most 5' end of the first intron including the splice donor
and the 174 bp Pstl-Sall fragment of the most 3' end of the first intron with the splice
acceptor. In our previous transient transfection studies, pAC4d construct expresses 16
fold better than the pAC4e construct indicating that the small amount of intronic
sequence left confers an enhancing activity when compared to the absence of intronic
sequences (McCready et al., 1997). Therefore, we screened the 61 Ibp Xho\-Pst\ region
for a sequence that had a T-cell-specific protein/DNA interaction, and localized it to a
124 bp Alul/Alul fragment (Figure 7). Based on these findings, we constructed a mini
gene expression system where the CAT gene was driven by the CD4 5' promoter, or a
combination of the 5' T cell-specific enhancer and the CD4 promoter. The two putative
positive control elements, El and E2, were then added to these constructs (Figure 8).
In order to determine the position- and orientation-independent enhancing ability of
the czs-acting elements in this intronic region, intronic enhancer constructs were created
which encode the CAT gene upon transfection into T cells. Both p900HEl and p900BEl
contained El, which was subcloned either in front of the 900 bp CD4 5' promoter or
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Figures. Diagrams of the p900 and pEPCl constructs. A. Map of the p900 construct.
The CAT gene is driven in the sense direction by the 900bp of CD4 promoter. The full
construct is 5351 bp. The green box represents the cw-acting element of interest, which
is inserted into the HincRW site (in front of the CD4 promoter) or the BamWl site (behind
the CD4 promoter) of p900 to test its function on the CD4 promoter. B. Map of the
pEPCl construct. The CAT gene is driven in the sense direction by the 900 bp of the
CD4 promoter and 339 bp of the CD4 5' enhancer. The full construct is approximately
5.7 kb in size. The green box represents the cA-acting element of interest, which is
inserted into the HindlW site (in front of the CD4 enhancer) or the Ascl site (behind the
CD4 promoter) of pEPCl to test its function together with the CD4 5' enhancer on the
CD4 promoter.
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behind the CAT gene of the p900 CAT expression vector, respectively. While p900HEl
and p900BEl contained El, p900HE2 and p900BE2 contained E2, which was subcloned
into the p900 expression vector. To determine the relationship between the 5' CD4
enhancer and the intronic enhancers, pEPCIHEl and pEPCl AE1 were constructed by
subcloning El either in front of the 339 bp CD4 5' minimal enhancer or behind the CAT
gene of the pEPCl CAT expression vector, respectively. The final two constructs,
pEPCl HE2 and pEPCl AE2, contained E2 instead of El, which was subcloned into
pEPCl in the same 5' & 3' sites (Figure 9).
2. The El and E2 Fragment from the First Intron have Enhancer Activity
These constructs were transiently transfected into SAKRTLS12.1, a mature CD4+ Tcell line. The phenotypes of the T cells were confirmed before transfection using
fluorescence-activated cell sorting (FACS) (Figure 10). The transfections were analyzed
for an increase in reporter gene activity over that observed with the promoter alone
(p900). Compared to the CAT activity of pEPCl, both El and E2 elements function in
both orientations relative to the CD4 promoter as well as both upstream and downstream
of the CAT gene (Figure 11). However, a comparison of the CAT activity of the
constructs pEPCl, pEPCIHEl, pEPCl AE1, pEPClHE2, and pEPCl AE2 indicate that
there is no additive enhancing activity on the CD4 promoter when the 5' enhancer and the
intronic elements are included in the same construct (Figure 11). This suggests that the
El and E2 elements can each function as an enhancer independently of the CD4 5'
enhancer.
To determine the specificity of these two elements, their activity was tested in TB2.1,
a CD4'CD8+ T cell line. Enhancer activity was also detected in this cell line. However,
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Figure 9. Intronic enhancer fragment/CAT reporter gene constructs. The diagram at the
top of the figure shows the 15 kb of the CD4 5' sequence and 8.9 kb of the CD4 sequence
3' of the promoter. DNase I hypersensitive sites (DH sites) are denoted by numbered
vertical arrows directly above the region in which they are located. The horizontal arrow
at DH site 8 shows the start of transcription. The letters directly below the line are the
positions of relevant restriction sites: N-AM, S-Sacl, E-ZscoRI, H-Xhol,
X-Xbal,
and L-Sall. Boxes below the line denote the restriction fragments used in the
construction of the vectors in (A). The green box corresponds to the 5' minimal 339 bp T
cell-specific enhancer located within the NoMSacl fragment. The red box located at the
promoter corresponds to a 900 bp fragment. The blue and pink boxes found in the first
intron correspond to a 124 bp Alul-Alul fragment (El) and 174 bp Pstl-Sall fragment
(E2) respectively. A. The constructs all contain the 900 bp promoter fragment, and some
constructs contain the 339 bp enhancer fragment. One copy of the El or E2 intronic
fragment was added to the Hindlll site of the p900 construct, p900HEl and p900HE2,
respectively. One copy of the El or E2 intronic fragment was added to the Hindlll site of
the pEPCl construct, pEPCIHEl and pEPClHE2, respectively. To test the intronic
enhancer's function in a position-independent way, one copy of the El or E2 intronic
fragment was added to the BamHl site of the p900 construct, p900BEl and p900BE2,
respectively. One copy of the El or E2 intronic fragment was added to the Ascl site of
the pEPCl construct, pEPCIHEl and pEPCl HE2, respectively. B. The map of the CAT
reporter vector. The CAT gene is fused immediately 3' of the promoter in each construct.
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Figure 10. FACS analysis of CD4 and CDS expression in different T cell lines. Cells
were stained directly with FITC-conjugated mCD4 and PE-conjugated mCDS mAbs,
then cells were recovered, washed, and analyzed by flow cytometry. The scale is logic
fluorescence intensity. A. Distribution of the SAKRTLS12.1 (CD4+CD8‘) subsets
defined from mCD4 and mCDS expression. B. Distribution of the TB2.1 (CD4'CD8+)
subsets defined from mCD4 and mCD8 expression. C. Distribution of the AKR
(CD4+CD8+) subsets defined from mCD4 and mCD8 expression. Each result was
reproduced three times in independent experiments.
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Figure 11. Effect of the intronic fragments on the 900 bp promoter activity in the
SAKRTLS12.1 (CD4+CD8 ) T cell line. Equi-molar amounts of each construct were
transiently transfected into SAKRTLS12.1 by electroporation. Constructs are described
in Figure 9. CAT activities are expressed as cpm of monoacetylated [14C]
chloramphenicol corrected for variation of the amount of total proteins. The relative
CAT activity of each construct reflects normalization to the CAT activity of p900, which
was arbitrarily given a value of 1. For each construct, three to nine experiments with at
least two preparations of DNA were performed. Each result represents the mean; the
error bars show the standard error of the mean (+_S.E.M.) for 3-9 separate determinations
(n = 3-9).
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Figure 12. Effect of the intronic fragments on the 900 bp promoter activity in the TB2.1
(CD4'CD8+) T cell line. Equi-molar amounts of each construct were transiently
transfected into TB2.1 by electroporation. Constructs are described in Figure 9. CAT
activities are expressed as cpm of monoacetylated [14C] chloramphenicol corrected for
variation of the amount of total proteins. The relative CAT activity of each construct
reflects normalization to the CAT activity of p900, which was arbitrarily given a value of
1. For each construct, three to nine experiments with at least two preparations of DNA
were performed. Each result represents the mean; the error bars show the standard error
of the mean (+_S.E.M.) for 3-9 separate determinations (n = 3-9).
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there were also no cooperative effects on the CD4 promoter when the 5' enhancer and the
intronic elements were put together (Figure 12). These results demonstrate that the El
and E2 fragments contain transcriptional enhancing activity and that they function
independently from the CD4 5' enhancer.
3. EMSA Analysis of Protein-DNA Interaction
In order to determine what transcription factors may be important in controlling CD4
transcription, EMSAs were performed on the two intronic enhancer fragments using
nuclear extracts purified from three thymoma cell lines. The thymoma cell lines
represent various stages of thymocyte development, from the immature CD4+CD8+ cells
(AKR1G1) to the more mature CD4+CD8'(SAKRTLS12.1) and CD4'CD8+ (TB2.1)
cells. Using the 122 bp Alul-Alul restriction fragment that contains the El element,
multiple complexes were detected in these T cell lines (Figure 13). Complexes A and D
were intense with the extracts from the SAKRTLS12.1 T cell line. Complex C was
intense only with the extracts from the TB 2.1 T cell line. Equally intense complexes A,
D and C were identified when the nuclear extracts from the AKR1G1 cells were used.
Furthermore, the proteins that form another higher molecular weight complex B was
present in the AKR1G1, but not present to any significant concentration in the other cell
lines. Formation of complexes A, B, and C were blocked in cold competition
experiments using the unlabeled wild-type probe but not in competition experiments
using non-specific fragments, indicating that the formation of these complexes is specific
for the internal El enhancer (Figure 13). Complex D was also partly blocked by a non
specific fragment from another region of the first intron of the murine CD4 gene. Since
this internal enhancer region was defined above as being capable of up-regulating the
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CD4 promoter's function in T cells, the nuclear factors that bind in these complexes may
contribute to the specificity and function of the internal enhancer. The nuclear factors
that bind to complexes A and D may be responsible for the expression of the CD4 gene,
while the nuclear factors that bind to complex C may be responsible for the expression of
the CDS gene. On the other hand, lack of nuclear factors that bind to complexes A and D
in TB 2.1 T cells resulted in the loss of the expression of CD4 gene in this cell line.
Multiple complexes were detected in different T cell lines when the 174 bp Pstl-SaH
restriction fragment that contains E2 element was assayed by EMSA (Figure 14).
Complex C was intense with the extracts from the SAKRTLS12.1 (CD4+CD8 ) T cell
line, while complex A was intense with the extracts the TB 2.1 (CD4'CD8+) T cell line.
Equally intense complexes A and C were identified when a nuclear extract from
AKR1G1 (CD4+CD8+) was used. Another high molecular weight complex B was
detected in AKR1G1. Complex D was observed in all three T cell lines. Formation of
complex D can not be inhibited in cold competition suggesting complex D results from
protein-DNA interactions. Formation of the other complexes was blocked in cold
competition experiments using the unlabeled wild-type probe but not in competition
experiments using non-specific fragments, indicating that the formation of complexes A,
B, and C is specific for the E2 fragment (Figure 14). Since this internal enhancer region
was defined above as being capable of up-regulating the CD4 promoter's function in T
cells, the nuclear factors that bind to these complexes may contribute to the specificity
and function of the internal enhancer. The nuclear factors that bind to complex C may be
responsible for the expression of the CD4 gene, while the nuclear factors that bind to
complex A may be responsible for the expression of the CDS gene. On the other hand,
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the low levels of nuclear factors that bind to complex C in TB 2.1 T cells resulted in the
loss of the expression of CD4 gene in this cell line.
4. Multiple Nuclear Factors Bind to the Intronic Enhancers
In order to determine which transcription factors could be responsible for the intronic
enhancers' activity, we performed DNase I footprint analysis on the region, using crude
nuclear extracts prepared from SAKRTLS12.1 (CD4+CD8‘) T cells. Three discrete
regions (FP1 to FP3) within El were reproducibly protected from DNase I digestion
(Figure 15). Sequence analysis of the El intronic enhancer revealed transcription factor
consensus sequences within several of the DNase I footprints (Figure 17A). While
footprint FP1 encompassed potential binding sites for GATA family transcription factors
(GATA-1), footprint FP2 encompassed potential binding sites for an Ets transcription
factor (Elf-1). Elf-1 has been shown to be capable of binding to T cell specific promoters
and enhancers, and to participate in complex formation, which correlates with the
regulation of gene expression during T cell activation and development (Salmon et al.,
1993). GATA-1 is preferentially expressed in erythroid cells, megakaryoctes and mast
cells and binds to enhancers in a number of erythroid-specifrc genes (Leiden and
Thompson, 1994). The FP3 footprint was consistently observed on the bottom strand and
was absent on the top strand. The sequences within footprint FP3 correspond to binding
sites for the ubiquitously expressed transcription families AP-1 (Lee et al., 1987). Elf-1
has been shown to bind to DNA in conjunction with API (Wang et al., 1994).
Two discrete regions (FP1 and FP2) within E2 were reproducibly protected from
DNase I digestion on both strands (Figure 16). DNA sequence analysis of the 174 bp E2
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Figure 15. DNase I footprint analysis of nuclear protein binding within the 5' intronic
enhancer. DNase I digestion of the probes in the absence of nuclear extracts is shown in
the (-) lanes; DNase I digestion of the probes incubated with nuclear extracts purified
from the SAKRTLS12.1 T cell line is shown in the (S) lanes. The top strand represents
the 5* end-labeled El probe; the bottom strand represents the 3' end-labeled El probe.
Footprinted regions are indicated by vertical lines and are labeled FP1 to FP3 for both
DNA strands. Mapping of the DNase I-footprinted regions was determined by a DNA
sequencing ladder (G + A) generated by piperidine cleavage of a formic acid-treated
probe. The nucleotide sequence of the footprinted regions and the transcription factor
consensus sites found within the footprinted regions correspond to the sequence in Figure
17(A).
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Figure 16. DNase I footprint analysis of nuclear protein binding within the 3' intronic
enhancer. DNase I digestion of the probes in the absence of nuclear extracts is shown in
the (-) lanes; DNase I digestion of the probes incubated with nuclear extracts purified
from the SAKRTLS12.1 T cell line is shown in the (S) lanes. The top strand represents
the 5' end-labeled El probe; the bottom strand represents the 3' end-labeled El probe.
Footprinted regions are indicated by vertical lines and are labeled FP1 and FP2 for both
DNA strands. Mapping of the DNase I-footprinted regions was determined by a DNA
sequencing ladder (G + A) generated by piperidine cleavage of a formic acid-treated
probe. The nucleotide sequence of the footprinted regions and the transcription factor
consensus sites found within the footprinted regions correspond to the sequence in Figure
17(B).
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enhancer element (Figure 17B) revealed that the footprint FP1 contains transcriptional
factor consensus sequences closely related to binding site specific for PU.l and IRF-1.
PU. 1 is an Ets domain transcription factor implicated in cell growth and differentiation
(Pongubala and Atchison, 1997). It is specifically expressed in hematopoitic tissues, with
high levels of expression in the monocytic, granulocytic and B-lymphoid lineages
(Leiden and Thompson, 1994). Footprint FP2 encompasses potential binding sites for a
GATA family transcription factor (GATA-1). Several other regions within the enhancer
elements that were not protected in the DNase I footprint analysis were also found to be
homologous or identical to nuclear protein binding sites found in other T cell-specific
enhancers.

B. DISCUSSION
Appropriate expression of CD4 is important for the proper development of the
immune system. If CD4 is not expressed during thymocyte maturation, MHC class II
restricted helper T cells fail to develop (Killeen et al., 1993) and thus the humoral branch
of the immune system lacks the ability to make antibodies in response to foreign antigens
(Rahemtulla et al., 1991). If CD4 is inappropriately expressed on mature cytotoxic T
cells, the coexpression of CD4 and CDS alters the MHC-specificity of the CD8+
cytotoxic T cells (Robey and Fowlkes, 1994). The self-reactive T cells can escape into
the periphery while overexpression of CD4 in thymocytes disrupts the CDS dependent
negative and positive selection of thymocytes (van Oers et al., 1992).
The regulation of CD4 expression is complex. Expression of CD4 is modulated by
many different types of stimuli during T cell development and once the T cell has
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matured. The CD4 gene is actively repressed by dominant trans-ading factors when the
pro-T cell enters the thymus (Wilkinson et al., 1991a). The up-regulation of CD4 at the
CD4+CD8+ stage of thymocyte development requires the stimulation of a T cell-specific
enhancer that is located 5' of the murine (Sawada and Littman, 1993) and human CD4
genes (Blum et al., 1993). The shut-off of CD4 expression in mature cytotoxic CD8+ T
cells requires a silencer that is present within the first intron (Siu et al., 1994). The
murine and human CD4 promoters have been analyzed and the ^ra/w-acting factors Myb
(Siu et al., 1992), Elf-1 (Sarafova and Siu, 1999), and Ets-related proteins (Salmon et al.,
1993) are implicated in regulation of CD4 expression. T-cell specific enhancers, located
13.5 kb (Sawada and Littman, 1991) and 25 kb 5' of the murine CD4 gene (Wurster et al.,
1994) and 6.5 kb 5' of the human CD4 gene (Blum et al., 1993), act through the transacting factors TCF-la/LEF-1 (Sawada and Littman, 1991), HEB, an E12-related protein
(Sawada and Littman, 1993), and an Elf-1 (Wurster et al., 1994) to stimulate the CD4
promoter. A T cell subclass-specific silencer, located within the first intron, acts through
the Notch pathway intermediate, HES-1, to silence CD4 gene expression in CD4'CD8+ T
cells (Kim and Siu, 1998).
Although the combinations of the minimal enhancer, promoter, and silencer can
direct developmental expression of CD4 in transgenic mice in a manner that is
indistinguishable from that observed for endogenous CD4 (Sawada et al., 1994; Siu et al.,
1994), several reports have suggested that additional elements within the first intron are
involved (Adlam et al., 1997; Boyer et al., 1997; McCready et al., 1997; Salmon et al.,
1996; Uematsu et al., 1997). Only constructs that contained the first intron were
expressed in a somewhat normal fashion. In this study, we have identified two intronic
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enhancers located downstream of the 5’ splice donor and upstream of the 3' splice
acceptor, respectively, in the first intron of the murine CD4 locus. Both enhancers are
capable of activating transcription of reporter gene constructs in a position- and
orientation-independent fashion when combined with the CD4 5' promoter. Enhancer
activity was observed in both CD4+CD8" and CD4’CD8+ mature T cells (Figure 11 and
12). To our surprise, no significant enhancer activity was observed in CD4+CD8+
immature T cells. The intronic enhancer has been suggested in transgenic mice studies to
be required to up-regulate CD4 expression at the CD4+CD8+ thymocyte stage (Salmon et
al., 1996; Uematsu et al., 1997). There is an apparent discrepancy between the function
of the intronic enhancer in vivo and in our cell line. This discrepancy may be due to the
AKR1G1 cell line itself. The equally high promoter activity in this cell line is observed
when transient transfection are transformed using either a reporter construct containing
only the 5' promoter (p900) or a reporter construct containing both the 5' promoter and
the 5' enhancer (pEPCl). A similar situation occurs when the constructs containing 5'
promoter and intronic enhancers were transfected. Taken together, our data suggest that
the intronic enhancers are functional in mature T cells. However, more transient
transfection studies using a heterologous promoter and non-T cells need to be performed
to determine whether they are T cell-specific. Also, the importance of the internal
enhancers in regulating CD4 expression during T cell differentiation needs to be
confirmed using transgenic mice.
A number of nuclear factors from three T cell lines are capable of binding to known
transcription factor consensus sites within the intronic enhancers (Figure 17; Table 1).
The EMSA analysis of the intronic enhancers indicates that DNA-binding factors that
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Table 1. Transcription factors involved in regulating gene expression during T-cell
development and activation.
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Functional
classification
Lineage determination
bHLH proteins
E12/E47
?
Homeobox proteins
LH-2
CBF

DNA-binding domain

Cognate sequence

Candidate targets

bHLH

CANNTG

TCRa, TCRp, TCR5,
CD3e

Homeobox
Homeobox

?
A/TGC/TGGT/AT/A

?
TCRa, TCR(3, TCR5,

ICRy
Zinc finger proteins
GATA-3
Ikaros
Chromatin structure
HMG proteins
LEF-1
TCF-1
SOX-4
GAT A proteins
Transcriptional
activation/repression
Generalized
transcription factors
API
CREB/ATF
Myb
NF-xB/rel
NFATp
Ets transcription factors
Ets-1
Elf-1
Fli-1
GABPa
Ets-2

C4 zinc finger

A/TGATAG/A

TCRa, TCRp, TCR8,
TCRy

Hunchback-like zinc
finger

TGGGGGT

CD38

HMG box
HMG box
HMG box
C4 zinc finger

A/TA/TCAAAG
A/TA/TCAAAG
AACAAAG
A/TGATAG/A

CD3e, TCRa, TCRP,
TCR8, CD4

Basic-leucine zipper
Basic-leucine zipper

TGANTCA
TGANNTCA
T/CAACG/TG
GGGAA/T A/TTT/CC/A
C
GAGGAAAA

IL-2, GM-CSF
TCRa, TCRP
TCR8, CD4
IL-2, IL-2R

C/AGGA
C/AGGA
C/AGGA
C/AGGA
C/AGGA

TCRa, TCRp
GM-CSF,EL-3, CD4
?
?
?

Ets-domain
Ets-domain
Ets-domain
Ets-domain
Ets-domain

CD3e

TCRa, TCRp, TCR8,
TCRy

IL-2, GM-CSF, IL-4

bHLH, basic helix loop helix; CBF, core-binding factor; CREB, cAMP response element
binding protein; Elf-1, E74-like factor-1; HMG, high mobility group; LEF-1, lymphoid
enhancer factor-1; NFAT, nuclear factor of activated T cells; GM-CSF, granulocytemacrophage colony-stimulating facotr; IL, interleukin; IL-2R, interleukin-2 receptor;
TCR, T-cell receptor. Adapted from {Leiden & Thompson 1994 ID: 676}
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Figure 17. The nucleotide sequence of the intronic enhancers. A. The nucleotide
sequence of the 5' intronic enhancer. Footprinted regions determined in Figure 15 are
indicated by brackets. The transcription factor consensus sites found within the
footprinted regions are in bold type and labeled. B. The nucleotide sequence of the 3'
intronic enhancer. Footprinted regions determined in Figure 16 are indicated by brackets.
The transcription factor consensus sites found within the footprinted regions are in bold
type and labeled.
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A)
GCTAATGTGC CGGAATGTTC TGGATpCAGT
FP1
GATA-1
TCTCTGTJCT CAGTTGTGGC CTGGGGTTCT
EIf-1
API
CCTGyATTCC TCTTg\GAACG GGTCAjTGAAC
FP2
AGTGATCTCC CACTGGAATC ATGAG
FP3

B)
AGGGTGCCCA CTTTTGTGTA TGCAGATAAT
PU.l
GTTCTCTGGG TTGGTTATCA AGGTCCTp7Kr
IRF-1
GAAGAGAAAG AqTTCTTGTG TGCCCCAGGC
FP1
CCAAGGAATA CCTGAAGACT| GATGATTTCT
GATA-1
FP2
ATCTTGCTCC GCCCCTGACA TTTTTGTAGG
CTCAGATTCC CAACCAACAA GAGCTC
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bind specifically to the intronic enhancers result in several major complexes. DNase I
footprint analysis located three protected regions on the 122 bp El intronic enhancer and
two protected regions on the 174 bp E2 intronic enhancer (Figure 15 and 16). Sequence
analysis of protected regions revealed the consensus sites of potential transcription
factors, which include GATA-1 (FP1), Elf-1 (FP2), and API (FP3) for the El enhancer;
and PU.l, IRF-1 (FP1), and GATA-1 (FP2) for the E2 enhancer (Figure 17). All of these
potential transcription factors, except IRF-1, have been shown to be involved in
regulating gene expression during T cell development and activation (Table 1). The
GATA family (GATA-1, GATA-2, GATA-3, and GATA-4) of transcription factors
shares a unique C4 zinc finger DNA-binding domain which recognizes the consensus
sequence A/TGATAG/A as well as some related sequences (Leiden and Thompson,
1994). Gene-knockout experiments have demonstrated that GATA-1 is required for
normal erythroid development in mice (Pevny et al., 1991). GATA-3 has been shown to
play an important role in early T cell development and lineage determination (Leiden and
Thompson, 1994). Both Elf-1 and PU.l belong to Ets proteins, which bind to elements
containing the core sequence C/AGGA, and are expressed in T cells (Leiden and
Thompson, 1994). Ets factors have been shown to be able to interact cooperatively in
binding and functional studies with a variety of other transcription factors that include
AP-1, Spl, core-binding factor, and Myb (Wurster et al., 1994). Elf-1, in particular, has
been reported to interact with AP-1 transcription factors in the inducible expression of the
T cell-specific interleukin-3 and GM-CSF genes (Gottschalk et al., 1993; Wang et al.,
1994). In both of these cases, the AP-1 factors and Elf-1 bind to sites that are directly
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adjacent to each other, and in the case of the GM-CSF promoter, the binding is
cooperative. There are two adjacent binding sites for AP-1 (FP3) and Elf-1 (FP2) within
the El intronic enhancer. Mutation studies need to be performed to determine whether
the mutation of these sites has significant effect on enhancer activity. Both PU. 1 and
IRF-1 have been shown to stimulate enhancer activity by playing an architectural role in
the assembly of a higher-order protein-DNA complex (Pongubala and Atchison, 1997;
Thanos and Maniatis, 1995). Furthermore, PU.l can participate in an active enhancer
complex without its transcriptional activation domain (Pongubala and Atchison, 1997).
Thus, it is possible that these two transcription factors work cooperatively to stimulate the
E2 enhancer. The specific role of these potential transcription factors in CD4 gene
regulation was not investigated. Since the possible binding sites within the intronic
enhancers were located, new construct mutants need to be made for these sites and
assayed for both loss of enhancer function and loss of factor binding so that careful
mapping of the protein-DNA contact sites can be done. This will help to determine
whether the above mentioned transcription factors actually bind to these sequences.
In the thymus, expression of the CD4 and CDS is positively regulated at early stages
and negatively regulated at later stages of development. In this study, we have
investigated the properties of the intronic enhancers that up-regulate transcription in a
CD4" thymoma, TB2.1. Activity of the intronic enhancers in TB2.1 may reflect an
abnormal property of this cell line, and the intronic enhancer may be properly downregulated in an appropriate developmental context. Alternatively, the endogenous CD4
promoter and/or intronic enhancers may be inactivated by a negative regulator, such as a
silencer element, which is missing in the transfected CAT construct. The latter
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possibility is especially attractive, as a silencer element outside of the TCRa enhancer
was shown to block enhancer function in TCRyb T cells and non-T cells but not in
TCRoc(3 T cells (Winoto and Baltimore, 1989). Additional cA-acting elements may be
required to detect T cell subset-specific expression in transfected cells.
A complete understanding of CD4 expression will require studies of the mechanism
of negative regulation during selection of CD8+ cells and of the ability of c/s-acting
elements to mediate temporal signals in thymic differentiation. Such an understanding
will require the analysis of the function of cz's-acting elements in transgenic mice. The
characterization of the intronic enhancers will significantly facilitate such future studies.
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II.

IDENTIFICATION OF THE INTERNAL PROMOTER WITHIN THE
FIRST INTRON OF THE MURINE CD4 GENE.

A. RESULTS
1. Construction of a Deletion Series to Locate the Basal Promoter
In order to determine if there is promoter activity within the first intron of the murine
CD4 gene, a construct containing the whole region of first intron of murine CD4 gene,
except a 1.1 kb Xbal-Spel fragment, fused to the CAT reporter gene in pKS(-) vector was
used to make a set of deletion constructs. While pBCO.5 contained most of the first
intron, pBCXbal and pBCHindlll contained 4660 bp and 1712 bp of the first intron,
respectively. Another construct pBCO.SA contained no first intron, while pBCAPstf
contained the majority of the 1712 bp Hindlll-Sall region except for a deletion of a 174
bp Pstl-Sall fragment. A series of systematic deletions of the 1712 bp Hindlll-Sall
fragment were prepared by Exonuclease III digestion from the 5' overhang of linearized
pBCHindlll (Figure 18).
Restriction enzyme analysis of the vectors containing different regions of the first
intron using Pvull is shown in Figure 19. In Figure 19, lane 2 is the cutting pattern of
pBCXbal, which has three expected bands (at ~ 1.7, 2.8, 4.9 kb, to total ~ 9.4 kb). Lane 3
shows the cutting pattern of the construct pBCHindlll, which has three expected bands
(at ~ 1.7, 2.8, and 1.9 kb). Lanes 6-11 and lanes 13-20 show the cutting patterns of the
deletion series prepared by Exonuclease III digestion from the 5' overhang of linearized
pBCHindlll. While the bands (at ~1.7 and 2.8 kb) were constant, another band (at ~1.9
kb) in the digestion pattern of pBCHindlll gets smaller due to Exonuclease III digestion.
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Figure 18. Schematic structure of various first intron-CAT fusion plasmid constructs.
A. The diagram shows the 8.5 kb of the first intron sequence of the murine CD4 gene.
The vertical arrows directly above the region show the positions of relevant restriction
sites: X-Xhol, V-Pvu\\, P-Pstl, S-Sacl, D-Xbal, E-Spel, B-BamHl, H-HindUl, and L-Sall.
The numbers indicate the relative positions of those restriction sites. B. Schematic
diagram depicting the extent of the 5' deletion in a series of constructs based on pBC0.5,
which contains the whole region of the first intron except the 1.1 kb Xbal-Spel fragment.
C. Schematic diagram depicting the reporter vector containing the CAT gene. The
backbone of the plasmids is pBluescript KS(-).
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C) Reporter Vector

Figure 19. Restriction enzyme analysis of vectors containing deletions. Approximately
0.5 pg of vector DNA was completely cut with PvuW (~ 5 units) for 3 to 5 hours. The cut
DNA was run on a 0.8% agarose gel, stained with ethidium bromide, and photographed
under UV light.
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Lane 4 shows the digestion pattern of pBCAPs/I, which has three expected bands (at
~1.7, 2.8, and 1.75 kb) since it lacks the 174 bp Pstl-Sali fragment contained in
pBCHindlll. Lane 21 is the digestion pattern of pBCA, which has three expected bands
(at -1.7, 2.8, and 0.25 kb). The sequence of intronic elements in these vectors was
further confirmed by automatic DNA sequencing using a 5' primer generated from the
pKS(-) vector.
2. The First intron of the Murine CD4 Gene Contains a Promoter That is
Transcriptionally Active in Mature CD4+ T cells but not Mature CD8+T cells
In order to study the functions of the internal promoter, the deletion constructs
described above were transfected into SAKRTLS12.1 (CD4+CD8‘) T cell line. CAT
activity was determined as a measure of the transcriptional activity of each construct
(Figure 21). Removal of the first intron from the pBCYM plasmid (pBCA) decreased
the CAT activity to the same level as that of the background, confirming that the pKS (-)
vector itself does not contain DNA elements that can function as promoters in T cell
lines. Transfection with either of the plasmids pBCXbal and pBCHindlll, which
contained the 3' first intronic fragment 3808/8468 and 6756/8468, separately, resulted in
a CAT activity that was approximately 30-fold higher than that obtained with the control
plasmid (pBCA) which is missing these fragments (Figure 20). This suggests that the 3'
region of the first intron can function as a promoter. A series of deletions was made to
determine the minimal sequences required for promoter activity. The constructs D1 to
D3 showed more than a 50-fold increase in CAT activity over that obtained with pBCA.
The increase in promoter activity observed following the deletion of sequences between
positions 6756 and 6907 indicates a potential silencer in this region. However, the
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construct D4 showed only a 20-fold increase in activity suggesting the presence of an
enhancer element between positions 7174 and 7499. The final deletion construct, D12,
showed around a 10-fold increase in activity indicating the presence of a basal promoter
between positions 8330 and 8468. Removal of the region from 8294 to 8468 (pBGPsrl)
abolished the CAT activity, further confirming the presence of a basal promoter within
this region. Taken together, this localized the basal promoter element to a 138-bp
fragment between position 8330 and 8468. Comparison of CAT activity between
constructs Dll and D12 (30-fold and 10-fold increase, respectively) indicated another
enhancer activity between positions 8111 and 8330, which has been decided in the
previous chapter.
The expression of CAT mRNAs was examined by specific RT-PCR in RNA purified
from the transfected SAKRTLS12.1 cells (Figure 24). As seen in this figure, transfected
SAKR cells had an intense 259 bp amplification product corresponding to CAT message.
However, no such band was detected in the RT-PCR reaction of nontransfected SAKR
cells. These results further demonstrated the existence of a promoter in constructs Dll
and D12, which can drive the expression of CAT gene.
The deletion constructs were also transfected into the TB2.1 (CD4'CD8+) T cell line
to determine stage specificity of the internal promoter (Figure 21). All the transfected
deletion constructs resulted in approximately a 2-fold increase in CAT activity.
Therefore, the internal promoter was most active in CD4+CD8‘ T cells, which suggested
that the internal promoter is stage specific.
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Figure 20. Relative levels of CAT expression in cell extracts from the SAKRTLS12.1
(CD4+CD8 ) T cell line transfected with individual deletion constructs. Equi-molar
amounts of each construct were transiently transfected into SAKRTLS12.1 by
electroporation. Constructs are described in Figure 20. CAT activities are expressed as
cpm of monoacetylated [14C]chloramphenicol corrected for variation of the amount of
total proteins. The relative CAT activity of each construct reflects normalization to the
CAT activity of pBC0.5A, which was arbitrarily given a value of 1. For each construct,
three to nine experiments with at least two preparations of DNA were performed. Each
result represents the mean; the error bars show the standard error of the mean (+.S.E.M.)
for 3-9 separate determinations (n = 3-9).
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sXj

Figure 21. Relative levels of CAT expression in cell extracts from the TB2.1 (CD4'
CD8+) T cell line transfected with individual deletion constructs. Equi-molar amounts of
each construct were transiently transfected into TB2.1 by electroporation. Constructs are
described in Figure 20. CAT activities are expressed as cpm of monoacetylated
[l4C]chloramphenicol corrected for variations of the amounts of total proteins. The
relative CAT activity of each construct reflects normalization to the CAT activity of
pBC0.5A, which was arbitrarily given a value of 1. For each construct, three to nine
experiments with at least two preparations of DNA were performed. Each result
represents the mean; the error bars show the standard error of the mean (+S.E.M.) for 3-9
separate determinations (n = 3-9).
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3. Multiple Factors Bind to the Internal Promoter Region
In order to study transcription factors that may be important in controlling CD4
transcription, EMSAs were performed on the basal internal promoter fragment by using
nuclear extracts purified from different T cell lines. Using the 138 bp restriction
fragment that contains the basal promoter element, multiple complexes were detected in
different T cell lines (Figure 22). While complex A is intense for the SAKRTLS12.1 T
cell line, complex B is intense for the TB 2.1 T cell line. Equally intense complexes A
and B were identified when the nuclear extracts from AKR1G1 were used. Formation of
these two complexes can be inhibited in cold competition experiments using the
unlabeled Pstl-Sali probe, indicating that the formation of these complexes is specific for
the internal promoter (Figure 22). Complex C was observed in all three T cell lines.
Formation of complex C could not be inhibited in cold competition, suggesting the
complex C results from nonspecific protein-DNA interactions. Since this internal
promoter region was defined above as being capable of directing CAT gene expression in
SAKRTLS12.1 cells, the nuclear factors that bind to complex A may contribute to the
specificity and function of the internal promoter. The nuclear factors that bind to
complex B may have a repressive effect on the internal promoter, which would explain
why the deletion constructs showed weak activity in AKR1G1 T cells. On the other
hand, lack of nuclear factors that bind to complex A in TB 2.1 cells appears to result in
the loss of internal promoter activity in this cell line.
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Figure 23. A. Gel analysis for the presence of 18 S and 28 S ribosomal bands in total
RNA samples to verify the integrity of the RNA prior to performing primer extension
analysis. Positions of 28 S and 18 S are indicated with arrows. The letters above each
lane indicate the particular T cell lines from which the total RNA is isolated. Dll or D12
represents the total RNA isolated from the SAKRTLS12.1 (CD4+CD8‘) T cell line 48
hours later since Dll or D12 was transiently transfected into this T cell line. B.
Northern blot analysis of the CD4 message in T cell lines. Total RNA extract (20 pg)
was run on a 0.75% agarose gel containing formamide, transferred onto a nylon
membrane and hybridized with 32P-labeled dATP oligomer generated from the second
exon of the CD4 gene. Lane 1 and 2 represent total RNA from SAKRTLS12.1
(CD4+CD8‘) T cells; lane 3 represents total RNA from AKR1G1 (CD4+CD8+) T cells;
and lane 4 represents total RNA from TB2.1 (CD4 CD8+) T cells.
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Figure 24. RT-PCR analysis of the SAKRTLS12.1 (CD4+CD8 ) T cell line transfected
with vectors encoding CAT. A. Schematic illustration of the relative position between
the forward and the reverse primer. B. RT-PCR analysis of the CAT message. A 10%
PCR reaction mixture was run on a 0.7% agarose gel. Lane 1 is the control, the
nontransfected SAKRTLS12.1; Lane 2 is the SAKRTLS12.1 transfected with pEPCl;
Lane 3 is the SAKRTLS12.1 transfected with the intronic promoter construct Dll; Lane
4 is the SAKRTLS12.1 transfected with the intronic promoter construct D12
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4. The Internal Promoter Utilizes a Single Initiation Site of Transcription
In order to determine the transcription initiation point, primer extension analysis was
performed using total RNA isolated from SAKRTLS12.1, AKR1G1 and TB2.1 cells
(Figure 23). The presence of 18S and 28S ribosomal bands in total RNA samples was
analyzed on gels to verify the integrity of the RNA prior to performing the primer
extension analysis (Figure 23, A.). Northern blot analysis confirmed that SAKRTLS12.1
and AKR1G1 T cell clones expressed CD4 mRNA (Figure 23, B.). The negative control,
which is the TB2.1, showed no CD4 mRNA as expected (lane 4 of Figure 23B). By
using a primer generated from the second exon of the CD4 gene and total RNA from
SAKRTLS12.1 and AKR1G1, an extension product of about 118 bp was detected. The
transcription initiation point defined by the 118 bp primer extension product is located
approximately 107 bp upstream from the ATG site (Figure 25). In addition, three other
extension products representing transcription start sites of the 5' CD4 promoter, were
identified approximately 165 bp upstream from the ATG site. These three sites match up
with the three initiation sites of the 5' CD4 promoter previously identified (Figure 25)
(Siu et al., 1992). No extension product was detected using total RNA from the TB2.1
cells. Analysis of the sequence that is immediately 5' to the internal initiation site
indicates that although there is no consensus TATA sequence, several recognition sites
for other transcription factors can be identified by sequence analysis in the promoter
region.
B. DISCUSSION
The complete developmental expression of CD4 requires multiple transcription
factors interacting with multiple sequence elements. In the murine CD4 gene the
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untranslated first exon is separated by a large 8.4 kb intron from the second exon. Long
introns are frequently associated with functional cw-acting elements other than those
needed for splicing. The primer extension data indicates that the murine CD4 first intron
contains an alternative promoter, which is located immediately 5' to the second exon. In
SAKR cells, it has the same activity as the CD4 5' promoter. The primer extension
analysis indicates that there is a single transcription initiation site located approximately
107 bp upstream from the ATG site in the second exon. The transient transfection studies
using deletion constructs indicate that a 138 bp fragment contains the DNA sequences
necessary for basal activity. Our results are in agreement with those recently reported
(Rushton et al., 1997) for a human CD4 gene internal promoter in a similar location.
Both the human and the murine internal promoters have the greatest activity in the CD4
T cell lines and show minimal activity in the CD4' T cell line.
Transcriptional regulation by multiple promoters has been reported for other genes
(Allen et al, 1992; Campos et al., 1992; Courchesne-Smith et al., 1992; Fatyol et al.,
1999). In all cases, the use of multiple promoters is associated with developmental and
tissue-specific expression patterns. In T lymphocytes, transcription of the human CD4
gene is initiated by an internal promoter that is preferentially activated in immature
CD4+CD8+ T cells (Rushton et al., 1997). The factors binding to the internal promoter
vary for different T cell lines. This, together with the data discussed above, which shows
preferential usage of the internal promoter in CD4+ T cells, suggests a general pattern of
gene regulation in T cell gene expression. The exact function of this internal promoter in
the regualtion of CD4 gene expression during differentiation needs to be confirmed using
transgenic mice.
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Figure 25. Primer extension analysis to locate the transcription initiation site. A.
Organization of the CD4 gene showing the relative position of the internal promoter and
extension product. The 5’ transcription start site is shown by the arrow. Some restriction
enzyme cutting sites were labeled. B. The transcription initiation site in the intronic
promoter of the murine CD4 gene, mapped by primer extension. The primer extension
product (approximately 118 bp) is indicated by the arrow; three 5' transcription start sites
were also indicated by an arrow. Lane 1 is the control, without total RNA from the cell
line; Lane 2 and 3 represent 30 jug and 50 pg total RNA from the SAKRTLS12.1
(CD4+CD8') T cells; Lane 4 and 5 represent 30 pg and 50 pg total RNA from the
AKR1G1 (CD4+CD8 ) T cells; Lane 6 represents 50 pg total RNA from the TB2.1
(CD4+CD8') T cells. A 32P-labeled Hinfl digest of <j)X174 DNA was used as a molecular
weight marker.
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Figure 26. Nucleotide sequence of the internal promoter. The primary transcriptional
start site and ATG translation start site are indicated in bold, with the primary
transcription start site designated as +1. The second exon is framed. The minimal
promoter element starts from D12. The potential transcription binding sites are
underlined and labeled.

148

Spl
-284 ACACATATGC CTCTGTGCCA GGGTCGGAG
-254 ACAATAACGG TGCACGTGA GGACCTAAAA
-224 CCGTAGTTTG TCTTTGACAC CCAGGAATAT
-194 ACTTATTTCT GGGTCTCTGT CATGCACTGC
Zta
-164 TGCTATTGCT CAGGATGTTT AAATTGCTCT
API
-134

tcagctactg acatcacagt cttagtttgg

-104 CAGGACCTTT GGGGTGCATT ACTGCAGGGT
•74 GCCCACTTTT GTGTATGCAG ATAATGTTCT
PU.l
D12
-44 CTGGGTTGGT TATCAAGGTC CTGAGGAAGA
+1
AP2
-14 GAAAGAGTTC TTGTGTGCCC CAGGCCCAAG
+16 GAATACCTGA AGACTGATGA TTTCTATCTT
Spl
+46 CCTCCGCCCC TGACATTTTT GTAG GCTCAG
San
ATTCCCAACC AACAAGAGCT CAAGGAGACC
ACCATG

Exon II
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The factors that regulate basal activity of the internal promoter need to be defined.
Like the CD4 5' promoter, the internal promoter does not contain a consensus TATA
recognition sequence. Also, the sequences around the cap site do not correspond to the
consensus of an initiator motif (CTCANTCT) (Salmon et al., 1993). The 138 bp basal
element contains a consensus sequence for the binding of the Ets protein (Figure 26). An
Ets protein present in high amounts specifically in CD4+ cells has been shown to bind
specifically the human CD4 core promoter (Salmon et al., 1993). As discussed for other
TATA-less promoters, Ets proteins could participate in the building of a CD4-specific
RNA polymerase complex (Wasylyk et al., 1993). The Ets proteins family is defined by
an 85 amino acid region of homology that mediates DNA-binding to a purine-rich core
motif (GGAA/T) (Clevers et al., 1993). T cells express multiple members of this family:
Ets-1, Ets-2, GABPoc, Elf-1, and Fli-1 (Clevers et al., 1993). Both Ets-1 and Elf-1 are
capable of binding to T cell specific promoters and enhancers, and to participate in
complex formation, correlating with the regulation of gene expression during T cell
activation and development (Leiden and Thompson, 1994). Elf-1 has been shown to be
expressed at high levels in T cells and has been implicated in the regulation of several
activation and T cell-specific cellular genes (interleukin-3 and GM-CSF genes)
(Gottschalk et al., 1993; Salmon et al., 1996; Wang et al., 1993). Elf-1 acts as a positive
regulator at the CD4 5' promoter and to plays a complex role in the induction of CD4
gene expression together with a novel factor (Sarafova and Siu, 1999). It is reasonable to
suggest that Elf-1 could be critically involved in the activity of the intronic promoter in
the CD4 locus. In many cases, Ets family members bind to DNA in conjunction with
other general transcription factors such as API or Spl (Wang et al., 1994). Sequence
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analysis of the upstream regions of the basal element indicated that potential transcription
factor-binding sequences in this region include Spl, Zta, and API. Thus, the cooperation
of these transcription factors could be a key mechanism for the function of the internal
CD4 promoter. Indeed, we observed that the upstream sequence of the basal internal
promoter has a strong positive effect on the intronic promoter in our transient transfection
studies. Further studies on the internal promoter by mutation analysis, DNase I footprint
analysis, and supershifts will be helpful to characterize the transcription factors
interacting with the internal promoter.
As mentioned before, the regulation of the CD4 gene is a complex, and tightly
controlled process. Thymocytes and mature T cells must be able to control genes by
more than an all-or-nothing mechanism. The promoter element identified in the first
intron at DH12 may play a role in fine-regulation of CD4 gene expression in CD4+ T
cells. Taken together, the results presented here strongly suggest that the first intron of
the murine CD4 gene may play an important role in the transcriptional regulation of the
CD4 gene in T cell development.
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III.

IDENTIFICATION OF THE NEGATIVE c/s-ACTING ELEMENTS
ASSOCIATED WITH THE 5’ CD4 PROMOTER.

A. RESULTS
1. Construction of Reporter Vectors to Identify a Silencer Associated with the
CD4 5' Promoter
Data from Dr. Sands' laboratory suggest that some of the DH sites associated with the
CD4 5' promoter have a negative effect on the function of the CD4 promoter and produce
T cell-specific gel shifts when assayed by EMSA. In order to further study these DH
sites, they were subcloned into pUC19 as a 200 bp Pst\-Hindl\\ fragment, a 250 bp
Haelll-HaelW fragment, and a 274 bp Hincll-Xhol fragment, and named 7B6, 8B2, and
B7 respectively (Figure 27). These three DNA sequences were tested for their ability to
regulate transcription from the CD4 promoter in T cell lines. A mini-gene expression
system was constructed where the CAT gene was driven by the CD4 5' promoter, or a
combination of the 5' T cell-specific enhancer and the CD4 promoter. The three control
elements were then added to these constructs (Figure 8). Initial transfection data
indicated that only the 8B2 had a negative effect on the CD4 5' promoter.
In order to further determine the position- and orientation-independent silencing of
the 8B2 element, reporter constructs were created for transfection into T cells (Figure
27). Two copies of the sense and antisense 8B2 fragment were subcloned upstream of
the CD4 promoter-CAT plasmid (p900) creating p900H8B2S2 and p900H8B2A2,
respectively. To determine if the 8B2 element could act as a silencer when the 5' CD4
minimal enhancer was present in the same construct, two copies and one copy of the
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Figure 27. Silencer fragment/CAT reporter gene constructs. The diagram at the top of
the figure shows the relative position of the potential silencers associated with the CD4
promoter. The horizontal arrow at DH site 8 shows the start of transcription. The letters
directly below the line are the positions of relevant restriction sites: Yi-HindiW, ?-Pst\, AHaeWl,
W-Xhol. Boxes below the line denote the restriction fragments used in
the construction of the vectors in (A). The green box corresponds to the 5' minimal 339
bp T cell-specific enhancer located within the NotVSacl fragment. The red box located at
the promoter corresponds to a 900 bp fragment. The gray boxes correspond to a 250 bp
Haelll-Haelll fragment (8B2). A. The constructs all contain the 900 bp promoter
fragment, and some constructs contain the 339 bp enhancer fragment. Two copies of the
sense and antisense 8B2 element were added to the Hindill site of the p900 construct,
p900H8B2S2 and p900H8B2A2, respectively. Two copies of the sense 8B2 element
were added to the Hindlll site of pEPCl construct, pEPClH8B2S2. To test the intronic
enhancer's function in a position-independent way, one copy of the sense 8B2 element
was added to the Ascl site of pEPCl construct, p900A8B2Sl. B. The map of the CAT
reporter vector. The CAT gene is fused immediately 3' of the promoter in each construct.
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sense 8B2 element were subloned upstream and downstream of the pEPCl to create
pEPClH8B2S2 and pEPCl A8B2S1, respectively.
2. The Silencer Element Suppresses Transcription Specifically in the
SAKRTLS12.1 T Cells
These constructs were transfected into a CD4+CD8‘ T cell line (SAKRTLS12.1) and a
CD4+CD8+ T cell line (AKR1G1). CAT activity was measured 2 days later (Figure 28).
The transfections were analyzed for an increase in reporter gene activity over that
observed with the CD4 promoter alone (p900). When two copies of the 8B2 elements, in
both orientations, were inserted 5' of the CD4 promoter, transcription was reduced about
50% to 70% in the CD4+CD8' T cells (Figure 28). The 8B2 element functions as a
silencer relative of the CD4 promoter when positioned upstream and downstream of the
CAT gene (Figure 28). The minimal CD4 enhancer activates CAT transcription from the
CD4 promoter in both cell lines. The addition of the 8B2 fragment either upstream or
downstream of the minimal enhancer resulted in a 60% to 80% repression in the
CD4+CD8' T cells (Figure 28). Thus, the 8B2 element is capable of repressing CD4
expression in the presence or absence of the T cell-specific enhancer specifically in the
SAKRTLS12.1 cells. Furthermore, silencer activity for this element is position- and
orientation-independent.
3. Thymocyte-Specific Protein/DNA Binding Complexes
The m-acting element in the 8B2 fragment, corresponding to DH8, is T cell-specific
(Sands and Nikolic, 1992). To study the protein-DNA interactions occurring within this
element, EMSA was performed using the 250 bp fragment and nuclear extracts from the
three T cell lines (Figure 29). These experiments identified at least two different
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Figure 28. Effect of the 8B2 silencer on the 900 bp promoter activity in the
SAKRTLS12.1 (CD4+CD8') T cell line. Equi-molar amounts of each construct were
transiently transfected into SAKRTLS12.1 by electroporation. Constructs are described
in Figure 27. CAT activities are expressed as cpm of monoacetylated [14C]
chloramphenicol corrected for variations of the amount of total proteins. The relative
CAT activity of each construct reflects normalization to the CAT activity of p900, which
was arbitrarily given a value of 1. For each construct, three to nine experiments with at
least two preparations of DNA were performed. Each result represents the mean; the
error bars show the standard error of the mean (jiS.E.M.) for 3-9 separate determinations
(n = 3-9).
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complexes, A and B. While both complexes, A and B, appeared using nuclear extracts
from SAKRTLS12.1 cells, only complex A or complex B was located using nuclear
extracts from TB2.1 or AKR1G1 cells, respectively. Furthermore, formation of both
complexes are inhibited in cold competition experiments when 200-fold excess of
unlabeled 8B2 fragment was used. Unexpectedly, a third complex C that appeared only
in the 200-fold excess cold competition experiments using nuclear extracts from TB2.1
cells. This particular complex C might be a contamination. Taken together, these data
indicate that a specific protein/DNA interaction is occurring within the 8B2 element, and
that the function of this interaction is a silencer.
B. DISCUSSION
The CD4 gene is regulated in a highly complex manner. There are multiple positive
and negative regulatory elements which control CD4 gene expression (McCready et al.,
1997; Uematsu et al., 1997). The murine CD4 promoter (Siu et al., 1992), proximal
(Sawada and Littman, 1991) and distal (Wurster et al., 1994) enhancers, and a silencer
(Sawada et al., 1994; Siu et al., 1994) have been identified. However, these regulatory
elements still cannot fully explain the complicated expression pattern of the CD4 gene
(Littman, 1996). Our analysis indicates that the DNA 5' of the promoter and within the
first intron has homology to various enhancers, silencers, promoters. These regions may
contribute to the tissue- and subclass-specific regulation of CD4 expression.
Although enhancers have been extensively described, the role of negative regulation
in gene expression is beginning to be appreciated as more examples are described among
eukaryotic gene systems. The molecular mechanisms underlying negative regulation
have been divided into four categories: (1) competitive inhibition of enhancer factors by
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binding of a silencer factor to a common sequence; (2) quenching of enhancer activity by
binding of a silencer factor to a common sequence; (3) direct repression of the promoter
complex; (4) squelching by sequestration of transcription factors by high concentrations
of enhancer factors (Levine and Manley, 1990). Recent studies'm Drosophila suggest
that repressors fall into two categories, short-range and long-range repressors (Gray and
Levine, 1996). The former permit enhancer autonomy in modular promoters, whereas
the latter function in a dominant fashion to silence multiple enhancers.
The intronic silencer is important for subclass-specific expression of CD4. It
functions at three stages of development (Siu et al., 1994). First, it functions to inhibit
CD4 gene expression in non-T hematopoietic cells. Second, the silencer inhibits
expression of CD4 in the CD4 CD8' population, an early precursor stage in the thymus.
Third, as the thymocyte matures to a CD4+CD8+ T cell, the silencer ceases to function,
permitting the expression of CD4. Either during or after the T cell repertoire selection
processes, the CD4 silencer may either remain non-functional, resulting in a CD4+CD8' T
helper cell, or resume function, thus silencing the CD4 gene and leading to the
development of a CD4'CD8+ T cytotoxic cell. Repressor binding to the CD4 silencer
element may directly inhibit the general transcriptional machinery at the transcription
initiation site or activators interacting with cfs-elements located at a distance. Although
the precise molecular mechanism in which this silencer functions to drive development of
mature CDS SP T lymphocytes is unclear, recent studies showed that the Notch pathway
intermediate HES-1 binds a functional site in the CD4 silencer and mediates silencer
function (Kim and Siu, 1998).
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In this study, we analyzed the regions associated with the 5' CD4 promoter, and
identified a novel negative regulatory region (8B2) that has a repressive effect on
expression of the CD4 gene particularly in the SAKRTLS12.1 cell line. This element has
two striking similarities with eukaryotic silencers (Ernst and Smale, 1995). First, the 8B2
element functions as a transcription inhibitor in our transient transfection studies.
Second, the element functions in a position- and orientation-independent fashion. Unlike
the intronic silencer, this silencer seems to function in the CD4+CD8‘ T cell line, which
seems to be contradictory to the silencer's function in down-regulating CD4 expression at
different stages of T cell development. One possible explaination is that this silencer
might participate in controlling the appropriate expression of the CD4 gene at those
stages of T cell development. EMSA studies on the 8B2 element indicated that there
were different specific protein-DNA interactions using nuclear extracts from different T
cell lines, suggesting this silencer functions differently in various stages of T cell
development. More transient transfection studies should be performed to understand the
exact function of this silencer in various stages of T cell development. The mechanism
by which this region of DNA is repressive could involve one of the negative regulatory
mechanisms outlined before. Also, the silencing machinery for CD4 and CDS gene
extinction may be coordinated with regulation of other genes associated with the lineage
commitment of T cells. For example, the negative factors involved in transcriptional
down-regulation of the CD4 gene may also up-regulate genes required for differentiation
of cytotoxic T cells. Sequence analysis of the 8B2 element shows that there is a binding
consensus for various potential transcription factors (Figure 30). Among them, nuclear
factor YY1 has been shown to repress transcription by physically interacting with the
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Figure 30. Nucleotide sequence of the silencer associated with the CD4 promoter. The
potential binding consensus sequences of the transcription factors binding sites are
underlined and labeled.
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NF-1
GCACCTTGGC CATGTGCTAC CCACTCAATCT
Core-binding

CCAGCAATGG AGTAAGGGAA AGCCAAACCA
factor
CTATGTCTTT AGCTGCCACA GAGCCGTGTX.
API
GACTCTTGCT GTTTCCCTAT GGGCTCTTTG
TCATCTCTAG AACAGCCGAC TTAGTGGATC
C/EBP
TGTTGGGCAA CGTAATCTAA ATTTTCCATT
YY1
GATTAAATTG CTAACTTTTTT TTTTAAAACA
TGGCATTACT GCATAGGCAG CCTAGTCTGG
CCTTGAGCT
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general transcription factors (GTFs) and various activators, as well as displacing
activators with overlapping binding sites (Ogboume and Antalis, 1998). Therefore,
characterization of factors interacting with the silencer will facilitate our understanding of
lineage commitment during T cell differentiation.
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CHAPTER FOUR
I.

CONCLUSIONS AND FUTURE PERSPECTIVES

A. CONCLUSIONS
The aim of this study was to identify cz's-acting control elements within region 5' of
the murine CD4 promoter and in the first intron that are important to the regulation of the
murine CD4 gene. Our work indicates that the CD4 gene is regulated in a much more
complex manner than simply through an enhancer located 13.5 kb 5' of the gene that upregulates the CD4 promoter in CD4+ cells and a silencer located 2.5 kb 3' of the first exon
that down-regulates the CD4 promoter in CD4' cells. Using transient transfection of
thymoma cell lines and other functional analysis, multiple additional czs-acting control
elements have been identified, which are required for tissue-specific expression of the
CD4 gene during T cell development (Figure 31). A summery of this work is as
followings:
1. There are two intronic enhancers, which are separately located in a 122 bp Alul-Alul
fragment 5' of the first intron and a 174 bp Pstl-SaJl fragment 3' of the first intron of the
murine CD4 gene. Transient transfection assays indicate that the intronic enhancers act
in an orientation- and position-independent manner in both CD4+ and CD4‘ T cells. The
intronic enhancers can stimulate the CD4 promoter to up-regulate the expression of a
reporter gene as the 5' enhancer does. However, there is no cooperative effect on the
CD4 promoter observed when the intronic promoters are put together with the 5'
enhancer in the same construct. EMSA assays indicate that various transcription factors
bind specifically to the intronic enhancers and that different protein-DNA interaction
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complexes form using nuclear extracts from different T cell lines. This suggests that the
intronic enhancers might function differently in different T cell lines. DNase I footprint
analyses were performed to locate the binding sites of transcription factors within the
intronic promoters. Sequence analysis of the protected regions revealed transcription
factor consensus sequences within the intronic enhancers (Figure 17). Potential
transcription factor-binding sequences in the protected regions include GATA-1, Elf-1,
and AP-1 for the El 5' intronic enhancer, and PU.l, IRF-1, and GATA-1 for the E2 3'
intronic enhancer. Among them, the AP-1 and Ets protein family members Elf-1 and
PU. 1 have been implicated in the regulation of some T cell-specific gene expression.
Further functional studies with these factors will be help in understanding their role in the
regulation of CD4 gene expression during T cell development.
2. An intronic promoter exists in the 138 bp fragment immediately 5' of the second exon
and corresponds to DH11. Transient transfection studies using deletion constructs
indicated that it functions preferentially in the CD4+ T cells and shows no activity in the
CD4'CD8+ T cells. RT-PCR analysis further confirmed that the promoter element can
drive the expression of the CAT message when transfected into the SAKRTSL12.1 cells.
Primer extension analysis located the transcription initiation point approximately 107 bp
upstream from the ATG site. No extension product was detected using total RNA from
TB2.1 T cells. However, no alternate CD4 message was detected using Northern
blotting. This could be due to the same size of the CD4 message from the 5' start site as
that from the internal start site. EMSA indicate that various transcription factors appear to
bind specifically to the intronic promoter and that different protein-DNA interaction
complexes form using nuclear extracts from different T cell lines. This suggests that the
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function of the internal promoter in different T cell lines is not the same. Analysis of the
sequence present immediately 5' to the internal initiation site indicates that although there
is no consensus TATA and initiator sequence, several recognition sites for other
transcription factors can be identified in the promoter region.
3. A 250 bp fragment corresponding to DH8 has a negative effect on the CD4 promoter.
Transient transfection assays indicated that the 5' silencer acts in an orientation- and
position-independent manner in both CD4+ and CD4' T cells. The 5' silencer can silence
the CD4 promoter to down-regulate the expression of reporter gene even when the 5'
enhancer exists. EMSA showethat various transcription factors bind specifically to the
silencer and there are unique protein-DNA complexes formed using nuclear extracts from
different T cell lines. Potential transcription factor-binding sequences in this region
include NF-1, core-binding factor, AP-1, C/EBP, and YY1.

B. FUTURE PERSPECTIVES
Ultimately, we would like to be able to define the cfs-acting control elements of the
CD4 gene in the more details. The last ten years of research into this area have
demonstrated that the regulatory elements controlling the expression of the CD4 gene are
very complex. Based on the locations of the T cell-specific DH sites identified by Dr.
Sands, numerous negative and positive czs-acting elements were identified within the first
intron and within a 15 kb region 5' of the CD4 promoter. Our work complements the
transgenic data that is now present in the literature and has provided many new insights
into CD4 gene regulation. Hopefully, we will be able to establish a functional model for
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transcriptional regulation of gene expression during T cell differentiation and increase the
feasibility of studying the molecular mechanisms involved in this process.
1. The first intron contains two enhancer elements. The El element, located just 5' of
the two negative c/s-acting elements found in the first intron (McCready et al., 1997),(Siu
et al., 1994) may be primarily functioning to counter the negative elements found in the
first intron in CD4+ cells. The El and E2 elements need to be analyzed further. This can
be accomplished using Bal31 deletions that progressively removes DNA from the 5' and
3' regions. The resultant constructs need to be tested in T and non-T cell lines to
determine the minimal requirements for the positive effect and the cell type-specificity of
the intronic enhancers. Another approach that could be taken is to replace the 900 bp 5'
promoter with another heterologous promoter such as the SV40 early region promoter or
(3-globin promoter in our constructs. This construction would confirm that the cell typespecificity was dictated by the enhancer element rather than by the CD4 5' promoter.
Eventually, transgenic mice constructs containing different c/s-acting control elements
should be carefully designed to examine how all these control elements interact to
regulate CD4 expression during T cell differentiation.
Since we localized the binding consensus sites of transcription factors within the
intronic enhancers by DNase I footprint, mutations could be introduced into these sites to
test their binding activities using EMSA. Supershift studies using antiboies to specific
transcription factors could be performed to identify those potential transcription factors
interacting with the intronic enhancers. The further characterization of the transcription
factors will provide a better picture of the regulation of CD4 gene expression during T
cell development.
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2. The use of multiple promoters is associated with developmental and tissue-specific
expression patterns. The deletion constructs should be tested in non-T cell lines to
determine whether the internal promoter is tissue-specific. The internal promoter could
be investigated further by creating vectors containing other regulatory elements such as
the 5' enhancer and intronic silencer together with the internal promoter. These
constructs should then be transfected into thymoma cell lines to test how they function
together. Furthermore, transgenic mice constructs should be carefully designed to
determine whether the internal promoter requires additional elements to function in vivo
and to confirm its importance in regulating CD4 expression during T cell differentiation.
The elements that regulate basal activity of the internal promoter need to be defined.
It is interesting to note that both the 5' promoter and internal promoter are TATA-less and
potential binding sites for Ets proteins and some other T cell-specific transcription factors
on the internal promoter. EMSA analysis using the nuclear extracts from other cell lines
should be performed to determine whether the factors binding to the internal promoter are
expressed in other cell lines. Functional analysis such as site-directed mutagenesis and
supershift will be helpful for us to identify those transcription factors interacting with the
internal promoter. The further characterization of the transcription factors will provide a
better picture of the regulation of CD4 gene expression during T cell development.
3. The 8B2 region located immediately 5' of the CD4 promoter has a silencing effect on
the function of the CD4 promoter. This silencer needs to be more clearly defined. Our
silencer constructs should be tested in the different cell lines that represent different
stages of thymocyte development to determine its exact function in these stages of T cell
development. Also, these constructs should be tested in the non-T cell lines to examine
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its silencing specificity. Finally, transgenic mice constructs containing the silencer
element should be carefully designed to confirm the silencer's function in different stages
of T cell differentiation in vivo. On the other hand, DNase I footprint on this region
should be performed to locate the binding consensus of transcription factors. Based on
this, functional analysis such as site-directed mutagenesis and supershift will be helpful
for us to identify those transcription factors interacting with the silencer. The further
characterization of the transcription factors should provide a better picture of the
regulation of the CD4 gene expression during T cell development.
4. Using transgenic mice, Uematsu and his collegues (1996) analyzed the activity of the
5' enhancer, the 5' promoter and the intronic silencer of the human CD4 gene during T
cell development. According to their results, they proposed the following model for CD4
gene regulation during T lymphocyte differentiation. This model consists of six different
regulatory elements, which come into play at different stages of differentiation. Among
these six elements, the promoter, the enhancer, and the late intronic silencer have been
characterized. The other three are an early silencer, an intronic enhancer and an anti
silencer, which have not been identified. With in vitro stidies we performed in
identification of c/s-acting control elements within the murine CD4 locus, it would be
interesting to note how these elements fit into this model (Figure 32). The 5' intronic
enhancer may act as an anti-silencer to overcome the silencing effect of the intronic
silencer in CD4+CD8‘ SP cells. The 3' intronic enhancer will function in both DP and SP
stages. The function of the 5' silencer associated with the CD4 promoter is not clear. It
may participate in the fine regulation of the CD4 promoter activity in different stages of
T cells. The identification of the internal promoter may also provide an alternative
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mechanism for regulation of CD4 gene expression during T cell differentiation. Taken
together, the speculations need to be further investigated before we can establish a more
refined model for CD4 gene regulation during T cell differentiation.
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CHAPTER SIX
I.

APPENDIX A

A. Agarose gel electrophoresis solutions (Maniatis et al., 1982)
1. THE stock buffer (5X): 450 mM Tris-borate and 10 mM EDTA
2. Gel running buffer: TBE (IX) and 0.5 pg/mL ethidium bromide
3. Bromophenol Blue loading buffer (1 OX): 20% Ficoll type 400, 0.1 MNa2EDTA,
pH 8.0, 1% SDS and 0.25% Bromphenol Blue.
B. DNase I footprint analysis solutions
1. Binding buffer: 10% glycerol, 10 mM HEPES-NaOH, pH 7.9, 4 mM Tris-HCl,
pH 7.9, 40 mM NaCl, 1 mM EDTA, 1 mM DTT, 300 pg BSA/ml.
2. Cofactor solution: 10 mM MgCb, 5 mM CaCb.
3. Stop solution: 1% SDS, 200 mM NaCl, 20 mM EDTA, pH 8.0, 40 pg/ml tRNA.
C. Eletrophoresis mobility shift assay (EMSA) solutions
1. 1 X AS buffer: 10% glycerol, 0.5 mM EDTA, 1 mM DTT, 20 mM HEPES pH
7.9, 50 mM KC1, 2 mM MgCl2.
D. Fluorescence activated cell sorter (FACS) solutions
1. Dulbecco’s phosphate buffered saline: Prepared by mixing 0.2 g KC1, 0.2 g
KH2PO4, 8 g NaCl and 1.15 g Na2HP04 in distilled water, bringing the final
volume to 1 L, and adjusting the pH to 7.4.
2. Diluent: 0.01M PBS, pH 7.4, 1% BSA, 0.1% NaN3.
E. Miniprep solutions (Maniatis et al., 1982)
1. Solution I: 25 mM Tris-HCl, pH 8.0, 10 mM EDTA and 50 mM glucose.
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2. Solution II: 0.2 N NaOH and 1% SDS.
3. Solution III: 3 M potassium acetate and 1.84 N glacial acetic acid.
4. 70% ethanol in double-distilled water
5. TE/RNAase buffer: 10 mM Tris-HCl, pH 8.0, 1 mM EDTA and 20 pg/mL of
RNAase.
F. Northern blot solutions (Chomczynski et al., 1987)
1. Solution D: 4 M guanidinium thiocyanate, 25 mM sodium citrate and 0.5%
sarcosyl.
2. TE/0.1% SDS buffer: 10 mM Tris-HCl, pH 8.0, 1 mM EDTA and 0.1% SDS.
3. STE buffer: 40 mM Tris-HCl, pH 8.0, 1 mM EDTA and 150 mM NaCl.
4. Deionized formamide: Formamide was melted at room temperature and 50 mL
was deionized with 5 g of AG501 x 8 resin (BioRad) by stirring for 30 minutes at
room temperature. The solution was filtered twice with Whatman #1 paper,
aliquoted and stored at -20°C (Ausubel et al., 1994).
5. Denhardt (1 OX) solution: 0.2% polyvinylpyrrolidone, 0.2% Ficoll type 400, 0.2
% BSA and 200 pg/mL sheared, denatured salmon sperm DNA.
6. DEPC water: 0.1% diethyl-pyrocarbonate was added to double-distilled water for
at least 1 hour. The treated water was then autoclaved.
7. MOPS (10X): 0.2 M 3-(N-morpholino) propanesulfonic acid, 5 mM sodium
acetate, 5 mM EDTA, pH 7.0 (Ausubel et al., 1994).
8. Northern samples loading buffer: 720 pL deionized formamide, 320 pL MOPS
(10X), 260 pL formaldehyde solution (37% stock solution), 100 pL glycerol,
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4 mg bromphenol blue, 4 mg xylene cyanol and 100 pL DEPC water (Ausebel et
al., 1994).
9. 20X SSC: 3.0 M NaCl and 3.0 M sodium citrate, pH 7.0 (Ausubel et al, 1994).
10. Prehybridization/Hybridization solution (2X): IX SSC and Denhardt’s solution
(10X).
G. Nuclear protein preparation solutions
1. Buffer A: 10 mM HEPES pH 7.9, 1.5 mM MgCl2, 10 mM KC1, 0.5 mM DTT.
2. Buffer C: 20 mM HEPES pH 7.9, 25% glycerol, 0.42 M KC1, 1.5 mM MgCl2, 0.2
mM EDTA, 0.5 mM PMSF, 0.5 mMDTT.
3. Buffer D: 20 mM HEPES pH 7.9, 20% glycerol, 0.1 MKC1, 0.2 mM EDTA, 0.5
mM PMSF, 0.5 mM DTT.
H. Polyacrylamide gel electrophoresis solutions (Laemmli et al., 1970)
1. 30% acrylamide stock solution: 0.3 g/mL acrylamide and 8 mg/mL methylene
bisacrylamide.
2. Denaturing gel buffer: 25 mM Tris-HCl, pH 7.4, 192 mM glycine and 0.1%
SDS.
3. Nondenaturing gel buffer: 25 mM Tris-HCl, pH 7.4, and 192 mM glycine.
4. Nondenaturing sample buffer: 125 mM Tris-HCl, pH 6.8, 10% glycerol, 2%
SDS and 0.003% Bromphenol Blue
5. Staining solution: 2.5 g/L Coomassie Brilliant Blue, 50% ethanol and 1.5 N
glacial acetic acid.
6. Destaining solution: 45.4% methanol and 0.58 N glacial acetic acid.
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I. Reverse transcriptase-PCR (RT-PCR) analysis solutions
1. 5X First Strand Buffer: 250 mM Tris-Cl, pH 8.3, 375 mM KC1, 15 mM MgC^),
2 pi 0.1 M DTT, and 1 pi 10 mM dNTP Mix (10 mM each dATP, dGTP, dCTP
and dTTP at neutral pH).
2. PCR reaction: 2.5 pi 10X PCR Buffer [200 mM Tris-HCl (pH 8.4), 500 mM
KC1], 0.75 pi 50 mM MgCl2,0.5 pi 10 mM dNTP Mix, 0.5 pi Amplification
Primer 1 (Forward primer) (100 pg/ml), 0.5 pi Amplification Primer 2 (Reverse
primer) (100 pg/ml), 2 pi cDNA from first strand reaction, distilled water to a
final volume of 24.5 pi.
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